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Abstract 
Many cellular processes are regulated by proteolysis, the majority of which, 
in eukaryotic cells, is carried out by the ubiquitin system. Covalent attachment 
of a ubiquitin polymer to a target protein leads to degradation of the protein 
in the proteasome. Ubiquitination provides a means of rapidly and irreversibly 
eliminating an unwanted protein from the cell, and is therefore a potentially 
effective tool for regulating cellular behaviour. Ubiquitin-mediated proteolysis is 
involved in such diverse physiological functions as growth control, cell signalling, 
differentiation and the immune response. The aim of this research has been 
to investigate its role in Drosophila embryogenesis. Protein ubiquitination is a 
stepwise process carried out by three classes of enzyme known as Els, E2s and 
E3s. The El (ubiquitin-activating enzyme), generates a thiolester linkage with a 
ubiquitin cysteine residue. The activated ubiquitin is then transferred to an E2 
(ubiquitin-conjugating enzyme) which, with the help of an E3 (ubiquitin-protein 
ligase), recruits the substrate protein which is to be degraded. I examined the 
embryonic expression patterns of several known and novel genes encoding each 
type of ubiquitinating enzyme. The E2 UbcD4 is transcribed during early to mid-
embryogenesis in a variety of tissues, with specific germ cell expression in stage 10 
embryos. This suggested a possible role for UbcD4 in germ cell migration towards 
the somatic gonadal precursors. I screened for UbcD4 - interacting proteins using 
the yeast two-hybrid system, and identified several putative substrates for, as well 
as ancillary factors involved in, ubiquitination by UbcD4. These included a novel 
E3 of the Hect-domain family, which has an expression pattern suggesting a role 
in epidermal morphogenesis. In an attempt to examine the function of UbcD4 
directly, I used RNA interference to disrupt UbcD4 function. The results suggest 
a post-germband retraction requirement for UbcD4. 
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1.1 Ubiquitin-mediated proteolysis - a historical 
overview 
Biologists interested in regulation of cellular behaviour have generally focussed 
on the synthesis of proteins rather than their degradation. When Monod's group 
(Hogness et al., 1955) showed that induced 0-galactosidase does not turn over in 
E. coli, the existence of protein turnover in any cell was questioned. Then evi-
dence was gathered for selective ATP-dependent destruction of mutant proteins 
(Goldberg and St. John, 1976). The importance of protein degradation in con-
trolling enzyme levels in eukaryotes was recognized through the work of Schimke 
in the 1960s and 1970s, (Schimke and Doyle, 1970), but the mechanism remained 
unknown. 
In the late 1970s, Hershko and Ciechanover were studying the selective ATP-
dependent degradation of abnormal proteins in reticulocyte lysates. They found 
that if a lysate was separated into two fractions by DEAE-cellulose chromatog-
raphy, ATP-dependent proteolytic activity was present only in fraction 1. The 
active component was found to be a heat stable, low molecular weight protein 
initially called ATP-dependent proteolysis factor 1 (APF-1) (Ciechanover et al., 
1978). APF-1 was later identified as a protein which had been isolated from thy-
mus by Goldstein et al. (1975) and was represented in all tissues and organisms 
studied (Wilkinson et al., 1980). This protein was called ubiquitin. When radio- 
labelled ubiquitin was incubated with fraction 2 of reticulocyte lysate, it formed 
a covalent linkage with high molecular weight proteins (Ciechanover et at., 1980). 
Ubiquitin had previously been observed to bind to a lysine residue on histone 2A 
through its C-terminus but the significance of this was not understood (Goldknopf 
and Busch, 1977). However when Hershko's laboratory found that ubiquitin con-
jugated to proteins which were good substrates of the proteolytic system, and 
that several ubiquitin molecules bound to each substrate protein, they proposed 
that a covalently-attached polyubiquitin chain tags a protein for recognition by 
a protease (Hershko et al., 1980). 
The enzymes which carry out polyubiquitination of a substrate were purified 
and characterised in the order of their action in the process. El was shown to carry 
out the ATP-dependent activation of the C-terminal glycine residue of ubiquitin 
before transfering it to a thiol site on El (Ciechanover et at., 1981). Two further 
enzymes were found to be required for ubiquitin-protein ligation. E2 accepts 
activated protein from El and transfers it to a substrate in a reaction requiring 
the third factor, E3 (Hershko et at., 1983). Ubiquitin-lysozyme conjugates were 
used as substrates to identify a high molecular weight ATP-dependent protease 
from rabbit reticulocyte lysates, the 26S proteasome (Hough et at., 1986). 
Recognition of the involvement of ubiquitin-mediated proteolysis in specific 
physiological processes began to emerge in the mid-1980s. A cell-cycle block in 
a mutant mouse cell line was shown to be due to a defective ubiquitin- activating 
enzyme (Ciechanover et at., 1984), and a yeast gene essential for DNA repair was 
found to encode a ubiquitin-conjugating enzyme (Jentsch et at., 1984). However it 
was not until the discovery that cyclin ubiquitination and degradation was a key 
event in exit from mitosis (Glotzer et al., 1991) that the ubiquitin-proteasome 
pathway was widely recognised as an important regulatory mechanism. Other 
more recent processes which have been shown to be mediated by the pathway 
include virally-induced tumorigenesis (Scheffner et at., 1990), and activation of 
the transcription factor NF-,cB (Palombella et at., 1994). It is now clear that 
selective protein degradation is central to maintaining homeostasis. 
In this chapter I describe the components of the ubiquitin-proteasome path-
way, namely ubiquitin itself; the enzymes which control its attachment to target 
proteins; the proteasome; and the elements in the target proteins which confer 
recognition by the ubiquitination machinery. I then discuss some of the physio-
logical processes controlled by ubiquitin- mediated proteolysis. 
1.2 Components of the ubiquitin-proteasome path-
way 
1.2.1 Ubiquitin 
Ubiquitin is the most conserved protein known in eukaryotes, with only three 
amino acid substitutions, all conservative, between the 76 amino acid yeast and 
mammalian proteins. Although absent from most prokaryotes, ubiquitin has been 
found in the cyanobacterium Anabaena variabilis (Durner and Boger, 1995) and 
the archaebacterium Thermoplasma acidophilum (Wolf et al., 1993). Ubiqui-
tin has a compact, globular structure with a protruding C-terminus, the site of 
ubiquitin- protein conjugation (Vijay-Kumar et al., 1987). All ubiquitin genes 
encode fusion proteins, either a polyubiquitin or a fusion with a small carboxyl 
extension protein (CEP), such as the ribosomal proteins S27a or L40 (Finley 
et al., 1989; Redman and Rechsteiner, 1989; Chan et at., 1995). In yeast, polyu-
biquitin genes are generally stress-inducible whereas ubiquitin-CEP genes provide 
most of the ubiquitin during vegetative growth (Finley et at., 1987). Synthesis as 
a ubiquitin fusion has functional significance for the ribosomal proteins, as slow 
growth and ribosomal defects result when they are expressed independently of 
ubiquitin (Finley et al., 1989). It is thought that the N-terminal ubiquitin assists 
folding of the CEP. Both polyubiquitin and ubiquitin-CEP fusions are processed 
by ubiquitin C-terminal hydrolases to release mature ubiquitin (see section 1.2.3). 
5 
1.2.1.1 Polyubiquitin chains 
Polyubiquitin chains formed by linking the K48 residue of one ubiquitin with the 
G76 of the next are the predominant means of tagging a protein for proteasornal 
degradation (reviewed by Pickart (1999)). There are two possible mechanisms 
for achieving a polyubiquitin-substrate conjugate: conjugation of a preassembled 
polyubiquitin chain to a substrate, and monoubiquitination of a substrate followed 
by extension of the chain. Both appear to operate in cells. E2-14K and E3a use 
monoubiquitin as the substrate to assemble polyubiquitin chains on N-end rule 
substrates (see section 1.2.5.1) (Chau et al., 1989). The mammalian E2 E2-25K 
can assemble K48-linked chains from free ubiquitin in vitro. While it is not clear 
whether this occurs in vivo, pools of unanchored polyubiquitin chains do exist 
in cells (Van Nocker and Vierstra, 1993; Spence et al., 1995; Haldeman et al., 
1995), and di- and tri-ubiquitin can be activated by El and transferred to E2s, 
and subsequently to target proteins, as efficiently as monoubiquitin (Van Nocker 
and Vierstra, 1993; Chen and Pickart, 1990). 
It appears that K48-G76 ubiquitin chains have properties which allow them 
to be efficiently assembled, to persist and to be recognised by the proteasome 
(see Pickart (1999)). However there are at least four other lysine residues in 
ubiquitin which can initiate chain assembly. There is some evidence that such 
alternatively linked chains can also function as tags for protein degradation. Mu-
tation of K63 in yeast leads to failure of the polyubiquitination of a small basic 
substrate, and to defects in the DNA repair pathway mediated by the E2 Rad6 
(Spence et al., 1995). The polyubiquitin binding subunit of the proteasome, S5a, 
does not appear to discriminate between ubiquitin chains linked through different 
lysines (Baboshina and Haas, 1996). It is not clear whether the existence of ubiq-
uitin chains harbouring distinct isopeptide linkages lends an additional degree of 
specificity to the ubiquitination machinery. Histones, receptors and several other 
proteins are modified by monoubiquitination and remain metabolically stable. In 
the case of receptors, the modification appears to trigger their internalisation (see 
section 1.3.3.2.1). The significance of histone ubiquitination is not clear. 
1.2.1.2 Ubiquitin-like proteins 
An number of proteins include domains with significant sequence similarity to 
ubiquitin. Ubiquitin-like (Ubi) domains can be divided into two classes : pro-
cessed (type 1) and unprocessed (type 2). Type 1 ubiquitin-like domains have a 
C-terminal diglycine which facilitates processing by ubiquitin C-terminal hydro-
lases. Such proteins have the potential to be conjugated in a similar manner to 
ubiquitin. The best-studied member of this class is the mammalian protein Small 
Ubiquitin-related Modifier 1 (SUMO-1), which, when conjugated to the GTPase 
activating protein RanGAP1, targets it to the nuclear pore complex (Mahajan 
et al., 1997; Matunis et al., 1996). The enzymes which carry out sumoylation are 
related to, but distinct from, the ubiquitinating enzymes (Saitoh et al., 1998). 
Type 2 UbI domains lack the C-terminal diglycine needed for processing and are 
therefore an integral part of the mature protein in which they occur. In the cases 
of elongin B (Aso et al., 1995) and Rad23 (Watkins et al., 1993), the Ubi domain 
may act as a chaperone, similar to the role of ubiquitin in synthesis of ribosomal 
proteins. Several type 2 Ubl proteins can associate with the proteasome and have 
been implicated in regulation of ubiquitin- mediated degradation. It has been 
proposed that such proteins may act as a link between the ubiquitination and 
proteolytic machineries. This topic is discussed further in section 4.3.1. 
1.2.2 The thioester cascade 
The ligation of ubiquitin to a target protein is carried out in a stepwise fashion by 
three classes of enzyme (Figure 1.1). First of all the ubiquitin must be 'activated' 
by a ubiquitin- activating enzyme (El). This reaction requires ATP hydrolysis 
and results in a high-energy thioester linkage between the ubiquitin C-terminal 
glycine and a specific cysteine residue on the El. The ubiquitin can now be 
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transferred in a similar fashion to a ubiquitin-conjugating enzyme or E2. The 
E2 transfers the ubiquitin to the substrate with the help of additional proteins 
termed E3s or ubiquitin ligases. While E2s are structurally related proteins, 
encoded by a gene family, E3s differ widely in their structure and in their mode 
of action. Some accept ubiquitin as a thioester from an E2 and transfer it to a 
substrate, while others appear to mediate E2 - substrate interactions, and others 
modulate E2 activity or localisation. It has been proposed that the term E3 
should apply only to those enzymes which can form a thioester with ubiquitin, 
and that other proteins involved in substrate selection should be termed 'ancillary 
factors' (Scheffner et al., 1999), but this has not achieved general use. The El 
enzyme has a general function and does not discriminate between different E2s. 
However E2s exhibit specificity both in their co-operation with different subsets 
of E3s and in their recognition of substrates. E3s in turn are apparently more 
numerous and more diverse than E2s, and may also be more sensitive to regulation 
by ancillary factors. Thus the three classes of protein provide the specificity and 
selectivity required of protein ubiquitination. 
1.2.2.1 Ubiquitin-activating enzymes 
Ubiquitin activating enzymes are abundant in both cytosol and nucleus. They 
seem to work as homodimers (Ciechanover et al., 1982) and share a conserved nu-
cleotide binding domain with a consensus G1yXG1yXXG1y motif, which is prob-
ably the ATP-binding site. 
Only one functional El, Ubal, is known in Saccharomyces cerevisiae (Mc-
Grath et al., 1991). A similar Saccharomyces cerevisiae protein, Uba2, does not 
appear to bind ubiquitin and may instead be involved in conjugating ubiquitin-
like molecules (Dohmen et al., 1995). The human Ubal homologue encodes two 
distinct isoforms of El by using alternative translational start sites (Handley-
Gearhart et al., 1994). Mice have two El-encoding genes, one of which is ex-
pressed specifically in the testis (Kay et al., 1991; Mitchell et al., 1991). Multiple 
r 





E2 	E3 	Substrate 
Figure 1.1: Schematic representation of the thioester cascade which results in pro-
tein polyuhiquitination. Ubiquitiri (Ub, black ovals) forms a high-energy thioester 
intermediate with a cysteine residue on the ubiquitin-activating enzyme (El), and 
is transferred to a cysteine residue on one of several related ubiquitin-conjugating 
enzymes (E2). Finally it forms an isopeptide linkage with a lysine residue on a 
substrate protein. Ubiquitin transfer from the E2 to the substrate is generally 
mediated by a ubiquitin ligase (E3). The E3 does not necessarily bind the ubiq-
uitin directly, and may he a single protein or a complex. Some E2s may target 
their substrate directly. Polyubiquitinated substrates are degraded by the 26S 
proteasome, yielding peptides and free ubiquit in. 
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El genes are present in wheat (Hatfield and Vierstra, 1992). 
Ubiquitin activation is pivotal to ubiquitin- mediated proteolysis, which is in 
turn required for a wide variety of cellular processes. Both Ubal and Uba2 are 
essential genes in S. cerevisiae. Mammalian cell lines with a thermolabile El 
display defects in cell-cycle progression and DNA replication (Mori et al., 1993; 
Kulka et al., 1988; Ciechanover et al., 1984; Finley et al., 1984). The human El 
isoforms display differential localisation in the cell, with the larger form (Ela) 
present in the nucleus and the smaller form (Elb) in the cytoplasm (Handley-
Gearhart et al., 1994). Ela is subject to cell-cycle dependent phosphorylation 
(Stephen et al., 1996). However there is no clear evidence that protein ubiquiti-
nation is regulated at the level of El activity. 
1.2.2.2 Ubiquitin-conjugating enzymes 
E2s share a conserved 160 - amino acid domain called the UBC domain, which 
includes the 'active site' cysteine residue which forms a thioester with ubiquitin. 
E2s can be divided into four classes based on their structure. Class I E2s consist 
of the UBC domain alone, while class II and class III E2s have C-terminal and 
N-terminal extensions respectively, and class IV E2s have extensions at both 
termini. E2s share 35-40% sequence identity in the UBC domain, while the N 
and C-terminal extensions are highly divergent (reviewed by Jentsch et al. (1990)). 
There is some evidence that, for the class II E2s at least, the C-terminal extensions 
are necessary for function and may mediate substrate specificity or intracelluar 
localisation (Silver et al., 1992; Kolman et al., 1992). Certain E2s function as 
homodimers (Gwozd et al., 1995; Pickart and Rose, 1985), or as heterodimers 
with other E2s (Chen et al., 1993). 
There are 12 ubiquitin-conjugating enzymes in Saccharomyces cerevisiae, which 
differ in their properties and intracellular localisation. Mutations in different 
E2s give distinct phenotypes, indicating their involvement in specific processes 
(reviewed by Jentsch (1992)). Only Ubc3 is essential for growth under normal 
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conditions, being required for cell-cycle progression (discussed in section 1.3.1). 
Ubcl, Ubc4, Ubc5 and Ubc7 are stress - inducible and show some functional 
redundancy (Jungmann et at., 1993; Seufert and Jentsch, 1990; Seufert et al., 
1990) : it is thought that these enzymes are responsible for turnover of abnormal 
proteins. Ubc2/Rad6 is a DNA repair enzyme (Jentsch et at., 1984). UbcG has 
a C-terminal transmembrane domain and interacts genetically with a component 
of the protein translocation component of the endoplasmic reticulum (Biederer 
et at., 1996; Sommer and Jentsch, 1993), suggesting that this E2 may be part 
of the pathway which degrades integral membrane proteins (see section 1.3.3). 
UbclO is also membrane bound, being found in the peroxisome membrane, and 
is required for peroxisome biogenesis (Wiebel and Kunau, 1992). 
Homologues of most yeast E2s have been found in higher eukaryotes. Yeast 
strains defective in UBCj (Zhen et al., 1993; Treier et at., 1992) and UBU21RAD6 
(Koken et at., 1991b) can be rescued by expression of homologues from various 
multicellular organisms. However expansion of the E2 family has taken place in 
multicellular organisms, as some yeast E2s have multiple homologues in higher 
organisms (Nuber et at., 1996; Jensen et al., 1995; Koken et al., 1991b). Higher 
eukaryotes also possess E2s unrelated to those found in yeast. For example, there 
are no class IV E2s in yeast, whereas the mammalian UbcMl has a short C-
terminal and large N-terminal extension to its UBC domain (Scheffner et al., 
1999). E2-230K, which has two active site cysteines (Berleth and Pickart, 1996), 
similarly has no counterpart in yeast. The complete Drosophila genome encodes 
39 putative E2s, and both mammals and plants have a greater number. 
1.2.2.3 Ubiquitin-protein ligases 
In vitro studies on substrate ubiquitination revealed that recognition of many 
substrates is not mediated by Els and E2s alone. The term E3 or ubiquitin-
protein ligase was coined as a general term for proteins, other than Els or E2s, 
which are required for substrate ubiquitination. The first E3 identified was S. 
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cerevisiae Ubri, the protein responsible for recognising destabilising N-terminal 
amino acids. The first E3 protein shown to catalyse ubiquitin transfer was the 
mammalian E6-associated protein (E6-AP). The identification of a conserved C-
terminal domain, the Hect domain, found in many proteins which proved to have 
similar activity, made it possible to identify putative E3s based on their sequence 
alone. The factor responsible for mediating Gi cyclin ubiquitination in yeast was 
later found to be a complex of three proteins: Cdc53, Skpl and the F-box protein 
Cdc4. Similar SCF complexes, and the related VBC complexes have now been 
shown to regulate other processes. Most recently, proteins bearing RING finger 
domains have been found to particiate in many ubiquitination events, and these 
may represent a fifth type of E3. 
1.2.2.3.1 The N-end recognition E3, Ubri 
Artificial proteins which bear different N-terminal amino acids, but which are oth-
erwise identical, have different in vivo half-lives. The N-end rule relates the stabil-
ity of a protein to the identity of its N-terminal residue (reviewed by Varshavsky 
(1999); see section 1.2.5.1). The protein responsible for recognising proteins with 
destabilising N-terminal residues (N-degrons) in S. cerevisiae is Ubri. Loss of 
Ubri function stabilises normally short-lived N-end rule substrates (Bartel et al., 
1990). Ubri has two independent substrate binding sites, one of which interacts 
with basic N-terminal residues and the other with bulky hydrophobic residues 
(Baker and Varshavsky, 1991). Strains with null UBR1 mutations have mild 
growth defects and are unable to import di- and tri-peptides (Alagramam et al., 
1995). Peptides are imported by the product of PTR, transcription of which 
is repressed by Cup9 (Byrd et al., 1998). Cup9 is a shortlived protein whose 
degradation requires Ubri (Byrd et al., 1998). Degradation of Cup9 is allosteri-
cally activated by binding of imported dipeptides, with N-terminal destabilising 
residues, to Ubri (Turner et al., 2000). This results in a increased transcription of 
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PTR2, creating a positive feedback loop which accelerates peptide uptake. Ubri 
also controls turnover of Ga, part of a complex which regulates cell differentia-
tion in response to mating pheromones (Madura and Varshavsky, 1994). E3a, the 
mammalian N-end rule E3, has been biochemically characterised in reticulocyte 
lysate (Hershko and Ciechanover, 1992). However it has not been purified and 
the gene has not been cloned. 
1.2.2.3.2 Hect domain proteins 
The only class of E3s with a well-understood ubiquitination mechanism are the 
Hect-domain proteins, members of which are present in all eukaryotes examined. 
The prototype of the family, E6-AP, was discovered as a host factor which medi-
ates complex formation between p53 and the human papillomavirus (HPV) onco-
protein E6 (Huibregtse et at., 1991). This event promotes p53 ubiquitination and 
degradation and contributes to HPV-associated carcinogenesis (Scheffner et at., 
1990; Werness et at., 1990). E6-AP can ubiquitinate cellular proteins in the ab-
sence of E6 (Scheffner et at., 1993). Like El and E2 enzymes, but unlike other 
classes of E3, E6-AP forms a thioester with ubiquitin (Scheffner et at., 1995). A 
cysteine residue near the E6-AP C-terminus is crucial both for thioester forma-
tion and for p53 ubiquitination. This suggests that ubiquitin is transferred from 
an E2 to E6-AP, which then ubiquitinates a substrate directly. 
The Hect domain is a conserved region of approximately 350 amino acids, 
homologous to the E6-AP ç-terminal, which is found in a number of other pro-
teins. Because the active site cysteine residue, as well as several surrounding 
residues, is absolutely conserved among Hect domain proteins, they are thought 
to be a family of ubiquitin ligases (Huibregtse et at., 1995). Several members 
of the family, including S. cerevisiae RspS, S. pombe Pub-i and rat p100, have 
been shown to form a thioester with ubiquitin (Huibregtse et at., 1995). The 
Hect domain is the minimal region of E6-AP and Rsp5 necessary for thioester 
formation (Schwarz et at., 1998). As well as the ubiquitin transferase activity, the 
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Hect domain contains the E2 interaction site of the enzyme. Hect domain Us 
interact with a particular subclass of E2s, namely Ubc4/Ubc5 in yeast and their 
relatives in higher organisms (Nuber et at., 1996; Scheffner et at., 1994; Kumar 
et at., 1997; Schwarz et at., 1998). The specificity of the interactions between E2s 
and Hect-domain E3s is discussed in section 4.3.5.3. 
Hect-domain proteins range from 90 kDa to over 200 kDa in size and their 
N-termini are highly divergent. This suggests that the enzymes are modular in 
structure, with substrate specificity residing in the N-terminus while the conserved 
C-terminus forms the core catalytic domain. Consistent with this model, the N-
terminus of E6-AP directs E6 and p53 binding (Huibregtse et at., 1993). The 
N-termini of the Nedd-4 family contain several protein-protein interaction motifs 
called WW domains, which preferentially interact with a small proline-rich se-
quence called a PY motif (Sudol, 1996). Nedd-4 downregulates the PY-containing 
epithelial sodium channel (ENaC) in a ubiquitin-dependent fashion(Dinudom 
et al., 1998; Staub et at., 1996). 
Substrates have been identified for relatively few other Hect-domain proteins. 
The substrates for E6-AP ubiquitination in HPV-negative cells may include the 
DNA repair protein hHR23a (Kumar et at., 1999), the replication protein MCM-
7 (Kuhne and Banks, 1998) and the Src family tyrosine kinase Blk (Oda et at., 
1999). Mutations in the human gene encoding E6-AP cause the mental retar-
dation condition Angelman's syndrome (AS) (Kishino et at., 1997; Jiang et at., 
1999), but the link between loss of E6-AP function and AS pathogenesis is un-
clear. S. cerevisiae Rsp5 has been implicated in ubiquitin-dependent turnover 
of several membrane proteins, including the general amino acid permease (Hem 
et al., 1995), the uracil permease (Galan and Haguenauer-Tsapis, 1997) and the 
maltose transporter (Lucero and Lagunas, 1997). RspS also targets the large sub-
unit of RNA polymerase II (Huibregtse et at., 1997). S. pombe Pubi targets the 
mitosis-activating phosphatase Cdc25 for degradation (Nefsky and Beach, 1996) 
14 
and is also implicated in the regulation of membrane permeases (Saleki et at., 
1997). 
1.2.2.3.3 SCF complexes 
CDC4 and CDC53 were identified by mutational analysis as genes required for 
progression from the Gi to the S phase of the cell cycle. Gi arrest in cdc1 and 
cdc53 mutant strains was found to be caused by failure to degrade the cyclin de-
pendent kinase (CDK) inhibitor Sici (Schwob et al., 1994). Similarly, both Cdc53 
and Grrl were shown to be necessary for degradation of Cl cyclins (Deshaies 
et at., 1995; Barral et at., 1995). Cdc53 and Cdc4 were shown to physically asso-
ciate with the E2 Cdc34 (Willems et at., 1996; Mathias et at., 1996). Meanwhile, 
a gene called SKP1 was identified, various alleles of which caused stabilisation of 
either Sici or GI cyclins. Further skpl alleles can suppress mutations in several 
genes including cdc4  and ctfl3-30 (Bai et al., 1996; Zhang et at., 1995; Connelly 
and Hieter, 1996). The human Skpl protein, after which the yeast homologue 
was named, was identified as part of a complex with cyclin F. Alignment of cyclin 
F with Cdc4 revealed a conserved motif called the F-box, which was also present 
in Grrl (Bai et at., 1996). Since degradation of Sici and GI cyclins share the 
requirement for Cdc34, Cdc53 and Skpl, but need different F-box proteins (Cdc4 
or Grrl), it was hypothesised that Cdc53 and Skpl form the core of a E3 complex 
which associates with Cdc34 (Bai et al., 1996). The model further proposed that 
different F-box proteins, which recognise different substrates, can dock onto the 
complex by binding Skpl, promoting ubiquitin transfer from Cdc34 to the sub-
strate (Skowyra et al., 1997) (Figure 1.2). No components of the SCF complex 
have been shown to form a covalent linkage with ubiquitin. 
There is now substantial evidence in support of the idea that the SCF ubiq-
uitin ligase can be targeted to different substrates via an array of F-box proteins. 
Further substrates for Cdc4-mediated degradation have been identified, such as 
the CDK inhibitor Fan (Henchoz et at., 1997), the kinetochore protein Ctf13 
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(Kaplan et al., 1997) and the transcription factor Gcn4 (Meimoun et al., 2000). 
Another F-box protein, Met3O, has been shown to associate with Cdc53 and Skpl 
(Patton et al., 1998a), and to target the transcriptional activator Met4 (Rouillon 
et al., 2000). The budding-yeast genome encodes 17 proteins that contain an ob-
vious F-box motif (Patton et al., 1998b). As well as their conserved Skpl-binding 
F-box, these proteins typically have other protein-protein interaction motifs such 
as WD40 motifs, which may be the substrate selection sites. 
A third 'core' subunit of SCF complexes, Hrtl, has been identified. Hrtl 
binds to Cdc53, Cdc34 and Cdc4, but not Skpl (Seol et al., 1999). Hrtl contains 
a RING finger - a series of cysteine and histidine residues arranged to form two 
zinc co-ordination sites. Hrtl potently stimulates the E3 activity of recombinant 
SCF complexes containing either of the F-box proteins Cdc4 or Grrl (Seol et al., 
1999; Kamura et al., 1999; Skowyra et al., 1999). A Cdc53/Hrtl subcomplex 
alone can ubiquitinate a substrate, suggesting that these two proteins define the 
minimal E3 whereas Skpl is the adaptor, whose interaction with Cdc53 links 
the F-box protein to the core (Figure 1.2). Cdc53 is stably modified at a single 
site by covalent attachment of the ubiquitin-like protein Rubl/Nedd-8 (Lammer 
et al., 1998). Although the significance of this event is not clear, it is necessary 
for optimal assembly or function of the SCF complex (Lammer et al., 1998). 
As well as stimulating substrate ubiquitination, Hrtl appears to activate Rubl 
modification of Cdc53 (Kamura et al., 1998). 
Metazoan homologues of Cdc53 and Skpl were initially identified in human 
cell lines, and shown to complex with the F-box protein Skp2 (Zhang et al., 1995; 
Yu et al., 1998). It is now clear that multicellular organisms have several Skpl 
and Cdc53-related proteins (cullins). Cullins share a highly-conserved region in 
the Cdc34-binding C-terminus, suggesting that they all participate in ubiquitin-
ligase complexes analogous to SCF complexes (Kipreos et al., 1996). This has 
been demonstrated only for Cul-2 (Figure 1.2). Cul-2 is associated with the Skpl- 
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Figure 1.2: Schematic representation of the three types of multisuhunit E3s. 
The APC, SCF and VBC complexes all feature a cullin subunit (red) and a 
RING-finger subunit (orange). They each use a specialised subunit for substrate 
recognition (yellow). SCF complexes use various different F-box proteins for this 
task : Cdc4 recognition of Sici is shown as an example. These E3s are thought 
to mediate ubiquitin transfer from an E2 to a substrate by bringing the two 
proteins into proximity. Arrows with question marks indicate interactions which 
are suspected but not yet proven. Taken from Zachariae and Nasmyth (1999). 
related protein elongin C. Elongin C in turn binds to the uhiquitin-like protein 
elongin B (Pause et al., 1999). Whereas Skpl recruits F-box proteins to the SCF 
complex, Elongin C binds to a family of proteins sharing a sequence element called 
the SOCS-box. The SOCS box was identified among suppressors of cytokine 
signalling, but is now known to contain an elongin C binding site (Kamura ci al., 
1998). The first SOCS box protein shown to form an E3 complex with Cul-2, 
elongin B and elongin C was the Von Hippel Lindau tumour suppressor protein 
(VHL) (Kamura ci al., 1998; Iwai ci al., 1999; Lisztwan et al., 1999) - hence these 
E3s are referred to as VBC complexes. Independently of the identification of 
Hrtl in yeast, an Hrtl homologue called Rhxl was identified as part of the VBC 
complex (Kamura ci al., 1999). The only putative target for VBC - mediated 
degradation known at present is the hypoxia-inducible factor 1 (HIF1) (Maxwell 
ci al., 1999; Cockman ci al., 2000). Other roles for SCF complexes in metazoans 
are discussed in sections 1.3.1.1 and 1.3.2. 
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1.2.2.3.4 The anaphase promoting complex 
The anaphase promoting complex (APC) was discovered as a high molecular 
weight complex, which, along with El and a specific E2, is sufficient for cyclin 
degradation in clam extracts (Hershko et al., 1994; King et al., 1995; Sudakin 
et al., 1995). The complex, initially called the cyclosome, was capable of acting 
as an E3 only when extracted from mitotic cells. Genetic studies in yeast revealed 
several mutants, defective in mitotic cyclin degradation, which were also unable 
to achieve sister chromatid separation (Irniger et al., 1995; Zachariae et al., 1996). 
Their products were found to be subunits of the APC (Zachariae and Nasmyth, 
1996). 
Nine vertebrate and twelve yeast APC subunits have so far been identified and 
the composition of the particle is conserved in eukaryotes. In most cases, their se-
quences give little indication of function. Some contain motifs also found in other 
proteins of the ubiquitin-proteasome pathway. Apcl shares some similarity with 
the proteasome regulatory subunits Rpnl and Rpn2 (Zachariae and Nasmyth, 
1996), and ApclO has a Doc domain also found in several Hect domain proteins 
(Grossberger et al., 1999). More attention has been given to the discovery that 
the APC shares some architectural similarity with SCF complexes. Apc2 is a 
distant cullin homologue (Zachariae et al., 1998; Yu et al., 1998), and Apcll is 
a RING-finger protein similar to Hrtl/Rbxl (Ohta et al., 1999). Like Cull and 
R,bxl, Apc2 and Apcll interact directly (Figure 1.2). Thus it has been proposed 
that cuhlin-RING partnerships define a new superfamily of multiprotein ubiqui-
tin higases, possibly derived from a single ancestral E3 (Zachariae and Nasmyth, 
1999). 
The APC collaborates specifically with a subclass of E2s represented by UbchlO 
in humans, E2-C in clam and UbcP4 in Schizosaccharornyces pombe, (Aristarkhov 
et al., 1996; Yu et al., 1996; Osaka et al., 1997; Townsley et al., 1997), but can 
collaborate with a number of E2s in S. cerevisiae (Zachariae and Nasmyth, 1999). 
The ancillary factors Cdc20/Fizzy and Cdhl/Fizzy-related are crucial to regu-
lating the substrate specificity of the APC, but is not clear whether they bind 
substrates directly. This topic is discussed further in section 1.3.1. 
1.2.2.3.5 RING finger proteins 
As well as the Hrtl and Apcll proteins, which are associated with multisubunit 
E3s, some RING finger proteins have intrinsic E3 activity. The best-studied of 
these is the p53 regulator Mdm2. 
The rapid turnover of p53 under normal conditions is dependent both on the 
proteasome and on the ability of Mdm2 to bind p53 (Kubbutat et al., 1997; 
Haupt et al., 1997). The stabilisation of p53 in response to stress is largely 
achieved through abrogation of Mdm2 binding, either by phosphorylation of p53 
(Unger et al., 1999) or by sequestering Mdm2 (Weber et al., 1999; Tao and Levine, 
1999). Mdm2 together with El and the E2 UbcH5b is sufficient to ubiquitinate 
p53 in vitro, demonstrating that Mdm2 is an E3 (Fang et al., 2000). Mutation of 
putative zinc co-ordination residues in the RING finger abolishes E3 activity in 
vitro, and also stabilises p53 in cells (Fang et al., 2000). 
The otherwise unrelated RING finger proteins Siah-1, BR,CA-1 TRC8 and 
Prajal also display the capacity to mediate ubiquitination (Lorick et al., 1999). 
Many other RING finger proteins, for which E3 activity has not been demon-
strated, associate with E2s and/or modulate the degradation of specific sub-
strates. An example is the Drosophila protein Seven-in-absentia (Sina), which is 
involved in photoreceptor specification. Sina binds to both the E2 UbcDl and the 
transcription factor Tramtrack (Ttk), causing Ttk to be ubiquitinated and de-
graded (Li et al., 1997; Tang et al., 1997). Several cellular proteins, including the 
nuclear body protein PML and the centromeric protein CENP-C, are targeted for 
degradation following infection by herpes simplex virus type 1. The viral RING 
finger protein \TmwllO is required for this (Everett et al., 1998, 1999). 
RING finger proteins have other cellular functions, such as mediation of 
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BRCA1 dimerisation (Meza et al., 1999) and binding RNA (Lai et al., 1998). 
The RING fingers of the proteins implicated in ubiquitination vary considerably 
in sequence, raising the possibility that, in addition to interacting with and ac-
tivating E2s, the RING fingers may help to select substrates. Consistent with 
this, not all proteins which bind Mdm2 are targeted for degradation (Zeng et al., 
1999). The tertiary structure of a given RING finger may juxtapose a RING - 
associated E2 with a particular subset of proteins. 
1.2.2.4 The E4 ubiquitination factor 
Recently Koegi et al. (1999) have described a novel factor which is needed for 
efficient ubiquitination of a test substrate in vitro. El, E2 and E3 are sufficient 
for conjugation of a chain consisting of 1-3 ubiquitin moieties, but this does not 
cause the substrate to be efficiently degraded. Assembly of a longer polyubiquitin 
chain requires a factor termed Ufd2 or E4. Ufd2 does not interact with the 
substrate directly but with its ubiquitin con .Mates. Ufd2 is essential for viability 
only under stress conditions. The activity of Ufd2 may be antagonised by Rad23, 
which inhibits formation of long polyubiquitin chains and degradation of test 
substrates (Ortolan et al., 2000). Rad23 co-precipitates with a substrate that 
contains a short multi-Ub chain. These studies suggest that polyubiquitin chain-
promoting and chain-inhibiting factors compete to modulate protein stability. 
1.2.3 Deubiquitinating enzymes 
Polyubiquitination of a protein can be reversed by hydrolysis of the isopeptide 
bond linking the ubiquitin residues. This process is catalysed by the deubiq-
uitinating enzymes (DUB), which are also required for processing of ubiquitin 
precursors. Currently there are more deubiquitinating enzymes than ubiquitinat-
ing enzymes known, with 17 in the Saccha'romyces cerevisiae genome. Presumably 
this reflects a degree of functional divergence and substrate specificity, although 
this is not well understood. There are two classes of deubiquitinating enzyme, 
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ubiquitin C-terminal hydrolases (Uchs) and ubiquitin-specific proteases (Ubps). 
1.2.3.1 Ubiquitin C-terminal hydrolases 
The first DUBs were identified by their ability to deubiquitinate a ubiquitin fusion 
peptide and were members of the Uch class (Liu et al., 1989; Mayer et al., 1989). 
These are small enzymes, 40 kDa or smaller, and generally cleave ubiquitin-fusion 
precursors or ubiquitin with small leaving groups. They may carry out the co-
translational processing of ubiquitin precursors and/or regenerate free ubiquitin 
from nonproductive derivatives, thereby maintaining a free pool of ubiquitin in 
the cell. The Uchs are unrelated to any other known proteases and share ap-
proximately 40 % sequnce identity with each other. There is a single Uch in S. 
cerevisiae, Yuhl, which is non-essential for growth under normal conditions (Liu 
et al., 1989). This suggests that Ubps may be able to functionally substitute for 
Uchs. Three mammalian Uchs are known, with different tissue-specific patterns 
of expression (Wilkinson et al., 1992). The Drosophila uch-D is strongly expressed 
in nurse cells, ovary and testis (Zhang et al., 1993). 
1.2.3.2 Ubiquitin-specific proteases 
The larger (50-250 kDa) Ubps were cloned using a screen based on cleavage of 
a ubiquitin-protein fusion (Tobias and Varshavsky, 1991; Baker et al., 1992). 
These enzymes are highly divergent but share several short consensus sequences 
which may form the catalytic domains (Baker et al., 1992; Papa and Hochstrasser, 
1993). There are 16 putative Ubps in yeast, many of which give no obvious 
phenotype when mutated (Hochstrasser, 1996; Baker et al., 1992). Some Ubps 
appear to have a broad role in cleaving proteolytic intermediates which may 
otherwise inhibit ubiquitin-mediated proteolysis. The S. cerevisiae Ubp Doa4 may 
be responsible for the recycling of free ubiquitin after proteasomal degradation 
of a substrate, as a doa4 mutant strain accumulates ubiquitin con jMated to short 
peptides (Papa and Hochstrasser, 1993) - see section 1.2.4.2.3. The mammalian 
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Ubp isopeptidase T acts specifically on unanchored polyubiquitin chains of up to 
four subunits (Hadari et al., 1992; Wilkinson et al., 1995). Mutation of the yeast 
homologue, Ubp13, causes proteolytic defects and accumulation of unanchored 
uhiquitin chains (Amerik et al., 1997). 
Another potential function of Ubps is the inhibition of ubiquitin-mediated 
proteolysis of specific substrates by deconjugation of their polyubiquitin chains. 
This could serve as a proofreading mechanism to prevent the degradation of in-
appropriately targeted proteins. This hypothesis requires discrimination by the 
enzymes between different substrates. Although not proven, the large number of 
different Ubps is consistent with this. There is evidence of substrate - specific 
inhibition of degradation for the Drosophila Ubp Fat facets (Faf). Faf is required 
maternally for cellularisation of embryos (Fischer-Vize et al., 1992). Zygotic faf 
mutants are viable but have excessive photoreceptors in the eye (Fischer-Vize 
et al., 1992; Huang et al., 1995). Genetic interaction studies suggest that Faf 
antagonises proteolysis, rather than enhancing it by maintaining a pool of free 
ubiquitin (Huang et al., 1995; Wu et al., 1999). A candidate for the Faf substrate 
is the product of Liquid facets (Lqf), mutations in which enhance the faf eye 
phenotype (Cadavid et al., 2000). Lqf is the Drosophila homologue of vertebrate 
epsin, which is associated with the clathrin-mediated endocytosis complex. Faf 
and Lqf function in common cells to prevent ectopic photoreceptor specification 
(Caclavid et al., 2000). Mutations in several other genes required for endocy -
t,051S, including those encoding clathrin, dynamin and adaptin, enhance the faf 
and lqf phenotypes (Cadavid et al., 2000). These experiments suggest that the 
enclocytosis complex is regulated by ubiquitination: specifically, that deubiqui-
tination activates endocytosis. It is not clear whether Lqf is a direct substrate 
of Faf, or whether another endocytotic protein is the direct Faf target, and Lqf 
is simply limiting for endocytosis. If Lqf is deubiquitinated by Faf, this may 
increase the Lqf level and thereby promote endocytosis. Further evidence that 
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Ubps can regulate specific processes comes from work on yeast Ubp3, deletion of 
which enhances silencing of genes located near telomeres and of the silent mating-
type locus (Moazed and Johnson, 1996). Ubp binds specifically to Sir4, which 
is required for gene silencing (Moazed and Johnson, 1996). The involvement of 
Ubps in growth control in mammals is implied by findings that several oncogenic 
mutations disrupt Ubp genes such as tre-2 (Papa and Hochstrasser, 1993). 
1.2.4 The proteasome 
The 26S proteasome was first detected as a barrel-shaped structure in electron 
micrographs of erythrocyte extracts, and named cylindrin (Harris, 1968). During 
the 1980s, several investigators isolated multicatalytic, high molecular weight (700 
kDa) proteases from a variety of tissues (Schmid et al., 1984; Ishiura et al., 1985; 
McGuire and DeMartino, 1986). At the same time, ubiquitin researchers were at-
tempting to identify the protease which degrades ubiquitinated substrates. Hough 
et (Li. (1986) identified an activity in reticulocyte lysate which degraded ubiquitin-
lysozyme con .jugates, but not unmodified lysozyme. This ATP-dependent pro-
tease was found to be a 26S particle which copurified with a smaller, ATP-
independent 20S protease (Hough et al., 1987). The smaller enzyme was identifed 
as the multicatalytic protease described earlier. The larger complex appeared to 
consist of the 20S protease with additional subunits. It is now accepted that 
the 26S proteasome consists of the 20S complex, which is the catalytic core, plus 
the 19S regulatory complex, which confers the ability to recognise ubiquitin con-
jugates in an ATP-dependent manner (Figure 1.3). Both forms are present in 
all eukaryotes studied. A simplified 20S complex is present in many species of 
arcliaebacteria and in the actinomycete family of eubacteria. 
1.2.4.1 The 20S proteasome 
The crystal structure of the yeast 20S proteasome shows a cylindrical 700 kDa 
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Figure 1.3: Schematic representation of the 26S proteasome and its subcoinplexes. 
The pioteolvtic active site resides in the 20S 1)roteasorx1( which consists of four 
rings of and 8 subunits. The 19S regulator can l)illd to either or both ends of the 
205 proteasome, enabling ATP-dependent degradation of polylll)iqllitinated 1)10-
I eiiis. The 19S regulator consists of the base and lid subconiplexes. 19S base-20S 
Ploteasolile complexes have been isolated. The base 5111)J)oItS elevated j)eI)ti(laSC 
a(tiVitV, but the lid kLPIWilIS  to be required for recognition of polyubiquitinated 
substrates. After Ferrehl (t (ii. (2000). 
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et at., 1997). Subunits fall into two families, the a and 0 families, on the basis of 
sequence similarity and position in the complex. Each of the two outer rings of 
the yeast 20S proteasome contains a subunits 1-7, and each of the two inner rings 
contain 0 subunits 1-7 (Figure 1.3). The four rings encompass three cavities, two 
'antechambers' between the a and 0 rings and a central cavity, containing the 
proteolytic active site, between the two 0 rings. The central channel through 
which proteins pass to reach the proteolytic cavity is 13 A wide. The entrance 
to the antechambers is blocked by N-termini of the a subunits. It appears that 
proteins must be unfolded and actively transported to the inaccessible proteolytic 
site, preventing their accidental degradation. Upon reaching the active site, pro-
teins are processively cleaved to peptides of between 4 and 25 residues (Wenzel 
et at., 1994; Dolenc et at., 1998; Nussbaum et at., 1998). The proteasome can 
cleave a substrate at hydrophobic or aromatic residues, at basic residues and at 
glutamate. Each of these three activities has been assigned to one of the three 
catalytically active 0 subunits (Heinemeyer et al., 1997, 1993, 1991; Enenkel et at., 
1994; Dick et at., 1998). 
Unlike eukaryotes, the archaebacterium Therrnoplasrna acidophilum has only 
one type of a and one type of /3 subunit. When expressed in E. coli, a subunits 
can spontaneously assemble into double seven-membered rings whereas /3 subunits 
cannot (Zwickl et at., 1994). Co-expression of a and 0 subunits yields mature 
and active proteasornes (Zwickl et at., 1992). The N-terminal propeptide of the 
0 subunits, which prevents its proteolytic activity, is autocatalytically removed 
(luring proteasome assembly (Seemuller et at., 1996). Assembly of eukaryotic 
proteasomes is more complex and not yet understood. It requires additional 
factors that are only transiently associated with the nascent complex and may 
act as chaperones (Schmidtke et at., 1997; Ramos et at., 1998). Only one of the 
CV subunits, human C8, has been shown to spontaneously assemble into rings 
(Gerards et at., 1997). Other a subunits cannot form rings alone but can co- 
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assemble into rings with C8 (Gerards et at., 1998). An intermediate in proteasome 
assembly, consisting of all 7 a subunits and 3 0 subunits has been detected 
(Nandi et at., 1997; Schmidtke et at., 1997). Incorporation of the remaining 
/3-type subunits triggers dimerization of these precursor complexes and cleavage 
of the 0 subunit N-terminal propeptides. As well as shielding the active site, 
these propeptides appear to promote correct folding and incorporation of the /3 
subunits. 
1.2.4.1.1 The immunoproteasome 
During an immune response in vertebrates, interferon-')' (IFN-'y) upregulates tran-
scription of three genes encoding non-constitutive proteasomal 0 subunits. These 
proteins, termed LMP2, LMP7 and MECL, can replace the catalytically active 
0 subunits of the 'housekeeping' proteasome to generate the 'immunoprotea-
some'. This is thought to be a form of the proteasome adapted for production 
of pathogen-derived peptides, for presentation by class I major histocompatibil-
ity complex (MHC) molecules (reviewed by Coux et al. (1996); Fruh and Yang 
(1999)) . Immunoproteasomes are preferentially localised on the cytoplasmic side 
of the endoplasmic reticulum (ER) (Brooks et al., 2000), and their products are 
transported into the ER lumen for association with MHC class I molecules. It 
is not clear how the IFN-'y - inducible subunits alter the spectrum of peptides 
generated. However the structure of LMP2 suggests that the immunoproteasome 
may have a decreased propensity to cleave after acidic amino acids (Eleuteri 
et at., 1997). MHC class I molecules associate poorly with peptides with acidic 
C-termini. Another pair of IFN-'y-inducible genes, PAa and PA/3, encode sub-
units of the PA28 proteasome activator (Realini et at., 1994). Association of PA28 
with the proteasome enhances degradation of fluorogenic substrates (Coux et at., 
1996) but its role in the immune response has yet to be proven. 
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1.2.4.2 The 19S regulatory complex 
Ubiquitin-mediated proteolysis requires the ATP-dependent association of the 20S 
proteasome with the 19S regulatory complex to form the 26S proteasome. The 19S 
regulator comprises 17 subunits and is thought to have several distinct activities 
recognition of polyubiquitinated substrates; recycling of free ubiquitin from the 
polyubiquitin chain; opening of the narrow pore into the central channel of the 
I)roteasollle; unfolding of the target protein and translocation of the unfolded 
protein into the central channel. The Saccharomyces cerevzsiae 19S complex can 
be dissociated into two subcomplexes termed the base and the lid (Glickman 
et at., 1998a). 
1.2.4.2.1 The 19S base subcomplex 
The base complex consists of six different members of the AAA-ATPase fam-
ily (Rpnl-6) and three non-ATPases (Rpnl, Rpn2 and RpnlO) (Glickman et at., 
1998b). The AAA-ATPases (TPases associated with a variety of cellular activities) 
are a functionally diverse family of proteins which share a conserved 230 amino 
acid ATPase module (see Patel and Latterich (1998) for review). All six 19S 
ATPases are essential and mutate to distinct phenotypes (Rubin et al., 1998). 
The ATPases associate in vitro in specific pairs (Richmond et at., 1997), and the 
three pairs can associate to form a hexamer (Gorbea et at., 2000). The base 
complex exhibits chaperone-like activity in vitro (Braun et at., 1999), suggest-
ing that the in vivo role of the ATPases may be to unfold the targeted proteins 
before translocating them into the 20S core. They may also participate in pro-
teasorne assembly. A particle called the'modulator', which promotes formation 
of the 26S proteasome from the 20S and 19S complexes has been identified as 
the Rpt5-Rpt6 ATPase heterodimer plus an additional protein, p27 (DeMartino 
et at., 1996; Watanabe et at., 1998). 
The best-studied of the non-ATPase base subunits is RpnlO (S5a in main- 
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inals). This is the only proteasomal subunit known to bind polyubiquitin (De-
veraux et al., 1994). There are two polyubiquitin binding sites, both located 
towards the C terminus (Young et al., 1998; Fu et al., 1998). However loss of 
RpnlO function impairs degradation of only a subset of test proteins (Van Nocker 
et at., 1996), and truncation studies show that the N-terminus rather than the 
C-terminus is required for RpnlO function in vivo (Fu et at., 1998). These data 
suggest that RpnlO has functions other than polyubiquitin recognition, and that 
RpnlO binding to polyubiquitin is not the only means of targeting a substrate 
to the proteasome. This topic is discussed further in section 4.3.1. The other 
non-ATPase base subunits, Rpnl and Rpn2 have KEKE (lysine and glutamate-
rich) and LRR (leucine-rich) protein-protein interaction motifs. They may serve 
to link the base and lid subcomplexes. 
1.2.4.2.2 The 19S lid subcomplex 
A complex of the 20S core and the base of the 19S complex is sufficient for ATP-
dependent degradation of nonubiquitinated peptides but not for degradation of 
ubiquitinated proteins (Glickman et al., 1998a). Therefore it is assumed that the 
lid is required for recognition and/or processing of a polyubiquitinated substrate 
prior to its degradation. Comparatively little is known about the activities of 
the eight lid subunits. Five of them contain a PCI domain - a sequence motif 
of unknown function also found in two subunits of the plant photomorphogenic 
regulator complex CON and in two subunits of the translation initiation factor 
eIF3 (Hofmann and Bucher, 1998). The PCI domain is discussed further in section 
4.3.2. 
1.2.4.2.3 A proteasomal deubiquitinating enzyme? 
While none of the 19S subunits bear any resemblance to known deubiquitinating 
enzymes, such an activity is associated with the proteasome. Recycling of free 
ubiquitin requires that a component of the proteasome can cleave the polyubiq- 
uitin chain from its target. Eytan et al. (1993) showed that such an isopeptidase 
activity cofractionates with the 26S proteasome. Lam et al. (1997) have described 
an isopeptidase activity associated with the 19S complex and which disassembles 
the polyubiquitin chain from its distal end. Potentially this could serve as an 
ecliting' isopeptidase, which rescues poorly-ubiquitinated proteins from degrada-
tion. In neither case was the identity of the deubiquitinatinq enzyme discovered. 
Recently, the yeast deubiquitinating enzyme Doa4 has been shown to associate 
with the yeast proteasome (Papa et al., 1999). This association is required for 
Doa4 function in vivo. doa4 mutant cells are deficient in degradation of a variety 
of proteins and also accumulate ubiquitin bound to small peptides (Papa et al., 
1999), suggesting that Doa4 may release ubiquitin from proteolytic intermediates 
generated by the proteasome. 
1.2.4.3 Subcellular distribution of proteasomes 
Pioteasomes exist in several forms and in several subcellular compartments. Yeast 
pioteasomes accumulate almost exclusively in the nucleus, possibly reflecting their 
importance in cell-cycle progression (Russell et al., 1999). In mammalian cells, 
proteasornes are found both in nucleus and cytosol, with a minor fraction associ-
ated with the ER (Palmer et al., 1996; Reits et al., 1997; Brooks et al, 2000). Most 
cytoplasmic proteasomes are associated with the intermediate filaments (Palmer 
et al., 1996). There are changes in the subcellular distribution of proteasomes 
in between different cell types, during cell-cycle progression and during devel-
opment in lower eukaryotes (reviewed by Rivett (1998). However the functional 
significance of these observations is unclear. 
1.2.5 Recognition signals in substrates 
Many proteins have short in vivo half-lives, allowing for rapid adjustment of 
their concentrations through altering the rates of their synthesis. Other proteins 
are degraded only under certain conditions. Features of a protein which confer 
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metabolic instability are called degradation signals, or degrons. The first degrons 
discovered were those which govern the 'N-end rule' of protein stability. Consen-
sus sequences recognised by specific E3s have been identified in a small number of 
proteins, including cyclins and I-kB. Their susceptibility to ubiquitination can be 
regulated by phosphorylation. The search for general features of a protein which 
render it susceptible to ubiquitination is currently under way. There are indica-
tions that structural elements rather that primary sequence may be recognised 
by some ubiquitinating enzymes. 
1.2.5.1 The N-degron 
The N-end rule states that the half-life of a protein can be related to the identity 
of its N-terminal residue. Its was first observed in S. cerevisiae using artificial
gal act osidase-derived substrates which were identical apart from their N-terminal 
residues. The E3 responsible for recognising N-end rule substrates (Ubrl/N-
recognin in S. ce'revisiae, or E3a in mammals), has been described in section 
1.2.2.3.1. This section describes the degradation signal in more detail. 
Ubri has at least two substrate binding sites (Varshavsky, 1999). The type 1 
site is specific for bulky or hydrophobic amino acids (Phe, Leu, Trp, Tyr and Tie), 
while the type 2 site is specific for basic amino acids ( Arg, Lys, His). These two 
groups are designated 'primary destabilising' residues. 'Secondary destabilising' 
residues are those which can be converted into primary destabilising residues 
under certain conditions: N-terminal Asp and Glu residues can be arginylated by 
Arg-tRNA protein transferase. Asn and Gin, the 'tertiary destabilising' residues 
can be deamidated by N-terminal amidohydrolase to yield Asp and Glu. The 
ierriaining amino acids are designated 'stabilising' by default, as they are not 
targeted by components of the N-end pathway. The strength of the interaction 
between N-recognin and a substrate is strengthened by the presence of an internal 
lysine residue on the substrate. This lysine, which is the site of ubiquitination, 
can be considered the second necessary component of the N-degron. 
30 
Since nascent proteins are synthesised with an N-terminal Met residue, which 
is stabilising, the protein must be processed to generate an N-degron. This could 
potentially be achieved by removal of the N-terminal Met, but the known yeast 
Met-aminopeptidases cleave only if the second residue is stabilising. However 
proteins which function in, or pass through, the ER or Golgi may bear N-terminal 
destabilising residues as a result of signal peptide cleavage. Thus, physiological 
N-end substrates may include previously compartmentalised proteins which have 
inappropriately been transported into the cytosol. Other potential substrates are 
the derivatives of viral polyproteins: the Sindbis alphavirus RNA polymerases 
has an N-terminal Tyr, replacement of which by a stabilising residue increases its 
half-life in reticulocyte lysate (de Groot et al., 1991). However degradation of the 
only known physiological substrates for N-recognin in yeast, Ga and Cup9, does 
not require their N-termini (Madura et al., 1993; Byrd et al., 1998). Therefore 
N-recognin must also recognise internal degradation signals, which have not yet 
been identified. 
1.2.5.2 The destruction box 
The first specific amino acid sequence shown to confer recognition by the ubiqui-
tination machinery was the destruction box', the sequence element required for 
proteolysis of mitotic cyclins (Glotzer et al., 1991). Mitotic cyclins are targeted 
by the anaphase promoting complex (see section 1.3.1.2). The consensus destruc-
tion box sequence is RXALGXIXN, although A- and B-type cyclins have slightly 
different sequences. Mutations in the destruction box severely reduce cyclin ubiq 
uitination and degradation (Glotzer et al., 1991). The destruction box of cyclin 
B can function as a portable recognition element, conferring instability on fusion 
proteins (Glotzer et al., 1991; Brandeis and Hunt, 1996; Yamano et al., 1996). 
The cyclin A destruction box can direct ubiquitination but not degradation of 
a hybrid protein, suggesting that cyclin A must be bound to Cdc2 or Cdk2 in 
order to be degraded (Klotzbucher et al., 1996). The different properties of the 
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two types of destruction box may influence the timing of their degradation. 
Destruction boxes are also found in some other substrates of the anaphase 
promoting complex, such as Pdsl/Cut2 (Cohen-Fix et al., 1996; Funabiki et al., 
1997) and Asel (Juang et al., 1997). The E3 activity of the APC is dependent 
on its association with Cdc20/Fizzy and Cdhl/Fizzy-related (see section 1.3.1.2). 
Destruction boxes may be recognised by these proteins (see section 1.3.1.2), al-
though this has not been proven. 
1.2.5.3 The KEN box 
Destruction boxes are present in all known Cdc20-APC substrates but only in 
a subset of Cdhl-APC substrates. Pfleger and Kirschner (2000) have identified 
a specific sequence, called a KEN box, required for degradation of Cdhl-APC 
substrates lacking a destruction box. The consensus sequence is K-E-N-X-X-X-
N. Like the cychin B destruction box, the KEN box works as a transposable motif 
which can confer instability onto hybrid proteins (Pfleger and Kirschner, 2000). 
1.2.5.4 Acidic transcriptional activation domains as degrons 
JVIyc is a short-lived transcription factor (TF) in which the transcriptional activa-
tion domain (TAD) overlaps closely with the sequences required for its turnover 
(Salghetti et al., 1999). Recently this correlation has been noted in several other 
unstable TFs (Salghetti et al., 2000) The activation domains of VP-16 and E2-
Fl, but not of other TFs, can confer instability on hybrid proteins (Saighetti 
(t al., 2000). Like Myc, their TADs are rich in acidic residues. With synthetic 
transcription factors, derived from repeats of the VP-16 TAD, there is an inverse 
correlation between transcriptional activation potential and ability to direct ubiq-
uitination (Saighetti et al., 2000). TAD-directed protein destruction may be a 
common mechanism regulating transcription factor stability. 
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1.2.5.5 The I-kB and /3-catenin recognition signals 
Activation of the transcription factor NF-icB requires ubiquitin-dependent degra-
dation of its inhibitor, I-kB (see section 1.3.2). I-icB ubiquitination occurs pri-
marily at lysines 21 and 22, and is triggered by phosphorylation of two senine 
residues at positions 32 and 36. Using peptides spanning the phosphorylation 
site to inhibit I-kB ubiquitination, Yaron et at. (1997) have defined the minimal 
p1ios)hory1ation-dependent E3 recognition element as DSGLDS. This element di-
rects ubiquitination of nearby lysine residues but does not itself include the site of 
polyubiquitination. The I-,cB ubiquitin ligase which binds to this element is the 
F-box and WD domain protein 18-TrCP (Yaron et at., 1998; Spencer et at., 1999; 
Winston et at., 1999). 1@-TrCP also mediates ubiquitination of the transcription 
factor -catenin through a short, phosphorylation-dependent recognition element 
similar to that in I-KB (Hart et at., 1999; Winston et at., 1999). The small size of 
the element recognised by 18-TrCP raises the question of how the enzyme achieves 
sufficient substrate specificity. Perhaps the short phosphorylat ion- dependent mo-
tif is the primary recognition site, and further substrate elements are required to 
stabilise the interaction. 
1.2.5.6 Hydrophobic regions as degrons 
In an attempt to find novel degradation signals, Gilon et at. (1998) screened ran-
dom sequences, 16-50 amino acids in length, for their ability to produce unstable 
fusions with reporter proteins. The stability of the proteins were then assayed 
in strains with mutations in various ubiquitinating enzymes, to determine which 
enzymes recognise which degrons. Degradation signals which are stabilised in 
uhc6ubc7 mutants display no identifiable consensus sequence but share a high de-
glee of hydrophobicity (Gilon et at., 1998). The yeast transcription factor a2 is 
uhiquitinated by Uhc6/Ubc7. The a2 degradation signal, Degi, is a 60-amino 
acid region predicted to form an amphipathic helix (Chen et at., 1993; Johnson 
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et al., 1998). Point mutations which inactivate Degi cluster on the hydropho-
bic surface of the predicted helix (Johnson et al., 1998). Taken together, these 
studies suggest that the Ubc6/Ubc7 ubiquitination complex recognises structural 
features of its substrates, specifically hydrophobic regions, rather than a primary 
consensus sequence. Since hydrophobic regions may be normally buried within 
the core of a protein, or at a protein-protein interface, this may serve to target 
iiiisfolded proteins or proteins which have failed to associate with their normal 
partners 
1.3 Physiological processes regulated by ubiquitin-
mediated proteolysis 
The ubiquitin-proteasome system provides a rapid, specific and highly regulated 
means of changing the protein composition of a cell, and hence of regulating cellu-
lar behaviour. The research presented in this thesis investigates possible roles for 
the ubiquitin system in regulating development of a model multicellular organism, 
Drosophila melanogaster. While the list of known substrates for the ubiquitin sys-
tern has expanded rapidly in recent years, there is still little specific information 
available on the role of the system in mediating developmental decisions. Instead 
this review focusses on three relatively well-studied groups of substrates: cell-
cycle regulators, transcription factors, and membrane proteins. It highlights the 
importance of controlled protein turnover in controlling the relevant physiological 
processes, and the diseases which can result from dysregulation of ubiquitination. 
1.3.1 Proteolysis as a means of regulating the cell cycle 
Phiosphorylation and proteolysis are the two interdependent processes which regu-
late the growth and division of eukaryotic cells. The cell cycle is controlled chiefly 
by cyclin-dependent kinases (CDKs), whose activity is dependent on forming a 
complex with a particular cyclin. Waves of synthesis and destruction of stage- 
34 
specific cyclins regulate CDK activity. CDK inhibitors prevent improper tran-
sition between different stages of the cycle. Ubiquitin-mediated proteolysis is 
crucial to rapid and timely destruction of both cyclins and CDK inhibitors at the 
transitions between the various phases (Figure 1.4). The phosphorylation state of 
cell-cycle proteins can decide their ability to be ubiquitinated. The two E3s which 
dominate cell cycle control are the SCF complexes and the anaphase-promoting 
complex (APC), previously described in section 1.2.2.3. SCF complexes catal-
yse ubiquitination of CDK inhibitors and Gi cyclins, as well as transcription 
factors and other proteins throughout the cell cycle. The APC is active from 
late metaphase until the next Gi phase, during which time it targets anaphase 
inhibitors, mitotic cyclins, spindle proteins and its own activators. 
1.3.1.1 SCF complexes and cell-cycle control 
Entry into S phase in yeast requires destruction of GI cyclins (Clnl-3) and of 
the CDK inhibitor Sici. As described in section 1.2.2.3.3, these proteins are 
targeted by the E2 Ubc3/Cdc34, and Cdc4-containing SCF complex. Recognition 
by the F-box protein Cdc4 is dependent on substrate phosphorylation by the CDK 
Cdc28, complexed to Gi cyclins (Feldman et al., 1997; Skowyra et al., 1997). 
Phosphorylated GI cyclins themselves are targeted for ubiquitination by the F-
box protein Grrl (Patton et al., 1998b). Proteolysis of the GI cyclins Clnl and 
C1n2 requires the presence of S phase cyclins, providing a mechanism for coupling 
synthesis of one class with the disappearance of the other (Blondel and Mann, 
1996). SCF complexes also act at the G2-M transition, targeting the mitotic 
inhibitor Swel through the F-box protein Met30 (Kaiser et al., 1998). Several 
F-box proteins are themselves turned over in an SCF-dependent manner (Zhou 
and Howley, 1998; Galan and Peter, 1999; Mathias et al., 1999). 
It is likely that the regulatory pathway described here have been conserved 
and elaborated in metazoans. In mammalian cells, the Cul-1/Skpl/Skp2 SCF 
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Figure 1.4: Schematic representation of the regulation of cell-cycle progression 
I )V ubiquitin-mediated proteolysis. Arrows indicate activation, a line at right 
angles indicates inhibition, (lotted outlines indicate proteolysis and a P imidi-
(f(5 j)llosphorvlation. Sici inhibits the CDK activity of the Clb-Cdc28 corn-
Plex: )110sph0rylati011(l(I)ende11t Sicl proteolysis (luring Cl, mediated by a Cdc4-
coiltaillilig SCF complex, enables progression into S phase. Similarly, G2-M pro-
gression requires proteolysis of the Swel CDK inhibitor : this event is mediated 
hv a Met30-containing SCF complex. Clb-Cdc28 phosphiorylates, and activates, 
time APC-Cdc2() complex, which then degrades the anaphase inhibitor Pdsl. Pdsl 
pioteolvsis enables time separin protein to cause sister chromatid separation. APC-
('dc20 also degrades flhit,OtiC cyclins, inactivating Cdc28. This activates the Cdcl4 
pliospliatase, which depimosphorylates Cdlii, allowing it to associate with the 
A PC. Cdc14 also depliospliorylates Sici , causing it to accimimitilate. APC-Cdhl 
iiiaintains the degradation of mitotic cyclins until after completion of cytokinesis. 
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the abundance of cyclin E (Singer et al., 1999). Skp2 is also important in turnover 
of the transcription factor E2F-1, which drives the expression of several genes 
needed for entry into S phase. Targeting of E217-1 may be limited by availablility 
of Skp2, which peaks just after entry into S phase (Marti et at., 1999). Other 
important growth control proteins targeted by Skp2 include p 2 16Ph/WAF1 (Yu 
et at., 1998) and p27 (Sutterluty et al., 1999). 
1.3.1.2 Regulation of mitosis by the anaphase-promoting complex (APC) 
The APC is needed for two distinct events in mitosis - execution of anaphase, 
and mitotic exit. Its activity is positively regulated by stage-specific association 
with two conserved accessory factors, Cdc20 and Cdhl (known as Fizzy and 
Fizzy-related in Drosophila) (Schwab et at., 1997; Visintin et at., 1997; Fang et at., 
1998). Cdc20 and Cdhl contain WD-40 repeats, which are also found in F-box 
proteins. It is not known whether they bind directly to APC substrates. 
Cdc20 is expressed during G2 and binds the APC during late metaphase. The 
ability of the APC to be activated by Cdc20 depends on the phosphorylation of 
core subunits by polo-like kinases (Kotani et at., 1998). APC-Cdc20 substrates 
include mitotic cyclins (Clb) and the anaphase inhibitor Pdsl/securin (Visintin 
et at., 1997). Pdsl sequesters the separin' protein Epsi in an inactive complex. 
Destruction of Pdsl allows Epsi to cleave the 'cohesin' protein Sccl which in turn 
allows sister chromatids to separate (Ciosk et at., 1998; Uhlmann et at., 1999). 
Cdc20 protein levels decline rapidly as cells exit mitosis and enter Gi. This is 
thought to be due to protein degradation targeted by APC-Cdhl (Fang et at., 
1998; Prinz et at., 1998). 
Unlike Cdc20, Cdhl is expressed throughout the cell cycle but CDK-dependent 
phoshorylation prevents it from binding the APC before the end of anaphase, 
when it is dephosphorylated by Cdc14 (Zachariae et al., 1998; Visintin et at., 
1998). Other mechanisms help to control the relative timing of APC-Cdc20 and 
APC-Cdhl activity, such as the inhibition of APC-Cdhl activity by the APC- 
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Ccic20 substrates Pdsl and C1b5 (Shirayama et al., 1998) and the degradation 
of Cdc20 by APC-Cdhl. APC-Cdhl targets the spindle protein Asel (Juang 
et al., 1997) and also maintains the degradation of Clbs intiated by APC-Cdc20 
(Schwab et at., 1997; Visintin et at., 1997). 
The formation and activity of the APC is influenced by the cAMP/protein 
kinase A (PKA) pathway (Yamashita et at., 1996; Yanagida, 1998). Mutations in 
the APC component Cut4 cause hypersensitivity to cAMP and to stress-inducing 
heavy metals. Negative regulation of APC activity by cAMP/PKA may integrate 
cell cycle control with the stress response, during which proteasomal availability 
to ubiquitinated proteins may become limiting. Inhibition of APC may therefore 
suppress entry into anaphase until normal conditions are restored. 
1.3.1.3 Ubiquitination and tumorigenesis 
In mammalian cells, ubiquitin-mediated proteolysis regulates the activity of many 
additional growth control molecules, including the proto-oncoproteins c-Jun (Treier 
et at., 1994), c-Fos (Stancovski et al., 1995) and c-Mos (Ishida et at., 1993). 
Growth control proteins can be transformed into oncoproteins by alterations 
which abrogate their ubiquitination. The C-terminal truncated version of c-Myb, 
found in murine myeloid leukaemias is less efficiently ubiquitinated, and more 
stable, than the full-length protein (Bies and Wolff, 1997). A tyrosine-aspartic 
acid substitution in the c-Kit receptor tyrosine kinase is often observed in mouse 
rnastocytoma cell lines. The mutation upregulates Kit signalling by altering its 
substrate specificity, leading to the phosphorylation of an unknown intermedi-
ate protein and to the ubiquitin-dependent degradation of the protein tyrosine 
phosphatase Shp-1, which is a negative regulator of Kit signalling (Piao et al., 
1996). Other sections in this review deal with abrogation of 0-catenin ubiquitina-
Lion (section 1.3.2.3), and with human papillomavirus-mediated p53 degradation 
(section 1.2.2.3.2), which also contribute towards cancer. 
1.3.2 Turnover of transcription factors by the ubiquitin 
system 
Recently, a novel case has been described in which the ubiquitination of a tran-
scription factor directly changes its activity. The yeast transcriptional activator 
Met4 is ubiquitinated by an SCF complex but remains stable: ubiquitinated 
Met4 can bind to promoters but cannot form functional transcription complexes, 
leading to repression of its target genes (Kaiser et al., 2000). However ubiquitin-
mediated transcriptional regulation generally involves degradation of transcrip-
tion factors. 
The cellular concentration of many transcriptional regulators can undergo 
rapid changes - this requires that the protein be short-lived. Most known cases of 
regulated transcription factor degradation involve the ubiquitin system (reviewed 
by Hochstrasser and Kornitzer (1999)). Previous sections have described the 
targeting of p53 by the RING finger protein Mdm2 (section 1.2.2.3.5), and of 
the yeast transcription factor Gcn4 by an SCF complex (section 1.2.2.3.3). This 
section describes the activation of NF-KB, which requires the activity of an SCF 
E3 both to process the inactive NF-6,13 precursor and to degrade an inhibitor. At 
least two other transcription factors, which are the terminal components of two 
different signalling pathways, are targeted by the same F-box protein, 3-TrCP 
(Figure 1.5). 
1.3.2.1 Regulation of NF-KB activation 
NF-kB is a dimeric transcription factor belonging to the Rel family, and is in-
volved in regulation of the immune response, development and differentiation, 
transformation and apoptosis. NF-KB activity is induced by a variety of stimuli 
including cytokines, oxidants and bacterial and viral peptides. Activation of NF-
,B involves the ubiquitin-proteasome pathway at two levels : processing of the 
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Figure 1.5: Schematic representation of the role of the uhiquitin system in the 
regulated degradation of I-tcB and /3-catenin, and in the processing of Cubitus 
interruptus (Ci). 
(A) Degradation of I-KB. Stimulation by cytokines, such as TNF (tumour necrosis 
factor), activates I-KB kinase (INK), which phosphorylates two serine residues of 
I-KB. This renders I-KB susceptible to polyubiquitination and proteasomal degra-
dation, resulting in the release and nuclear translocation of NF-KB. (B) Degra-
dation of 3-catenin. In the absence of signalling through the Wnt/Wg pathway, 
3-catenin forms a complex with GSK3/3, axin and APC. This enables GSK30 
to phosphorylate -catenin, which causes it to he ubiquitinated and degraded. 
The TCF/LEF transcription factor, which is the terminal component of the Wnt 
signal transduction pathway, requires 0-catenin as a cofactor. In the presence of 
Wnt signalling, the GSK3/3-axin-APC--catenin complex is dissociated, leading 
to accumulation and nuclear translocation of /3-catenin. (C) Processing of Cu-
hitus interruptus (CO. In the absence of Hh signalling, Ci forms a microtuhule-
associated complex with Cos-2, Fu and Su(fu). PKA phosphorylates Ci, and 
this may target Ci for ubiquitination. Ci is cleaved in a proteasome-dependent 
fashion to yield a 75 kDa N-terminal fragnent, Ci75, which acts as a transcrip-
tional repressor. Hh signalling inhibits Ci phosphorylation. Taken from Maniatis 
(1999). 
with its inhibitor, I-,cB. 
1.3.2.1.1 Processing of the NF-kB precursor 
NF-KB is derived from the precursor proteins p105, which undergo ubiquitin- and 
proteasome-mediated cleavage to generate the active subunit p50 (Palombella 
et al., 1994). This is the only established case in which the ubiquitin-proteasome 
pathway achieves processing rather than complete destruction of its target, and 
the mechanism is not fully understood. The N-terminal signals required for p105 
processing include a glycine-rich region which may serve as a 'stop' signal for 
proteasomal degradation (Lin and Ghosh, 1996; Orian et al., 1999), two nearby 
lysine residues which are the sites of polyubiquitination, and a downstream acidic 
region that may function as an E3 recognition motif (Orian et al., 1999). Although 
the N-terminal domain can support basal processing, C-terminal sequences appear 
to be important for accelerated, signal-induced processing (Belich et al., 1999; 
Heissmeyer et al., 1999; Orian et al., 2000). A C-terminal 20 amino-acid motif 
is phosphorylated by I-kB kinase, and phosphorylation promotes recognition by 
the SCF-fi-TrCP E3 (Orian et al., 2000). However p105 lacking the 0-TrCp 
recognition motif can be ubiquitinated by crude extracts, suggesting that p105 
is targeted by multiple E3s recognising different structural motifs (Orian et al., 
2000). 
1.3.2.1.2 Degradation of the NF-icB inhibitor, I-cB 
The active NF-,cB transcription factor is formed by heterodimerisation of p50 
with another member of the Rel family, p65. Under resting conditions, the het-
erodimer is sequestered in the cytosol by binding to I-itB, which masks the nuclear 
translocation signal. Following stimulation, I-KB is degraded and NF-kB is re-
leased for nuclear export. The E3 which recognises and ubiquitinates I-KB is an 
SCF complex containing the 0-TrCP F-box protein (Yaron et al., 1998; Winston 
et al., 1999). As discussed in section 1.2.5.5, recognition of I-KB is dependent on 
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its phosphorylation on serine residues 32 and 36. Two homologous and cytokine-
activated I-icB kinases (IKKs) have been identified, termed IKKc and IKK/3 
(Mercurio et al., 1997; Woronicz et al., 1997; Zandi et al., 1997). A knockout 
mouse lacking both IKKs shows a complete lack of NF-,cB activity and dies at 
day 12 of embryogenesis (Li et al., 2000). 
The Drosophila transcription factor Dorsal is homologous to NF-icB, and is 
involved in patterning the dorso-ventral axis. Binding of Dorsal to the I-KB ho-
mologue Cactus prevents its translocation to the nucleus. Signalling through the 
Toll receptor results in Cactus degradation. Flies lacking the 0-TrCP homologue, 
Slimb, fail to activate Dorsal-dependent genes such as twist and snail (Spencer 
et al., 1999), suggesting conservation of the NF-icB activation mechanism in flies. 
Signal-dependent phosphorylation of Cactus is required for its degradation (Reach 
et al., 1996). Dorsal is also phosphorylated, while bound to Cactus, and this is 
essential for its translocation to the nucleus (Drier et al., 1999). Phosphorylation 
may be carried out be Pelie, a serine-threonine kinase which functions downstream 
of Toll, but this has not been proven. 
1.3.2.1.3 8-catenin proteolysis and Wnt signalling 
0-catenin is a coactivator of the transcription factor TCF/LEF, and both pro-
teins are terminal components of the Wnt signalling pathway. In the absence 
of Wnt signalling, 0-catenin is phosphorylated by the glycogen synthase kinase-
3-,8 (GSK30), a modification which renders it susceptible to ubiquitination and 
degradation (Orford et al., 1997; Polakis, 1997). 3-catenin is a poor substrate 
for GSK30 in vitro, and efficient phosphorylation is thought to require its asso-
ciation with the adenomatous polyposis coil tumour suppressor protein (APC) 
and conductin/axin (Ikeda et al., 1998; Behrens et al., 1998). Axin acts as a 
scaffold protein, bringing together GSK30 and its substrates, 0-catenin and APC 
(Behrens et al., 1998). While APC mutations stabilise 0-catenin (Rubinfeld et al., 
1997), its role in the complex is riot well understood. 
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Activation of Wnt signalling inhibits phosphorylation of 18-catenin, via the 
cytoplasmic Wnt effector Dishevelled. It is thought that activated Dishevelled 
binds to axin and effects a change in the 0-catenin-axin-APC-GSK30 complex 
(Salic et al., 2000; Zhang et al., 2000). The result is accumulation and nuclear 
translocation of 0-catenin and transcription of downstream genes. 
The first indication of the identity of the /3-catenin E3 came from studies 
of the Drosophila Wingless signalling pathway. The Drosophila homologue of 
0-catenin, Armadillo, is stable in flies lacking Slimb (Jiang and Struhl, 1997), 
suggesting that Arm/6-catenin, like Cactus/1-KB, may be targeted by an SCF 
complex containing the F-box protein Slimb//3-TrCP. This has been confirmed 
in mammals and in Xenopus (Latres et al., 1999; Hart et al., 1999; Kitagawa 
et al., 1999). 3-catenin/TCF activity elevates the expression of 0-TrCP mRNA 
and protein, resulting in a negative feedback loop (Spiegelman et al., 2000). The 
upregulation of /3-TrCP by /3-catenin elevates NF-kB activity as it lowers 3-
catenin activity, providing co-ordination between the two signalling pathways. 
1.3.2.2 Cubitus interruptus proteolysis and Hedgehog signalling 
The Drosophila transcriptional regulator Cubitus interruptus (Ci), a component 
of the Hedgehog (Hh) signalling pathway, presents another possible case of lim-
ited processing by the ubiquitin-proteasome system. The full-length Ci protein, 
termed Ci155, is cytoplasmic (Aza-Blanc et al., 1997). In the absence of Hh 
signalling, Ci155 is cleaved to produce the Ci-75 derivative, which translocates 
to the nucleus and functions as a transcriptional repressor (Methot and Basler, 
1999). While Hh signalling prevents Ci-155 cleavage, Ci stabilisation alone cannot 
mimic Hh signalling (Methot and Basler, 1999). It is thought that Ci can also 
function as a Hh-responsive transcriptional activator (Aza-Blanc et al., 1997), but 
the 'activator' form of Ci has not been identified. 
Ci processing can be blocked by proteasome inhibitors (Ingham, 1998). Since 
flies mutant for the F-box protein Slimb accumulate Ci-155 (Jiang and Struhi, 
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1997), an SCF complex containing Slimb may be involved in the cleavage event, 
although this has not been proven. Hh signalling may influence Ci processing 
by modulating its phosphorylation state. Protein kinase A (PKA) activity is re-
quired for repression of Hh-responsive genes, and mutating each of the putative 
PKA sites in Ci results in its stabilisation (Chen et al., 1998). The process-
ing of Ci also depends on its subcellular localisation, which is regulated by the 
kinesin-like Costal-2 protein. Costal-2 forms a complex with Fused, Suppressor 
of Fused and Ci, which is localised to the microtubules (Robbins et al., 1997). 
Hh signalling causes dissociation of the complex (Robbins et al., 1997). Loss of 
Costal-2 function causes accumulation of Ci-155, suggesting that the association 
of Ci with microtubules may be essential for its processing (Sisson et al., 1997). 
1.3.2.3 3-TrCP and human disease 
Dysregulation of Wnt signalling is established as a causative factor in cancer, and 
this can be caused by a number of different genetic defects (reviewed by Polakis 
(2000)). Many of these defects result in failure of ,8-catenin ubiquitination and 
degradation. The APC tumour suppressor is important in 3-catenin destabili-
sation, but mutant forms of APC, such as those found in colorectal carcinomas, 
fail to downregulate 3-catenin (Munemitsu et al., 1995). Many human tumours 
and cancer cell lines have mutations in the 13-catenin gene itself (Rubinfeld et al., 
1997; Morin et al., 1997). Commonly, mutations affect the serine residues which 
are normally phosphorylated by I-kB kinase : these mutations abolish recogni-
tion of fi-catenin by the F-box protein 0-TrCP (Hart et al., 1999). Axin is also 
required for 3-catenin destabilisation. Recently, mutations in the axin gene have 
been found in human hepatocellular cancers and cell lines (Satoh et al., 2000). 
All of the mutations were predicted to affect the /3-catenin binding sites. 
Thus /3-catenin can be stabilised either by direct genetic mutation,or by the 
inactivation of its regulators, and this stabilisation appears to contribute towards 
carcinogenesis. Activation of gene transcription through LEF/TCF, which is 
coactivated by ,8-catenin, is probably involved in transformation. The proto-
oncogene c-myc is one of the targets of the APC pathway (He et al., 1998), and 
many more of the LEF/TCF target genes are involved in growth control. 
The human immunodeficiency virus type 1 (HIV-1) uses 0-TrCP function to 
reduce the amount of its receptor molecule CD4 on the surface of infected cells. 
The viral Vpu protein induces formation of a complex, consisting of CD4, Vpu 
and fl-TrCP, at the ER membrane (Margottin et al., 1998). This complex targets 
CD4 for rapid degradation, downregulating its secretion to the cell surface and 
avoiding superinfection of a host cell. 
1.3.3 Ubiquit in- mediated proteolysis of membrane pro-
teins 
The ubiquitination system can target secretory and membrane proteins as well as 
intracellular proteins. Ubiquitination is important both in 'quality control', the 
degradation of aberrant proteins which have been retained in the endoplasmic 
reticulum, and in regulating the trafficking of cell surface receptors and other 
plasma membrane proteins. 
1.3.3.1 Degradation of ER proteins 
The endoplasmic reticulum (ER) is the site at which secretory proteins and mem-
brane proteins enter the central vacuolar system which includes the ER, Golgi 
apparatus, lysosomes, and plasma membrane. Protein folding and assembly into 
complexes occurs in the ER. Misfolded or uncomplexed proteins are retained in 
the ER by chaperones and eventually degraded. 
The first indication that the ER integral membrane proteins could be targets 
for ubiquitin- mediated proteolysis came from the identification of a yeast ER-
membrane-bound E2, Ubc6, which interacts genetically with a component of the 
ER protein import apparatus, SEC61 (Sommer and Jentsch, 1993). A mutant 
form of Sec6l was subsequently confirmed to be polyubiquitinated by Ubc6 and 
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degraded by the proteasome (Biederer et al., 1996). Studies on several aberrant 
proteins, implicated in human disease, showed that ER luminal proteins could 
also be targeted. The mutant cystic fibrosis transmembrane regulator (CFTR) 
encoded by the L508 CFTR allele (Ward et al., 1995) and a mutant form of the 
prion protein (Jin et al., 2000) are retained in the ER before being degraded by the 
cytosolic ubiquitin-proteasome pathway. Sec6l is the central component of the 
translocation apparatus which mediates protein import into the ER. Degradation 
of ER proteins requires their retrotranslocation across the membrane and this 
is also mediated by the Sec6l complex (Wiertz et al., 1996b; Plemper et al., 
1997). After retrotranslo cation, substrates are probably delivered directly to the 
proteasomes which have been identified observed to the cytoplasmic face of the 
ER (Palmer et al., 1996; Brooks et al., 2000). 
While ER quality control prevents the cellular accumulation of non-functional 
endogenous proteins, the system can be subverted by viruses. The U52 and US11 
proteins of human cytomegalovirus cause MHC class I molecules in the ER to be 
retrotranslocated and degraded by the proteasome (Wiertz et al., 1996b,a). 
1.3.3.2 Ubiquitination and cell-surface signalling. 
The activity of cell-surface proteins is often regulated by controlling the level 
of protein localized at the plasma membrane. For example, receptors can be 
downregulated by endocytosis into the cell after stimulation, allowing the cell to 
return to an unstimulated state. Internalized receptors can either be degraded 
or recycled to the plasma membrane to function again. It has become clear that 
ubiquitination plays a key part in downregulating receptors and other cell-surface 
proteins. However, this does not always involve degradation by the proteasome - 
some ubiquitinated membrane proteins are degraded in the lysosome. 
1.3.3.2.1 Ubiquitination as a means of downregulating receptors 
The first evidence for ubiquitin-dependent receptor downregulation came from 
studies on two G-protein coupled receptors in yeast. The a factor receptor and 
the a-factor receptor are activated by mating pheromones, and expressed on yeast 
cells of opposite mating types. Ligand binding induces receptor ubiquitination, 
endocytosis and lysosomal degradation. Receptor internalisation requires Ubc4 
and Ubc5, and the ubiquitination signal sequences on the cytoplasmic tails of the 
receptors (Hicke and Riezman, 1996; Roth and Davis, 1996; Roth et al., 1998). 
While there is no evidence for ubiquitination of G-protein-coupled receptors 
in metazoans, a number of mammalian receptor tyrosine kinases (RTKs) undergo 
ubiquitin-dependent downregulation. RTKs have a variety of roles in controlling 
growth and differentiation. Ligand binding induces receptor autophosphorylation 
and dimerisation, and also ubiquitination. Downregulation of a number of RTKs 
has been shown to depend on their ubiquitination (Strous et al., 1996; Mon 
et al., 1995), and in some cases this appears to be mediated by the proteasome 
rather than the lysosome (Mori et al., 1995; Jeffers et al., 1997). The signal for 
sorting a ubiquitinated receptor to either the proteasome or the lysosome may 
reside in the length or degree of branching of the polyubiquitin chain : the yeast 
mating pheromone receptors, which are degraded by the lysosome, are mono- or 
di-ubiquitinated (Hicke and Riezman, 1996). 
1.3.3.2.2 Membrane protein ubiquitination and human disease 
Defects in ubiquitin- mediated downregulation of plasma membrane proteins can 
result in various human diseases. For example, desensitisation of ErbB RTKs can 
cause malignant transformation. cCbl is a RING-finger protein which normally 
participates in ErbB ubiquitination and degradation (Levkowitz et al., 1999), 
but its activity can be antagonised by the viral ocoprotein vCbl. The epithelial 
sodium channel (ENaC) is targeted for ubiquitination by the Hect domain E3 
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Nedd-4. Defects in ENaC regulation in human kidney cells result in Liddles's 
syndrome, an inherited form of hypertension (Staub et al., 1996). All the mu-
tations associated with Liddle's syndrome identified to date affect the sequences 
necessary for interaction with Nedd4. 
1.4 Conclusion 
The information presented in this chapter demonstrates that ubiquitin- mediated 
proteolysis can facilitate the correct spatial and temporal expression of regula-
tory proteins. Given that multicellular organisms have many more ubiquitinating 
enzymes than yeast, it seems likely that they exploit the system to control dif-
ferentiation and development. However the physiological functions of most of the 
ubiquitinating enzymes in metazoans have not been studied. The research de-
scribed in the following chapters aimed to uncover roles for the ubiquitin system 
in controlling Drosophila embryogenesis. 
Materials and Methods 
Chapter 2 
Materials and Methods 
2.1 Materials 
2.1.1 Media 
2.1.1.1 Bacterial media 
Luria broth (L-broth): 10 g Difco Bacto tryptone; 5 g Difco bacto yeast 
extract; 5 g NaCl; per litre, adjusted to pH 7.2 
Soc broth: 100 ml L-broth; 1 ml 1 M M902; 1 ml 1 M MgSO4 . 
Luria agar (L-agar) : As Luria broth with 15 g per litre Difco agar. 
Ampicillin was added to a final concentration of 100 ,ug m1 1 , or chioram-
phenicol to a final concentration of 34 pg/mi, or kanamycin to a final concentra-
tion of 30 ug - m1', when appropriate. 
2.1.1.2 Drosophila media 
Dundee food: 10.7 g agar; 78.6 g glucose; 44.3 g brewers' yeast; 71.4 g maize; 
5.7 g live yeast; 2.7 g nipagin ; 3.2 ml propionic acid; per litre. 
Grape juice agar: 22.5 g agar; 25 g sucrose; 1.5 g nipagin; 125 ml red wine 
concentrate; per litre. 
2.1.1.3 Yeast media 
YPDA: 1% (w/v) yeast extract; 2% (w/v) Bacto-peptone; 2% (w/v) glucose; 
0.003% (w/v) adenine. 
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YMG/CAS: 0.67% (w/v) yeast nitrogen base without amino acids; 2% (w/v) 
casamino acids; 2%(w/v) glucose. For plates 2% (w/v) agar was added. Media 
was supplemented with other amino acids as required. 
Complete minimal medium (CM): 0.67% (w/v) yeast nitrogen base without 
amino acids; 2 % (w/v) glucose or 2 % (w/v) galactose and 1 %(w/v) raffinose. 
For plates 2% (w/v) agar was added. For drop-out media, CM was supplemented 
with 0.2% (w/v) of the appropriate drop-out powder. For X-gal plates, CM was 




Annealing buffer: 1 mM Tris pH 7.2; 1 mM EDTA. 
AP detection buffer: 100 mM NaCl; 50 mM MgC12 ; 100 mM Tris.HC1, pH 9.5. 
Boiling mix: 1 ml stacking gel buffer; 0.8 ml 25% (w/v) SDS; 0.5 ml
mercaptoethanol; 1 ml glycerol; 0.05% (w/v) bromophenol blue. 
1OxBU salts: 70 g Na2 HPO4 ; 30 g NaH2 PO4 ; per litre. 
Church buffer: 0.5 M NaPi (72 ml 1 M Na2 HPO4 ; 28 ml 1 M NaH 2PO4 ) ; 7 % 
(w/v) SDS; 1 mM EDTA. 
Denaturation solution: 0.5 M NaOH; 1.5 M NaCl. 
DNA extraction buffer: 0.1 M Tris.HC1, pH 9.0; 0.1 M EDTA, pH 8.0; 1 % 
(w/v) SDS) 
DNA loading buffer: 20% (w/v) glycerol; 100 mM EDTA; 0.1 % (w/v) bro-
mophenol blue. 
Hybridisation solution: 50% (v/v) deionised formamide; 5 x SSC; 100 jtg• m1' 
E. coli tRNA; 50 m1' heparin; 0.1% (w/v) Tween20; pH adjusted to 6.5 
with HC1. 
Injection buffer: 0.1 mM NaPi, pH 6.8; 5 mM KC1. 
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10xM0PS buffer: 41.86 g MOPS; 11 50 mM sodium acetate; 2 ml 0.5 M 
EDTA; adjusted to pH 7.0 with 10 N NaOH. 
Neutralisation solution: 1 M Tris, pH 7.5; 1.5 M NaCl. 
10xPBS: 80 g NaCl; 20 g KC1; 0.2 g Na 2HPO4 ; 20 g KH 2 PO4 ; per litre. 
Resolving gel buffer: 18.15 g Tris; 0.4 g SDS; per 100 ml, adjusted to pH 8.9 
with HC1. 
RNA extraction buffer: 4.7 g guanidinium thiocyanate; 0.333 ml 0.75 M 
sodium citrate, pH 7; 1 ml 10% (w/v) N-laurylsarcosine; 78 pl /3-mercaptoethanol 
added immediately before use; per 10 ml. 
RNA loading buffer: 50% (w/v) glycerol; 1 mM EDTA; 0.4 % (w/v) bro-
mophenol blue. 
RNA sample buffer: 10 ml formamide; 3.5 ml formaldehyde; 2 ml lox MOPS 
20xSSC: 175 g NaCl; 88 g tn-Na citrate; per litre. 
Stacking gel buffer: 5.1 g Tris; 0.4 g SDS; per 100 ml, adjusted to pH 6.7 with 
HC1. 
10xTBE: 108 g Tris; 55 g boric acid; 9.3 g EDTA; per litre. 
10xTBS: 60.5 g Tris; 87.6 g NaCl; per litre, adjusted to pH 7.5 with HC1. 
T.E.: 10 mM Tris; 50 mM EDTA. 
30 ml 1 M potassium aetate, pH 7.5; 12 g RbC1; 9.9 g MnC1 2 .4H2 0; 1.5g 
CaC1 2 .2H2 0; 150 ml glycerol; per litre, adjusted to pH 5.8 with acetic acid. 
20 ml 0.5 M MOPS pH 6.8; 1.2 g RbCl; 11 g CaC1 2 .2H2 0; 300 ml glycerol; 
per litre, adjusted to pH 6.8 with KOH. 
10xTGS: 30 g Tris; 144 g glycine; 10 g SDS; per litre. 
Transfer buffer: 47.5 g glycine; 10 g Tris; per 3 litres. 
Yeast extraction buffer: 2 % (w/v) TritonX-100; 1 % (w/v) SDS; 100 mM 
NaCl; 10 mM Tris.Cl pH 8.0; 1 mM EDTA pH 8.0. 
Wash solution: 0.1% (w/v) SDS; 0.2xSSC. 
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2.1.2.2 Radioisotopes 
a32 PdCTP (3000 Ci/mM) 
2.1.2.3 Suppliers 
Oligonucleotides : MWG-Biotech and Gibco. 
Enzymes: New England Biolabs, Roche and Promega. 
Nucleic acid purification kits : Stratagene and Qiagen. 
Chemicals: BDH and Sigma. 
Radioisotopes: Amersham. 
2.1.2.4 Bacterial strains 
Name Genotype Use [Referen] 
DH5a 080dlacZLM15, General cloning appli- Hanahan 
recAl, endAl, gyrA96, cations (1983) 
thi-1, 	hsdR17, 	(ri, 
MK , 	supE44, 	relAl, 
deoR, L(lacZYA- 
_________________ argF) Ui 69  
MC1066 galU, 	galK, 	strA', Rescue 	of 	pJG4-5 P. Legrain, 
leuB6, trpC-9830, from yeast plas- Institut 
pyrF7:: Tn5(KnT)hsdr  ,mid 	preparations 	in Pasteur 
LacIPOZYA)74 two-hybridscreen  
BL21(DE3)pLysS F-, 	ompT, 	hsdS, Expression of recom- Studier 
(ri, 	mi), 	dcm, 	gal, binant proteins et 	al. 
)(DE3),pLysS(Cmr)  (1990) 
Table 2.1: 
2.1.2.5 Yeast strains 
Name I Genotype 	 I Use 	 I Reference 
EGY48 MA Ta, 	his8, 	trpi, Strain used for yeast Gyuris et al. (1993) 
'araS, 6LexA op-LE Us). 
I 




Name Description Use Reference 
pSPT18/19 pUC 18/19 derivatives Production 	of 	DIG- Roche catalogue 
with 	polylinkers 	in labelled RNA probes 
opposite orientations, 
flanked 	by 	T7 	and 
SP6 promoters  
pGEM-T Cloning 	vector 	with Cloning of PCR prod- Promega catalogue 
single 'T' overhangs ucts 
pET15b Polylinker flanked by Expression 	of 	C- Novagen catalogue 
T7 promoter and six- terminally-tagged 
histidine tag recombinant 	protein 
in E. coli  
pEG202 Yeast 	plasmid 	with Expression 	of 	LexA Gyuris et al. (1993) 
LexA coding se- fusion protein as bait 
quence downstream of in 	yeast 	two-hybrid 
polylinker system  
p18-34 Yeast plasmid carry- Screening 	for 	lacZ Gyuris et al. (1993) 
ing lacZ reporter gene transcriptional activa- 
with 	LexA 	binding tion due to bait-prey 
sites near promoter interactions 	in 	yeast 
two-hybrid screen  
pJK101 Yeast plasmid carry- Testing 	two-hybrid Gyuris et al. (1993) 
ing lacZ reporter gene bait protein 	for 
with strong promoter translocation 	to 	nu- 
repressible by LexA cleus and binding to 
LexA operators  
pJG4-5 Yeast 	plasmid 	with Expression 	of 	tran- Gyuris et al. (1993) 
polylinker flanked by scriptional activator 
GALl promoter and fusion proteins as prey 
acidic 	transcriptional in 	yeast 	two-hybrid 
activation 	domain screen 
coding sequence  
Table 2.3: 
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2.1.2.7 Drosophila stocks 
[Name Genotype Use Reference 
Oregon R53 Wildtype Embryo collection for Lindsley 	and 
expression analysis Gre!! (1968) 
Lgc1 yw; rev3901CyO; cmp4E, Obtaining 	embryos T. Jongens  
rescue (w)/+=/.gcl-51 lacking germ cells  
2535 w1118 ; ry506 , Sb', P[ry12- Source of P element A.Jarman 
3]1 TM6, Ubx transposase in muta- 
____________ _______________________ genesis  
P1329 cn1 , Carries P element in- Bloomington 
P[ry+t72 =PZ]Uba103405/ sertion in Dubal Stock Center 
Cy O; ry506  
P1558 P[ry+t72 =PZ]1(3)00220, Source of P element in Bloomington 
ry506/ 	TM3, 	ryRI, 	Sb', UbcD4 mutagenesis Stock Center 
Ser'  
233 w1lS; Sco / CYO Used in excision of P A. Jarman 
element from P1329  
232 w" 8 ; Dr'0/TM3,  ry, 5cr Used in UbcD4 muta- A. Jarman 
genesis crosses 
CyO-30 w' 118 ; 	 Pin/CyO, Source of GFP bal- Casso 	et 	al. 
p[w+mc=GAL4 ancer used to identify (2000) 
Kr. c]Dc4, P[W+mC=UAS 1(2)0305 	homozy- 
__________ GFP. S65 T]D C8 gotes  
Table 2.4: For explanation of gene symbols see Lindsley and Zimm (1992). 
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2.1.2.8 Oligonucleotides 
Name Sequence Comments 
DUBA1-1 GAA 	AACTGAAT- corresponds to positions 4189-4207 in the 
GAGCCAGG Thibal cDNA '+' strand 
DUBAI-2 GAA GTC AAT TTC corresponds 	to 	positions 	107-124 	on 	the 
CCG TGG Dubal cDNA '— strand 
DUBAI-3 TCT GAG TCG TTC corresponds to positions 85-104 on the Dubal 
GAG GAG '—' strand 
6067 GGG TGA TTA AAA corresponds to positions 1432-1452 on the 
GGA TGG CG Dubal '—' strand 
Y4104 GGG GGG TTG ACA corresponds 	to 	positions 453-471 	on 	the 
TTT GGG Dubal '+' strand 
D4.B1 GAA TTG 	ATG forward primer used to amplify the UbcD4 
GCG 	AAG ATG coding sequence for cloning into yeast two- 
GGA G hybrid bait vector and E. coli expression vec- 
tor 
D4.132 GGA TGG TAA GTG reverse primer used as for D4.B1 
AAG AGG GGG  
E2p1 ATG GGG GGT GGG corresponds to positions 295 to 318 on the 
CCT GAG GAG GGG UbcD4 cDNA +' strand 
E2p5 TAG GGG ACC ACT corresponds to positions 563 to 546 on the 
GGG TGG UbcD4 cDNA '—' strand 
P31 GGA GGG GAG GAG corresponds to 31 bp inverted repeats of P 
GTT ATG TTA TTT element 
CAT GATG  
LEX1 GGT GAG GAG AGG 40 bp upstream of EcoRI site in pEG202 
TTG ACC ATT G polylinker; used for sequencing two-hybrid 
bait 
BGO1 GGA GGG TGT TGG 70 bp downstream of EcoRI site in pJG4- 
TGA GTG GAG ATG 5 polylinker; used for sequencing two-hybrid 
prey 
BG02 GAG AAG GGG ACA 40 bp upstream of XhoI site in pJG4-5 
ACC TTG ATT GGA polylinker; used for sequencing two-hybrid 
G prey 
T7 GTA ATA GGA GTG T7 promoter sequencing primer  
ACT ATA GGG G  
M13 rev GGA AAG AGG TAT M13 reverse sequencing primer 
GAG GAT G  
Table 2.5: All oligonucleotides are shown in 51  - 3 orientation. Restriction enzyme 
sites are underlined: BamHI = GGATGG ; EcoRI = GAATTC. 
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2.2 Methods 
2.2.1 Manipulation of bacteria 
2.2.1.1 Growth of E. coli bacterial cultures 
L-broth, with antibiotic if necessary, was inoculated with a single colony using a 
sterile metal loop. Cells were shaken at 37 °C for an appropriate length of time. 
5 ml cultures were grown in 2 oz glass bottles and larger cultures were grown in 
conical flasks with a maximum volume 5-10 times greater than that of the culture. 
2.2.1.2 Storage of E. coli bacterial cultures 
Bacteria were stored as liquid overnight cultures or on L-agar plates, with appro-
priate antiobiotics, at 4 °C for up to 6 weeks. For long-term storage, 0.8 ml of 
overnight culture was mixed with glycerol in sterile vials, snap-frozen in dry ice 
or liquid nitrogen and stored at -70 ° C. Bacteria were recovered by thawing vials 
and streaking cells onto appropriate agar plates. 
2.2.1.3 Preparation of competent E. coli cells 
A 5 ml overnight culture of E. coli was grown from a single colony. 1 ml was then 
used to inoculate 20 ml of L-broth and the culture was grown at 37 °C, shaking, 
for approximately 90 minutes, until it reached an O.D. 600 of 0.3-0.5. Cells were 
pelleted by centrifugation at 5,000 rpm for 10 minutes in a cold Sorvall centrifuge. 
The pellet was resuspended in 10 ml of cold TFB1. After a 30 minute incubation 
on ice, cells were pelleted as before and resuspended in 2 ml cold TFB2. The 
suspension was aliquotted into microfuge tubes, snap-frozen on dry ice and stored 
at -70° C. 
2.2.1.4 Transformation of plasmid DNA into competent cells 
100 pl of competent cells were used per transformation. The cells were thawed 
slowly on ice and mixed with half a ligation reaction, or 0.1 - 10 ng of plasmid 
DNA. The cells were incubated on ice for 30 minutes, heat-shocked in a 42 ° C water 
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bath for 60-90 seconds and chilled on ice for 2 minutes. 0.9 ml of Soc medium 
was added and the cells were shaken gently at 37 °C for 45 mm - 1 hour. 150 - 
200 til of the transformation reaction was spread on an L-agar plate containing 
appropriate antibiotics. 
2.2.1.5 Preparation of electrocompetent E. coli cells 
500 i1 of a 5m1 overnight culture was used to inoculate 50 ml of L-broth and the 
culture was grown to an O.D. 600 of approximately 0.5. The cells were pelleted by 
centrifugation at 5000 rpm for 10 min at 4°C and resuspended in 50 ml ice-cold 
distilled water. This wash was repeated twice more before finally resuspending 
the cells in 1 ml ice-cold water. 
2.2.1.6 Electroporation of DNA into competent cells 
50 ul electro competent E. coli cells was mixed with 2 ul of a ligation reaction 
on ice. The mixture was transferred to a 0.2 cm electroporation cuvette and 
electroporated at 25 jtF; 2.5 kV; 200 ft 1 ml of SOC medium was added and the 
cells were transferred to a microfuge tube and incubated at 37 ° C for 45 - 60 mm 
with gentle shaking. 200 t1 cells were spread on L-agar plates with appropriate 
antibiotics. 
2.2.1.7 Small scale preparation of plasmid DNA 
A single bacterial colony was inoculated into 5 ml of L-broth with antibiotic and 
grown for 14-16 hours at 37°C with shaking. 1.5 ml of the culture was decanted 
into a microfuge tube and spun down for 30 seconds in a microfuge. Plasmid DNA 
was isolated using the StrataPrep Plasmid Miniprep kit (Stratagene) according to 
the manufacturers' instructions. The method involved alkaline lysis of the cells 
followed by binding of DNA to a silica-based fibre matrix in a microspin cup. 
Impurities were removed using a wash buffer. DNA was eluted in 10 mM Tris pH 
8.5. 
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2.2.1.8 Large scale preparation of plasmid DNA 
A single bacterial colony was inoculated into 5 ml L-broth with antibiotic and 
grown for 8 hours at 37 ° C with shaking. 50 Ml was used to inoculate a 25 ml culture 
which was grown overnight. Plasmid DNA was isolated using the Qiagen Plasmid 
Midi Kit according to manufacturer's instructions. The method involves alkaline 
lysis of cells followed by binding of plasmid DNA to anion-exchange resin under 
low-salt and pH conditions. Impurities were removed by a medium-salt wash. 
Plasmid DNA was eluted in a high-salt buffer and concentrated and desalted by 
isopropanol precipitation. 
2.2.2 Manipulation of yeast 
2.2.2.1 Growth and storage of yeast cultures 
For liquid cultures, 5-20 ml YPDA or the appropriate dropout medium was in-
oculated with a single colony and incubated with shaking at 30 ° C overnight. For 
plate cultures, appropriate plates were streaked with a single colony and incu-
bated at 30 ° C for 2-3 days until colonies formed. Yeast were stored on plates or 
as liquid cultures for 6-8 weeks. 
2.2.2.2 Transformation of yeast with plasmid DNA 
A 20 ml overnight culture of yeast was grown in the appropriate medium. The 
culture was diluted into 300 ml medium to an O.D. 600 of 0.1 (corresponding to 
2 x 106  cells/ml). The culture was grown until the O.D. 600 reached 0.5, then 
centrifuged at 2000xg for 5 mm. The pellet was resuspended in 20 ml sterile 
distilled water. This step and all the following manipulations were carried out at 
room temperature unles otherwise stated. The cells were centrifuged at 2000xg 
for 5 mill and resuspended in 5 ml LiOAc/T.E. (10 mM Tris HC1 pH 7.5, 1 mM 
EDTA, 100 mM lithium acetate). They were pelleted as before and resuspended 
in 2 ml LiOAc/T.E.. 50 Ml competent cells were used in each transformation. The 
cells were mixed with plasmid DNA (0.1-2 pg) and carrier DNA (50 Mg salmon 
sperm DNA, boiled for 10 min before use). DMSO was added to 10 % (v/v). 300 
l of PEG solution (40% (w/v) PEG 4000 , 10 mM Tris HC1 pH 7.5, 1 mM EDTA, 
100 mM LiOAc) was added and the tubes were inverted several times to mix the 
contents. After a 30 min incubation at 30 ° C, the cells were heatshocked in a 42 ° C 
water bath for 15 mm. They were then placed in a room temperature water bath 
and 200 l of the reaction was plated on the appropriate medium. 
2.2.2.3 Collection of primary transformant cells 
Plates containing transformant colonies were cooled at 4 ° C. Yeast was scraped 
off the plate using a glass microscope slide, and placed in a 50 ml centrifuge 
tube. The cells were washed twice in an equal volume of T.E., pelleting them 
by centrifugation at 1500xg for 5 mm. The pellet was resuspended in an equal 
volume of glycerol, aliquoted and stored at -70 ° C. 
2.2.2.4 Calculation of replating efficiency 
Replating efficiency was calculated by thawing yeast, diluting 1/10 in Gal/Raff/CM 
-Ura -His -Trp medium and incubating at 30 °C for 4 hours. Serial dilutions of 
yeast were plated on Gal/Raff/CM- Ura -His -Trp dropout plates and incubated 
for 2-3 days until colonies formed. The colonies were counted and the number of 
colony-forming units (cfu) per ml of transformed yeast was determined. 
2.2.2.5 Screening of transformant cells for bait-prey interaction 
107 cells were thawed, incubated in Gal/Raff/CM -Ura -His -Trp as described 
above and plated on a total of 20 Gal/Raff/CM -Ura -His -Trp -Leu plates con-
taining X-gal. The plates were incubated at 30 °C for 3-4 days until colonies ap-
peared. Blue colonies were streaked onto fresh Gal/Raff/CM -Ura -His -Trp plates 
and incubated at 30 °C for 3-4 days. Cells were restreaked onto Glu/CM -Ura -His 
-Trp plates and grown overnight. Cells were then streaked onto Glu/Xgal/CM 
-Ura -His -Trp, Gal/Raff/Xgal/CM -Ura -His- Trp, Glu/CM -Ura -His -Trp -Leu 
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and Gal/Raff/CM -Ura -His -Trp -Leu plates and incubated at 30 ° C for 3 days. 
Colonies which grew on Gal/Raff/CM -Ura -His -Trp -Leu but not on Glu/CM 
-Ura -His -Trp -Leu, and which appeared blue on Gal/Raff/Xgal/CM -Ura -His 
-Trp -Leu but not on Glu/Xgal/CM -Ura -His -Trp, were chosen for further anal-
ysis. 
2.2.2.6 Small scale preparation of plasmid yeast DNA 
2 ml Glu/CM -Trp medium was inoculated with a single yeast colony and in-
cubated at 30 °C overnight with shaking. The yeast was pelleted for 10 sec in a 
microfuge and the pellet was resuspended in 200 MI yeast extraction buffer. 200 il 
glass beads and 200 MI phenol/chloroform were added before vortexing for 5 mm 
and spinning for 5 mm. 160 tl of the aqueous phase was transferred to a clean 
eppendorf. 500 bid ethanol and 80 p1 7.5 M ammonium actetate was added and the 
tubes were incubated at -20 ° C for 30 min before being spun in a cold microfuge 
for 10 mm. The pellet was washed in 70% ethanol, air-dried and resuspended in 
10 p1 T.E.. 
2.2.2.7 Extraction of yeast proteins for immunoblot analysis 
5 ml Glu/CM -Ura -His was inoculated with a single colony, incubated overnight 
at 30°C with shaking and used to inoculate a fresh 5 ml culture to O.D. 600 =0.15. 
This was shaken at 30 ° C until the 0.13. 600 reached 0.45 to 0.7. 1.5 ml of the 
culture was pelleted for 3 min in a microcentrifuge and resuspended in 50 Al of 
boiling mix. The suspension was snap-frozen on dry ice and boiled for 5 mill. 
Large cellular debris was pelleted for 5 seconds. SDS-PAGE was performed on 
20-50 ttl supernatant. 
61 
2.2.3 Manipulation of Drosophila 
2.2.3.1 Culture of Drosophila melanogaster 
Flies were kept on Dundee food in vials or bottles at 25°C. Adults were allowed to 
lay eggs for 3-4 days before being removed. Progeny were placed onto new vials 
after another 10-11 days. Virgin females were obtained by collecting progeny 
every 4 hours at 25 ° C during the day. Vials were then stored at 18 ° C overnight 
so that virgins could be obtained the following morning. 
2.2.3.2 Collection of Drosophila developmental stages 
Embryos were collected on grape juice agar plates, spread with yeast, placed at 
the bottom of fly cages. The embryos were washed into a nylon mesh using a 
paintbrush and distilled water. Larvae were obtained by allowing eggs laid on a 
grape juice agar plate to hatch. Pupae and third instar 'wandering' larvae were 
collected from the sides of bottles using a paintbrush. 
2.2.3.3 Preparation of embryos for in situ hybridisation and immunos-
taming 
Embryos were dechorionated by shaking in 50% bleach in a nylon sieve for 2 mm. 
After thorough washing in tap water they were transferred to a glass bottle con-
taining 10 ml 3.7% formaldehyde in PBS and 10 ml heptane. The embryos were 
fixed for 15-20 mins at the formaldehyde/heptane interface with gentle agitation. 
The heptane and half the formaldehyde was removed and the bottle was filled 
with methanol. The embryos were shaken vigorously for 1 min in order to re-
move the vitelline membrane. Devitellinised embryos sank to the bottom of the 
tube and were collected using a plastic Pasteur pipette. They were placed into 
microfuge tubes, rinsed 3-4 times with methanol and stored in methanol at -20 ° C. 
2.2.3.4 Injection of embryos with double-stranded RNA 
Embryos were collected for one hour and dechorionated as described previously. 
Thirty embryos were placed onto a strip of double-sided sticky tape on a glass 
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coverslip. The coverslip was placed in a petri dish containing dried silica gel for 
5-10 minutes, to desiccate the embryos. The embryos were covered with series 
700 halocarbon oil (KMZ chemicals) and injected with approximately 100 - 300 p 1 
double-stranded RNA in injection buffer. Injections were performed using a fine 
glass capillary (Eppendorf Sterile Femtotip) and a transjector 5246 (Eppendorf). 
2.2.3.5 Preparation of Drosophila genomic DNA 
10 adult flies were placed into a microfuge tube and frozen at -70 °C for 5 mm. 
The flies were homogenised in 200 il of DNA extraction buffer for 3-5 mm. They 
were incubated at 70 ° C for 30 mm. 28 l of 8M potassium actetate was added 
and the tubes were incubated on ice for 30 mm. They were centrifuged in a 
cold microcentrifuge for 15 mm. The supernatant was decanted into a fresh tube 
and the step was repeated to obtain a clear supernatant. 100 pl isopropanol was 
added and the DNA was allowed to precipitate for 10 min at -70 °C. After a 5 mm 
centrifugation, the pellet was washed in 70 % ethanol, air-dried and dissolved in 
20 t.tl T.E.. 
2.2.4 DNA manipulation and detection 
2.2.4.1 Digestion of DNA with restriction endonucleases 
0.1-10 /,tg of DNA was incubated with 0.5 tl of each appropriate enzyme in the 
appropriate buffer for 1-12 hr at 37 °C. For genomic DNA digests, the reaction was 
stirred with a glass rod and stored for an hour on ice prior to addition of enzyme. 
After 3 hours of digestion, another 0.5 il of enzyme was added, the reaction was 
stirred again and allowed to proceed overnight. 
2.2.4.2 Agarose gel electrophoresis of DNA 
Agarose gels were made by dissolving agarose in 1 x TBE buffer to a concentration 
of 0.8-1.2 % (w/v), and adding 0.5 Mg - m1' ethidium bromide. DNA samples 
were mixed with 0.1 volume DNA sample buffer. Hindlil - digested .A DNA or 
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HaeII - digested qX174 DNA (New England Biolabs) was used as a size marker. 
Electrophoresis was carried out horizontally at approximately 10 v/cm. DNA was 
visualised by UV transillumination. 
2.2.4.3 Recovery of DNA from agarose gels 
After electrophoresis, the gel slice containing the desired DNA band was cut 
out. The DNA was extracted using the Qiagen Gel Extraction Kit following 
manufacturers' instructions. The method involves dissolving the agarose, binding 
the DNA to an anion-exchange resin in a microspin cup under low salt conditions, 
removing impurities in a medium-salt wash and eluting DNA in a high-salt wash. 
2.2.4.4 Ligation of cohesive termini 
Vector and insert DNA were digested with restriction enzymes to yield compatible 
overhanging ends. The DNAs were ligated at a vector:insert molar ratio of 1:1 - 
1:10 in a 10 pl reaction using T4 DNA ligase (New England Biolabs) and ligase 
buffer. Ligation was carried out overnight at 16 °C. 
2.2.4.5 Southern blotting 
After electrophoresis, the agarose gel was soaked in denaturing solution for 30 mm, 
followed by incubation in two changes of neutralisation solution, for 25 min each 
time. The gel was then placed on a perspex support covered in a wick of blotting 
paper which was soaked in 10 x SSC. The gel was surrounded by Paraflim and 
covered with a nylon membrane, 3 sheets of 10 x SSC-soaked Whatman 3MM 
paper, two inches of paper towels and a weight such as a bottle. The transfer was 
allowed to proceed overnight before the membrane was rinsed in 2 x SSC and 
cross-linked in a Stratalinker. 
2.2.4.6 Random primed radioactive labelling of DNA 
DNA was labelled with a32 P-dCTP using the T7 Quickprime kit (Amersham) 
following manufacturers instructions. Briefly, approximately 50 ng of linear DNA 
was mixed with random hexanucleotide primers and boiled for 5 min before adding 
50 ILCi a32P-dCTP, 10 /Ll labelling mix (provided in kit) and 2 tl Kienow DNA 
polymerase. The reaction was incubated at 37 °C for 20 mm. Unincorporated 
nucleotides were removed using NucTrap push columns (Stratagene) following 
manufacturers instructions. 
2.2.4.7 Hybridisation of radioactively labelled DNA probes to nucleic 
acid immobilised on nylon membranes 
Nylon membranes, with bound nucleic acid, were immersed briefly in 2 x SSC and 
placed in Techme hybridisation cylinders, in a hybridisation oven prewarmed to 
65 ° C, containing 20 ml of prewarmed Church buffer. Prehybridisation was carried 
out for 1-2 hours. The radiolabelled DNA probe was boiled for 5 min and added 
to the cylinder. Hybridisation was carried out at 65 ° C overnight. Membranes 
were washed twice for 20 minutes each in wash solution before being wrapped in 
Saran wrap, placed in an autoradiographic cassette and exposed to X-ray film at 
-70°C for 4 hours - 1 week. The film was developed in an automatic X-ray film 
processor. Alternatively, the membrane was exposed to a Phosphorlmager screen 
for 4 hours or overnight. The signal was detected by scanning the screen in a 
Phosphorlmager. 
2.2.4.8 Polymerase chain reaction (PCR) 
50 tl PCR reactions were set up using 1 x Taq buffer (Promega), 1.5 mM MgC1 2 , 
50 pmol each primer, 20 nmol dNTPs, and 0.5 il Taq polymerase (Promega). The 
template was either 50 pg plasmid DNA, 10 ng genomic DNA or a few bacterial 
cells from a colony. Reactions were carried out in a Hybaid OmniGene thermal 
cycler. A typical PCR programme consisted of 25 - 30 cycles, with each cycle 
consisting of a denaturation step ( 94 °C for 1 mm), an annealing step (55 ° C-
65 ° C for 30 mm) and an extension step (72 ° C for 1 - 3 mm). For genomic DNA 
templates, an initial denaturation period of 5 min at 94 °C was included. PCR 
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products were purified, if necessary, using PCR purification columns (Qiagen) 
following manufacturers' instructions. 
2.2.4.9 Cloning of PCR products 
PCR products were cloned using the pGEM-T cloning kit (Promega) following 
manufacturer's instructions. 3 ul PCR product was mixed with 1 jtl pGEM-
T cloning vector, 5 tl ligation buffer and 1 fLI T4 DNA ligase. The reactions 
were incubated at room temperature for one hour. If a proofreading polymerase 
had been used for PCR, 'A' overhangs were added before ligation, by incubating 
purified PCR product with 2 mM dATP, 1 x Taq buffer and 1 1 Taq, for 20 mm 
at 72°C. 
2.2.4.10 DNA sequencing 
Automated DNA sequencing reactions were carried out using the dRhodamine 
sequencing kit (Perkin-Elmer) following manufacturer's instructions. Approxi-
mately 100 ng plasmid DNA was mixed with 5 pmol primer and 4 ILI reaction 
mix. The reaction was incubated in a thermal cycler with the following pro-
gramme : 1 cycle of 96 °C for 10 sec; 25 cycles of 96 ° C for 10 sec, 50 ° C for 15 
sec and 60 ° C for 4 mm; one cycle of 60 °C for 4 mm. Sequencing products were 
precipitated by adding 2 jil 3M sodium acetate, pH 5.2, and 50 il 95 % ethanol, 
and pelleted at in a cold microfuge for 15 - 30 mm. The pellets were washed in 
70 % ethanol and air-dried. 
2.2.5 RNA manipulation and detection 
2.2.5.1 Preparation of total RNA 
50-100 mg of tissue was homogenised in 0.5 ml RNA extraction buffer on ice. 
50 pl 2M sodium actetate, pH 4.0, was added, followed by 0.5 ml phenol, pH 
6.7, and 0.1 ml of 49:1 chloroform/isoamyl alcohol. The tubes were vortexed and 
incubated for 15 min on ice. After centrifugation at 4°C for 20 mm, the upper 
layer was removed to a clean tube and an equal volume of isopropanol was added. 
The tubes were incubated at -20°C for 30 min and spun for 10 min at 4 °C. The 
pellet was resuspended in 0.15 ml RNA extraction buffer. An equal volume of 
isopropanol was added and the tubes were again incubated at -20 °C for 30 mm 
and spun at 4 °C for 10 mm. The pellet was resuspended in 1 ml 75 % ethanol 
and incubated at room temperature for 10 mm. After a 10 min centrifugation 
the supernatant was discarded and the pellet airdried and resuspended in 50 Al 
10 mM Tris pH 8.0. The RNA content and purity was calculated by measuring 
the O.D. 260 and O.D. 280 of the samples. 
2.2.5.2 Gel electrophoresis of RNA 
To prepare a formaldehyde gel, 1.3 g agarose was dissolved in 109 ml 1 x MOPS 
buffer. The solution was cooled and 21 ml 37 % formaldehyde was added before 
pouring. Prior to loading the samples, the gel was pre-run at 50 volts for 10 mm. 
The appropriate amount of RNA, in a volume of 12 it1,  was added to 38 tl RNA 
sample buffer and heated to 65 °C for 15 mm. The samples were spun briefly and 
chilled on ice before addition of 4 ttl RNA loading buffer. Electrophoresis was 
across a potential difference of 50 volts. The gel was stained in 50 pg - m1 1 
ethidium bromide for 30 mm, and destained in distilled water for several hours. 
RNA was visualised by U.V. transillumination. The ethidium bromide staining 
was omitted if Northern blotting was to be carried out. 
2.2.5.3 Northern blotting 
After electrophoresis, RNA gels were washed in a large excess of distilled water 
for one hour, then blotted as for Southern blots (section 2.2.4.5). 
2.2.5.4 Preparation of DIG-labelled RNA probes 
cDNAs were inserted into cloning vectors pSPT18 and pSPT19, which have mul- 
tiple cloning sites in opposite orientations with respect to their T7 and SP6 pro- 
67 
moters. DIG-labelled RNA probes were produced using the DIG-RNA labelling 
kit (Roche) according to manufacturers instructions. Briefly, 1 pg of plasmid 
DNA was linearised and used in a 20 pun vitro transcription reaction with either 
T7 or SP6 polymerase and rNTPS including DIG-labelled rCTP. For each gene 
to be analysed, both sense and antisense RNAs were produced. After two hours 
the template DNA was removed by digestion with DNAse. 2.5 Ml of 4 M LiC1 
and 75pl  of ethanol was added and the RNA was allowed to precipitate at -20 °C 
overnight. It was then pelleted in a microcentrifuge for 15 mm, washed in 70 
% ethanol, airdried, resuspended in 20 pl T.E. with 1 p1 RNAsin, aliquoted and 
stored at -70 °C. 2 p1 of probe was subjected to formaldehyde gel electrophoresis. 
DIG-labelling of the probe was verified by spotting serial dilutions onto nylon 
membrane, probing with anti-DIG conjugated to alkaline phosphatase (AP) and 
incubating the membrane in the AP substrates nitroblue tetrazolium (NBT) and 
5-bromo-4-chloro-3-indolyl-phosphate (BCIP). 
2.2.5.5 RNA in situ hybridisation on wholemount embryos 
The method used is a modified version of that described by Tautz and Pfeifle 
(1989). Briefly, embryos prepared as described in section 2.2.3.3 were rehydrated 
in PTW (PBS with 0.1% Tween20) and postfixed for 15 min in 3.7% formaldehyde 
in PTW. The embryos were washed 5 times for 5 min each in PTW, then for 10 
min in 50% PTW; 50% hybridisation solution, then for 10 min in hybridisation 
solution. Prehybridisation was carried out in hybridisation solution at 70 ° C for 1-2 
hours in a water bath. Hybridisation was carried out overnight at 70 ° C in a water 
bath, using approximately 0.5 Mg . m1' probe in hybridisation solution. Embryos 
were washed once in hybridisation solution, once in 50% hybridisation solution, 
50% PTW and four times in PTW. All washes were at 70 °C with no agitation. 
The anti-DIG alkaline phosphatase-conjugated antibody (Roche), which had been 
preadsorbed by incubation overnight at 4 °C with fixed and rehydrated embryos, 
was diluted 1 in 2000 in PTW and incubated with the probed embryos for 1-2 
hours at room temperature on a rolling wheel. The embryos were washed 3 times 
for 20 min each in PTW. They were then rinsed in AP detection solution for 2 
mill. 45 MI NBT and 35 ul BCIP were added to 1 ml AP detection solution and 
the embryos were incubated in this substrate mixture for several hours - overnight 
at room temperature. They were then washed several times in PTW, incubated 
for 2 hours in 50% glycerol, 50% PTW, and mounted upon a glass microscope 
slide in 80% glycerol, 20% PTW. 
2.2.5.6 Production of double-stranded RNA 
Single-stranded RNA was produced from both the sense and antisense strands 
of cDNA as for section 2.2.5.4, except that the rNTPs were used were not DIG-
labelled. After removal of the template using DNase I, the RNA was extracted 
with an equal volume phenol /chloroform/isoamyl alcohol (25:24:1). After vortex-
ing and 2 min centrifugation, the aqueous phase was removed to a new microfuge 
tube and an equal volume chloroform/isoamyl alcohol (25:1) was added. The 
tubes were vortexed and spun as before and the aqueous phase placed in a new 
tube. 0.5 x volume 7.5 M ammonium acetate and 2.5 x volume ethanol was 
added and the tubes were incubated at -70 °C for 1 hour. The RNA was pelleted 
by 10 min centrifugation in a microfuge, washed in 70 % ethanol, air-dried and 
resuspended in 5 til annealing buffer. The single-stranded RNA was quantitated 
by U.V. spectrophotometry. Equimolar amounts of each strand were mixed to 
a final concentration of 0.45 mM in annealing buffer. 12 /11 aliquots of the mix-
ture were boiled for 1 min and left at room temperature for 18 hours to allow 
annealing of the strands. 6 - 10 Mg of the mixture was used for native agarose gel 
electrophoresis to verify that most of the RNA was in the double-stranded form. 
The double-stranded RNA was stored as a sodium actetate/ethanol precipitate 
at - 80 °C until immediately before use. 
2.2.5.7 Reverse transcription of total RNA 
20 pl reverse transcription reactions were set up using 2 jtg total RNA, 4 ,al reverse 
transcriptase buffer (Promega), 2 pl dNTPs (10 mM each), 12.5 pmol primer, and 
AMV reverse transcriptase (Promega). The reactions were incubated at 55 ° C for 
one hour, then at 65 ° C for 10 mm. 
2.2.6 Protein manipulation and detection 
2.2.6.1 Expression of proteins in E. coli. 
Plasmids encoding tagged recombinant proteins under the control of a T7 pro-
moter, were transformed into the BL21(DE3)pLysS strain of E. coli. A single 
colony was used to inoculate 100 ml L-broth with appropriate antibiotics and 
the culture was shaken at 80 rpm at 30 °C overnight. 10 ml of this culture was 
used to inoculate 1 L L-broth with antibiotics and this culture was grown at 
37° C with vigorous shaking, to an O.D. 600 of approximately 0.5. 2 ml of 0.5 M 
IPTG was added and the culture was shaken for an additional 3 hours at 37 °C. 
The cells were pelleted at 10,000 rpm for 20 minutes and stored at - 20 ° C. The 
pellet was resuspended in 10 ml Binding Buffer (5 mM imidazole, 0.5 M NaCl, 
20 mM Tris.Cl pH 7.9) and the cells were sonicated on ice in three bursts of 45 
seconds each. The lysate was centrifuged at 12,500 rpm for 30 min to pellet in-
soluble proteins. Recombinant proteins containing a 6 x His tag were purified by 
nickel affinity chromatography using His-Bind resin (Novagen) according to man-
ufacturers' instruction. Briefly, the soluble protein extract was passed through a 
charged 2 ml His-Bind column at 4 °C under gravity flow. The column was washed 
with Binding Buffer followed by Wash Buffer (60 mM imidazole, 0.5 M NaCl, 20 
mM Tris.Cl pH 7.9) to remove bacterial proteins. The recombinant protein was 
eluted in Elute Buffer (1 M imidazole, 0.5 M NaCl, 20 mM Tris.Cl pH 7.9). 
Fractions were analysed by SDS-PAGE. The recombinant protein was dialysed 
into PBS and concentrated to 1 mg . m1 1 using Vivaspin columns according to 
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manufacturers' instructions. 
2.2.6.2 Extraction of proteins from Drosophila embryos. 
Embryos were homogenised in Boiling Mix. Samples were boiled for 10 min before 
loading on an acrylamide gel. 10 pg- 100 jig was loaded per well for Western 
blot analysis. 
2.2.6.3 Separation of proteins by SDS-PAGE 
A 15% acrylamide resolving gel was prepared from 2.8 ml distilled water, 2.4 
ml resolving gel buffer, and 4.8 ml 30% acrylamide. 30i1 25% ammonium per-
sulphate and 3 p1 TEMED was added to catalyse polymerisation. The stacking 
gel, prepared from 2.8 ml distilled water, 1.2 ml stacking gel buffer, 0.8 ml 30% 
acrylamide, 30 pl 25 % ammonium persuiphate and 3 p1 TEMED, was poured 
on top of this. Protein samples were mixed with an appropriate volume of 6 x 
boiling mix and boiled for 2 min before loading on the gel. Electrophoresis was 
carried out at 200 volts in 1 x TGS buffer. 
2.2.6.4 Western blotting 
Following SDS-PAGE, proteins were transferred to polyvinylidene difluoride (PVDF) 
membrane (Roche) in transfer buffer. Transfer was carried out in an electroblot-
ter at 200 V for 90 min at 4 °C. Detection was carried out using the Chemilumi-
nescence Western Blotting Kit (Roche). Briefly, membranes were incubated in 
blocking solution (provided in kit) for 2 hours at room temperature with agita-
tion. Primary antibody was diluted to an appropriate concentration in blocking 
solution and incubated with the membranes overnight at 4 °C with no agitation. 
Membranes were washed twice in 1 x TBS, and twice in 0.5 x blocking solu-
tion, for 15 min each. HRP-conjugated secondary antibodies were added, diluted 
1 in 2000-5000 in 0.5 x blocking solution, and incubated for 1 hour at room 
temperature. The membranes were washed four times for 15 min in 1 x TBS. 
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The chemiluminescent HRP substrate was added and the membranes exposed to 
X-ray film for 1-30 mill. 
2.2.6.5 Dot blots 
Protein was applied directly to strips of PVDF membrane in spots of 1 pl. De-
tection was carried out as for Western blots. 
2.2.6.6 Affinity purification of antibodies 
20 pg recombinant protein was electrophoresed in each lane of an SDS-PAGE 
gel and transferred to nitrocellulose. The filter was blocked for one hour at room 
temperature, then the lanes at each end of the filter were cut off and probed 
with antiserum, washed and probed with HRP-conjugated secondary antibody 
as described in section 2.2.6.4. The bands were detected on the filter using 3-
3' diaminobenzidine (DAB) as a HRP substrate. These were used as guidance 
markers to cut out slices containing the band of interest from the rest of the 
filter. The slices were incubated with a 1 in 10 dilution of antiserum overnight 
at 4°C. Unbound antibodies were removed by washing 3 times for 15 minutes in 
PBS. Bound antibodies were eluted by incubating filter slices in 180 Al 100 mM 
glycine, pH 2.5 for 10 mm. The antibody solution was then neutralised by adding 
20 t1 1 M Tris pH 8.2. 
2.2.6.7 Immunostaining of whole embryos 
Embryos prepared as described in section 2.2.3.3 were rehydrated in PTW. Tm-
munostaining was carried out using the ABC Vectastain kit (Vector Laboratories) 
following manufacturers' instructions. Briefly, embryos were blocked by incubat-
ing in 5% normal horse serum for 2 hours at room temperature, then incubated 
overnight at 4 °C with the appropriate concentration of primary antibody. Af-
ter washing 4 times for 15 minutes in PBST (PBS with 0.03% TritonX-100), 
the embryos were incubated with a prediluted biotinylated secondary antibody, 
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then washed and incubated with a streptavidin-HRP conjugate. After washing, 
the embryos were incubated in 3,3'-diaminobenzidine (DAB) until a signal was 
detected. 
2.2.7 Computer methods 
2.2.7.1 Database queries 
DNA and protein sequences were retrieved from GenBank using the Entrez search 
engine (http: //www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed) . Drosophila 
EST sequences were retrieved from the Berkeley Drosophila Genome Project 
(http://www.fruitfly.org ). Information on Drosophila genes was retrieved from 
FlyBase (http://flybase.bio.indiana.edu ), GadFly (http: //hedgehog.lbl.gov:  8000/cgi-
bin/annot/query) and GeneSeen (http: //www.fruitfiy.org/annot/geneseen-launch-
static.html) . Genes are referred to by their GenBank names, or acccession num-
bers where specified. Predicted Drosophila genes and their products are referred 
to by their GadFly identifiers, which begin with the letters CG. 
2.2.7.2 Similarity searches. 
Sequence similarity searches were carried out using the Basic Local Alignment 
Search Tool (BLAST). Sequences were searched against GenBank from the Na-
tional Center for Bioinformatics website (http://www.ncbi.nlm.nih.gov/BLAST)  
and against Drosophila sequences from the Berkeley Drosophila Genome Project 
(http://www.fruitfiy.org/BLAST) . Default parameters were used in all searches. 
2.2.7.3 Sequence alignments. 
Protein sequence alignments were carried out using the CLUSTALW algorithm 
provided by the Multiple Alignment General Interface (MAGI) at the Human 
Genome Mapping Project website (http://www.hgmp.mrc.ac.uk ). Default pa-
rameters were used in all alignments. 
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2.2.7.4 Primary sequence analysis 
Motifs were identified in protein sequences by scanning them against the PROSITE 
database, and by using the Sequence Analysis Modular Architecture Research 





Expression analysis of genes 
encoding components of the 
ubiquitination pathway 
3.1 Introduction 
Ubiquitination was once thought of only as a housekeeping process which medi-
ated the turnover of damaged and misfolded proteins. While this is an essential 
function, it is now clear that the ability to destroy the right protein at the right 
time also provides the cell with a powerful regulatory mechanism. Since multi-
cellular organisms have many more E2s and E3s than yeast, it seems likely that 
they exploit the regulatory power of the ubiquitin-proteasome pathway to control 
the processes of differentiation and development. 
Drosophila melariogaster has proved a powerful model for understanding the 
mechanisms which control embryogenesis. In this project, I aimed to identify de-
velopmental processes in which ubiquitin-mediated proteolysis of specific proteins 
is used as a regulatory mechanism. I focussed on the process of embryogenesis 
due to the greater body of research on the molecular mechanisms of this devel-
opmental stage than of larval or pupal development. I hypothesised that E2s 
and E3s with roles in specific processes of embryogenesis would have correspond-
ingly specific spatial and temporal distributions, whereas those enzymes required 
for housekeeping would be present in every cell. I therefore undertook an anal- 
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ysis of the embryonic expression patterns of genes encoding components of the 
ubiquitination pathway. 
When the project was begun, there was a putative El, five putative E2s 
and one putative E3 known in Drosophila. The gene encoding the El, Dubal. 
was cloned by a degenerate PCR approach followed by screening of .A libraries 
(zur Lage, unpub). The first E2 identified was Dhr6/UbcD6, the Drosophila 
homologue of S. cerevisiae RAD6 (Koken et al., 1991a). It was shown to rescue 
the defects in U.V. resistance and U.V. - induced mutagenesis in the S. cerevisiae 
rad6 deletion strain (Koken et al., 1991a). The genes encoding UbcDl and UbcD2 
were identified in a hybridisation screen to identify ubiquitin-conjugating enzymes 
in model multicellular organisms (Matuschewski et al., 1996; Treier et al., 1992). 
They were shown to partially rescue yeast ubcubc5 double mutants. Cenci et al. 
(1997) reported that mutations in UbcDl cause frequent end-to-end association of 
chromosomes during meiosis and mitosis. The effete gene, originally identified as 
a male-sterile mutation (Castrillon et al., 1993), was later shown to be identical to 
UbcDl. There were no reports on the physiological role of UbcD2 in Drosophila. 
The UbcD31bendless gene was discovered as a mutation which affected patterns 
of neuronal connections in the developing central nervous system (Oh et al., 1994; 
Thomas and Wyman, 1984). In bendless mutant flies, the giant fibre axon fails to 
bend, and hence fails to connect with the tergotrochanter muscle. Kirby (1996) 
used a degenerate PCR approach to identify new Drosophila E2s, which resulted 
in the cloning of UbcD. 
The only known candidate for a Drosophila Hect-domain E3 was Hyperplastic 
Discs (Hyd), which controls proliferation of imaginal disk cells in the larva (Mans-
field et al., 1994). Supernumerary limbs (Slimb) was the only known Drosophila 
F-box protein, and was therefore a putative component of an SCF - type E3. 
Slimb was identified as a mutation which caused ectopic activation of Hedgehog 
and Wingless signalling (Jiang and Struhl, 1997). 
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I identified novel E2 and E3 - encoding genes by screening cDNA sequences de-
posited in the EST (Expressed Sequence Tag) database produced by the Berkeley 
Drosophila Genome Project. I have analysed the embryonic transcription pattern 
of these novel genes as well as many of the genes mentioned above. 
3.2 Expression of the El-encoding gene Dubal 
during development 
3.2.1 Developmental Northern analysis 
I isolated total RNA from flies at various stages of development from embryos 
aged 0-3 hours, 3-8 hours and 8-22 hours, from larvae, pupae and adults. I 
probed a Northern blot of this RNA using radiolabelled Dubal cDNA (Figure 
3.1). No transcripts were detected in 8 - 22 hour embryos. At all other stages, 
two transcripts were detected in approximately equal amounts. Transcript levels 
appeared to be highest during the first eight hours of embryogenesis. 
The largest known Dubal cDNA (GenBank accession Y15895) is 4337 bp in 
size. On a Northern blot, the Dubal probe hybridised to a band of approximately 
4.3 kb and also to a larger transcript, of approximately 5 kb. This is unlikely to 
represent cross-hybridisation to a similar transcript, as there are no Drosophila 
genes highly similar to Dubal. I carried out 5' and 3' rapid amplification of 
cDNA ends (RACE) analysis in order to investigate whether Dubal transcripts 
with extra 5' and 3' sequences exist. 
3.2.1.1 3' RACE analysis of Dubal 
Total embryonic RNA was reverse transcribed using the primer RACE-1, which 
consists of an oligo-dT sequence preceded by an anchoring nucleotide and a 22-
nucleotide sequence which is used as a priming site for subsequent PCR amplifica-
tion. The 3' ends of Dubal transcripts were amplified by PCR using the primers 
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Figure 3.1: Developmental Northern analysis of Dubal expression. 
The blot was sequentially probed with rp9 (loading control) and Dubal. Each 
lane contains 2 jig of total RNA isolated from flies at the following stages of 
development : 2 - 0-3 hour embryos : 3 - 3-8 hour embryos : 4 - 8-22 hour 
embryos : 5 - larvae of mixed ages : 6 - pupae : 7 - adults. Lane 1 contains E. coli 
ribosomal RNA and lane 8 contains DIG-labelled RNA molecular weight markers. 
The arrows on the right indicate the positions of hands from the molecular weight 
markers after detection with AP-conjugated anti-DIG. 
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Dubal 'plus' strand. RACE-2 corresponds to the priming site introduced to the 
cDNA ends by RACE-1. The sequences of all primers are given in Table 2.5. 
After two rounds of amplification a band of approximately 130 bp was observed. 
Sequencing confirmed that this product resulted from amplification of a 4337-nt 
Dubal transcript. No larger bands were observed, either by subsequent rounds 
of PCR amplification or by blotting the PCR products onto nylon filters and 
probing using a Dubal probe (Figure 3.2). The larger band on the developmental 
Northern is therefore unlikely to reflect Dubal transcripts with extra 3' sequence. 
3.2.1.2 5' RACE analysis of Dubal 
The 5' ends of Dubal cDNAs were reverse transcribed from total embryonic RNA 
using the reverse primer DUBA1-2, which corresponds to positions 124-107 on 
the Dubal 'minus' strand. 3' polyA tails were added to the resulting cDNA 
using terminal transferase, and PCR was carried out using the primers RACE-1 
(described above) and DUBAI-3, which corresponds to positions 85-104 on the 
Dubal 'minus' strand. This would be expected to yield a 104 bp product from 
the a Dubal 4.3 kb transcript. A transcript with extra 5' sequence would yield 
larger products. After two rounds of amplification, two bands were observed on a 
gel, sized approximately 200 and 150 bp. Sequencing showed that these products 
derived from the 5' end of Dubal and extended upstream of the reported cDNA 
sequence (GenBank accession Y15895). When the gel was blotted onto a nylon 
filter and and probed with radiolabelled Dubal DNA, a smear of larger and smaller 
products was observed (Figure 3.2). 
This analyis indicates that Dubal transcription can initiate from a site up-
stream from that reported. It can be difficult to identify the true transcrip-
tional start site using RACE analysis because secondary structure can impede 
reverse transcription of the full-length RNA. It is possible that two major PCR 
products observed both reflect true transcriptional start sites. These would give 






Figure 3.2: 5' and 3' RACE analysis of Dubai transcripts. 
PCR products resulting from amplification of the 5' or 3' ends of Dubai cDNAs 
were blotted and probed with the full-length radiolabelled Dubai cDNA. As a 
negative control, amplifications were carried out on cDNA ends to which polyA 
tails were not added. As a positive control for hybridisation, the full-length Dubai 
cDNA in pBluescript was loaded. 
5' RACE products. Lane 1 - PCR products from embryonic cDNA. Lane 2 - 
Negative control PCR products from embryonic cDNA. Lane 3 - PCR products 
from adult cDNA. Lane 4 - Negative control PCR products from adult cDNA. 
Lane 6 - Dubai cDNA. Lane 1 - Hindlil-digested \ DNA. 
3' RACE products. Lane 1 - PCR products from embryonic cDNA. Lane 2 - 
PCR products from adult cDNA. Lane 3 - negative control PCR products from 
embryonic cDNA. Lane 4 - negative control PCR products from adult cDNA. 
Lane 5 - Hindill-digested ,\ DNA. Lane 6 - Dubai cDNA. 
II 
on the Northern blot. Alternatively, the larger product may reflect a region of 
the transcript where reverse transcription frequently terminated due to secondary 
structure. If the 5 kb band on the Northern blot was a Dubal transcript with 
extra 5' sequence, a PCR product of approximately 800 bp would be expected. 
It is possible that cDNA with the intact 5' sequence was present in such small 
quantities that PCR products were not produced in quantities detectable on a 
gel. However the largest of the smear of PCR products observed after blotting 
and probing was approximately this size and may correspond to the full-length 
cDNA. Together with the Northern analysis, these results suggest that there is a 
Dubal transcriptional start site approximately 700 bp upstream of the reported 
site, and that the two transcripts are produced in approximately equal amounts. 
3.2.2 Embryonic in situ hybridisation analysis of Dubal 
In order to detect the spatial expression pattern of Dubal during embryogenesis, 
in situ hybridisation of a DIG-labelled antisense mRNA probe on wholemount 
embryos was performed (Figure 3.3). The probe was detected using anti-DIG an-
tibodies conjugates to alkaline phosphatase (AP). When the embryos were stained 
with AP substrates, a purple colour was produced where the probe had hybridised 
to mRNA. Dubal sense RNA probes were used as a negative control. 
Maternal Dubal transcripts are abundant in freshly laid eggs, decreasing 
slightly during cellularisation. Zygotic expression of Dubal is high in anterior 
and posterior midgut primordia and the extending germband during stages 6-10. 
In germband-retracted embryos, expression is high in gut and nervous system, 
particularly in the head. After dorsal closure, expression is highest in the foregut 
and nervous system, particularly the brain. Dubal expression is low and uniform 
in stage 15-17 embryos. 
aing 	 amg qM 
A 	p 
	




fg 	 fg 
D vnc 	 E 
- 
Mg 
Figure 3.3: In situ hybridisation analysis of Dubal expression. Embryos are 
oriented with anterior to the left and dorsal uppermost.A - stage 1-3. B - stage 
6. C - stage 8. D - stage 12. E - stage 14. F - stage 15 . Abbreviations: 
amg=anterior midgut, hr=brain, cf=cephalic furrow, fg=foregut, hg=hindgut, 
mg=midgut, prng=posterior midgut, vnc=ventral nerve cord. 
3.2.3 Discussion 
Since ubiquitination is required for housekeeping, and Dubal is expected to catal-
yse an essential first step in the pathway, it is to he expected that the gene would 
be transcribed in all cells. I found that Dubal transcripts are abundant in RNA 
extracted from flies at all developmental stages except for 8 - 22 hour embryos. 
In situ hybridisation showed that Dubal transcripts were detectable in all tissues 
at all stages, but were extremely low in embryos which had completed dorsal 
closure and head involution (approximately 13 hours). There is an apparent dis-
crepancy between the results of Northern analysis and of in situ hybridisation 
for embryos aged 8 - 13 hours. It seems likely that, in the RNA sample from 
8-22 hour embryos used in the Northern, the transcripts from 8-13 hour embryos 
were underrepresented compared to those from 13 - 22 hour embryos, and were 
therefore not detected. Both results suggest there is little ubiquitination during 
late embryogenesis. The high level of expression in gut and nervous system may 
reflect particularly high levels of uhiquitin-mediated proteolysis in these tissues. 
83 
3.3 Expression analysis of known E2-encoding 
genes 
I carried out in situ hybridisation analysis of the embryonic expression patterns 
of all five known E2-encoding genes (Figure 3.4). UbcDl and Dh7-6 transcripts are 
widely distributed, particularly in gut and nervous system primordia. Expression 
of UbcD2 is detectable above background only in the cellular blastoderm and in 
the nervous system of stage 12-13 embryos. As previously reported, (Mansfield 
et al., 1994), UbcD3 is highly expressed in the embryonic nervous system, from the 
ventral ectodermal neurogenic region in gastrulae to the brain and central nervous 
system of stage 15-17 embryos. The expression pattern of UbcDi is described in 
section 3.5. 
3.4 Expression analysis of novel genes encoding 
putative E2s and E3s 
3.4.1 Identification of cDNAs encoding putative E2s and 
E3s from an Expressed Sequence Tag (EST) database. 
I used UbcD4 and UbcDl as query sequences in BLAST searches of six-frame 
translations of the EST database produced by the Berkeley Drosophila Genome 
Project (BDGP). The searches were performed in September 1997. From the 
resulting 'hits' with an Expect value of less than 6, I discarded ESTs which 
only hit one of the query sequences, or which encoded known E2s. The searches 
resulted in the identification of two putative E2-encoding cDNA sequences, each 
represented by several EST clones. I obtained a cDNA fragment representing 
each of the two sequences from the BDGP. The cDNAs were termed LD06921 
and LD1021. Both cDNAs came from a library derived from 0-22 hr embryos. 
The alignment of the LD10212 and LD06921 products with UbcDl and UbcD4 
are shown in Figure 3.5. 















Figure 3.4: In situ hybridisation analysis of UbcDl, UbcD2, UbcD3 and Dhr6 
expression. 
Embryos are oriented with anterior to the left and dorsal uppermost. LA-C 
UbcDl expression. II.A-C: UbcD2 expression. IlI.A-C : UbcDS expression. IV.A-
C : Dhr6 expression. A : stage 4-5 embryos. B - stage 8-9 embryos. C - stage 
12-14 embryos. 
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which are predicted to have ubiquitin-ligase activity. I used the Hect domains of 
the human E6-associated protein (E6-AP), and the S. cerevisiae Rsp5 protein, as 
query sequences. Again I identified two novel cDNA sequences encoding putative 
E3s, and obtained representative cDNA fragments. These were termed HLO1984  
and HL02858. Both came from a library derived from adult heads. The alignment 
of the HLO1394 and HL02858 products with the C-termini of E6-AP and Rsp5 is 
shown in Figure 3.6. 
Finally I searched for potential components of SCF complexes. By using 
the yeast Cdc53 and Skpl as query sequences I identified a putative Drosophila 
homologue of each. The Skpl homologue was encoded by EST clone LD19283 
from the embryonic cDNA library. The Cdc53 homologue was encoded by a 
full-length eDNA, called lin-19 for its similarity to the C. elegans lin19 gene. C. 
elegans 1i09 had since been renamed cull (Kipreos et al., 1996) but the similarity 
of the Drosophila lin-19 to the cullin proteins had not been noted. The alignments 
of the Drosophila cullin and Skpl homologue with the corresponding proteins from 
yeast, nematodes and humans are shown in Figures 3.7 and 3.8. Despite carrying 
out searches with several F-box proteins I failed to identify any convincing novel 
members of this family in Drosophila. 
3.4.2 Embryonic in situ hybridisation analysis of novel E2 
- and E3 - encoding genes. 
In situ hybridisation analysis was performed as described previously. Both of the 
putative E2 genes, LD1O212 and LD06921 are weakly but detectably expressed in 
gut primordia. HL01334 and HL02858 transcripts are present at low levels in gut 
and nervous system primordia from gastrulation onwards. Both the putative SCF 
components are transcribed at high levels in all tissues throughout embryogenesis 
(Figure 3.10). 
Since the expression analysis of the novel E2 and E3 genes failed to indi-
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Figure 3.5: CLI STAL\V alignment of the novel E2s encoded by LD10212 and 
LD06921 with UbcD4 and Ubcdl. The full sequences encoded by the EST cDNA 
clones LD10212 and LD06921, and the hill UbeDi sequence, are shown. The 
LbcD4 sequence oiiiits the C-terminal 50 residues. Identical residues are shaded 
in black and similar residues are shaded grey. 
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Figure 3.6: CLUSTAL\V aligiimeiit of t lie iiovel E3s encoded by HLO1334 and HL-
2858 with the Hect domains of E6-AP and RspS. The E6-AP and RspS sequences 
sliowii start respectively at positions 601 and 667 of the hill-length proteins and 
finish at the C-termini. The full sequences encoded by the EST cDNA clones 
HL02858 and HL01334 are shown. Identical residues are shaded in black and 
similar residues are shaded grey. 
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Figure 3.7: CL USTALW alignment of the putative Drosophila cullin (liii 19) with 
Yeast Cd(:03, C. elegans cul-1 and human Gui-I. Identical residues are shaded 
black and similar residues are shaded grey. Abbreviations : D.m.= Drosophila 
'm(-1anoqaste'r, S.c. =Saccharomyces cereviszae, C.e. = Cueno'rhabditis dc guns, H. S.  
Homo sapiens. 
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Figure 3.8: CLUSTAL\V alignment of the novel Skpl-related protein encoded 
1w LD19283 with the yeast, nematode and human Skpl proteins. Identical 
residues are shaded black and similar residues are shaded grey. Abbreviations 
S.c.=Saccharornyces cereviszae, G.e. = Caenorhabditis elegaus, H.s. = Homo 
.S(Ljfl(flS. 
Since this analysis was carried out, HL02858 has been identified as Suppressor 
of (leltex, Su(dx) (GenBaiik accession AAD38975) (Cornell et al., 1999). Muta-
tional analysis suggests that Su(dx) is it negative regulator of Notch signalling 
(Fostier et al., 1998). It is expressed in the pupa and prepupa. HL01334 is now 
called HERC2 (GenBank accession AAF61856). As well as its Hect domain, it 
has a niotif fund in guanyl-nucleotide exchange factors. LD 10212 and LD06921 
are now called UbcDlO (GeniBank accession AAF57787) and CG2257 (GenBank 
accession AAF46318) respectively. There is no further inforuiatioii on the expres-
sion patterns or physiological role of either these or of HERC2. LD01343 and 
LD19283 are now designated Cul-1 (GeiiBank accession AAD33676) and SkpA 
(GenBank accession AAF64674 ) respectively. Expression of Drosophila cull in 
it yeast cdc53 mutant strain rescues the Cl arrest (Filippov et al., 2000). The 
participation of SkpA in ubiquitination has not been demonstrated. Since they 
are predicted to form the catalytic core of the SCF complex, rather than the 
substrate recognition part. it is perhaps not surprising that their expression is 
1 tiuversal in embryos. On the other hand. multicellular organisms have multiple 
(lilhins and Skpl-related proteins, presumably reflecting some degree of functional 
















Figure 3.9: In situ hybridisation analysis of LD0691, LD10212, HL02858 and 
HL01334 expression in embryos. 
Embryos are oriented anterior to the left and dorsal uppermost. LA-C : LD06921 
expression. ILA-C : LD10212 expression. III.A-C : HL02858 expression. IV.A-C 
HLO 1 334 expression. A - stage 4-5 embryos. 13 - stage 8-9 embryos. C - stage 
12-14 embryos. 
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Figure 3.10: Embryonic in situ hybridisation analysis of cul-1 and skpA expres-
sion. l.A-C : cui-1 expression. ILA-C : skpA expression. A - stage 4-5 embryos. 
B - stage 8-9 embryos. C - stage 12-14 embryos. 
diversity. The complete Drosophila genome encodes a total of six putative cullins 
and seven putative Skpl homologues. There are no reports on their physiological 
roles. 
3.5 Expression analysis of UbcD4 
3.5.1 Developmental Northern analysis of UbcD4 expres-
sion 
I probed a developmental Northern blot, made as described previously, with ra(li-
olabelled UbcD4 cDNA (Figure 3.11). The probe hybridised to two RNA bands, 
both of which were present only in the RNA extracted from 0-3 and 3-8 hour 
embryos. Probing of the blot with an rp49 probe showed that the absence of 
a signal in the remaining lanes was not due to unequal loading of RNA. The 
two transcripts detected were approximately 1.1 kb and 600 hp in size. The 
larger transcript has the size predicted from the UbcD4 cDNA (GenBank acces-
sion Y11394). The significance of the smaller band is unknown. It may represent 
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Figure 3.11: Developmental Northern analysis analysis of Ub(., D4 expression. 
Each lane contains 2 jtg of total RNA isolated from flies at the following stages 
of development : 2 - 0-3 hour enhl)ryos : 3 - 3-8 hour embryos : 4 - 8-22 hour 
eIIll)ryos : S - larvae of mixed ages : 6 - pupae : 7 - adults. Lane 1 contains E. coli 
ribosomal RNA and lane 8 contains DIG-labelled RNA molecular weight markers. 
The arrows on the right show the positions of the markers after detection with 
AP-conjugated anti-DIG. The bottom panel shows the result of probing the same 
1 ) 1 ()t with rp4 9. 
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3.5.2 Embryonic in situ hybridisation analysis of UbcD4 
expression. 
Hybridisation and detection of a DIG-labelled UbcD4 RNA probe to 0-22 hour 
embryo revealed a dynamic expression pattern (Figure 3.12). Maternal tran-
scripts were abundant in 0-2 hour embryos, decaying slightly as cellularisation 
progressed. During gastrulation, expression appears to be highest in the invagi-
nating posterior midgut primordium, with high expression also in the cephalic 
furrow and ventral ectodermal neurogenic region. UbcD4 transcripts are abun-
dant in the anterior midgut primordium and extending germband during stage 
5-7. In stage 10 embryos, expression is very low throughout most of the embryo, 
but high in a cluster of cells in the pocket formed by the posterior midgut pri-
iriordium. In stage 11 embryos, overall expression remains low, but a group of 
the UbcD4 positive cells can be observed on the dorsal side of the PMG pocket. 
These appear to split into two groups on either side of the ventral midline. Dur-
ing germband retraction, transcription reinitiates in many tissues, especially the 
gut and nervous system. After dorsal closure, UbcD4 transcripts are detectable 
at low levels throughout the embryo. 
The spatial and temporal specificity of UbcD4 transcription suggested that it 
was the best candidate for a ubiquitination enzyme which mediates specific de-
velopmental decisions during Drosophila embryogenesis. Particularly interesting 
was the expression pattern during maximal germband extension. The position 
of the cluster of UbcD4 positive cells in stage 10-11 embryos suggested that they 
may be the primordial germline or 'pole' cells. 
3.5.3 Investigation of whether UbcD4 transcription is re-
stricted to the germ cells in stage 10-11 embryos. 
The primordial germ cells cellularize at the posterior pole of the embryo during 
stage 5 of embryogenesis. They divide asynchronously with the soma to form a 
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Figure 3.12: Embryonic in situ hybridisation analysis of LTbcD4 expression. 
A : stage 4-5 embryo. B : stage 6. C : stage 7-8. D : stage 9-10. E : stage 11. 
F : stage 11, dorsal view. C : stage 12. H: stage 13-14. I: stage 16-17. Abbre-
viations: amg=anterior midgut, cf=cephalic furrow, fg=foregut, gh=gerrnband, 
hg=hindgut, mg=midgut, pmg= posterior midgut, vne=ventral neurogenic ecto-
derm. 
uiidgiit piiinoidium (P1MG) and h(cOriie illcorj)orated into the pocket formed b 
P1MG uivagination. The pocket moves anteriorly (luring germband extension, to 
I(adl approximately 50% egg length. \Vlien the gerniband is maximally extended, 
during stage 10, the pole cells migrate through the wall of the P1MG towards the 
lateral uheso(Ierin in )aIasegrnents 11-13. They separate into two groups, one 
on either side of the ventral midline. During germband retraction, the germ cells 
associate xvith the mesoolerinal somatic gonadal precursor (SGPs) in parasegments 
10-12. The SGPs and germ cells coalesce to form the gonad (luring stage 15. 
3.5.3.1 Staining stage 10-11 embryos for UbcD4 mRNA and Vasa pro-
tein 
\ìsn i 	J)roteill specifically expressed in gernicells throughout embryogene- 
sis. We carried out in situ hybridisation using it U1)cD4 probe, and subsequent 
iltiltiunostaining using anti-Vasa antibodies, on 5-7 hour embryos. The results 
demonstrate that the Ub(:Di positive cells in stage 10-11 embryos are also Vasa-
Positive. and therefore are the germline cells (Figure 3.13). 
3.5.3.2 Analysis of UbcD4 transcription patterns in embryos lacking 
germ cells 
The A -qel strain of flies carry a null allele of qe'inicell-le.ss. (qel,) over the balancer 
chromosome CyO (see Table 2.4). Maternal contribution of gel inflNA is essen-
tial for formation of germ cell Precursors. Approximately 80% of embryos derived 
front qel hiornozvgous females fail to form pole cells. I collected embryos from 
f/d liouiiuiygous mutant, finales, identified by lack of the Cy() balancer, and Per-
formed UheD4 in stu hybridisation and Vasa immunostaining. The majority of 
(1II1h)1vus were Vasa-negative and these ernbr os also showed no UbeD4 expression 
during stage 10-11 (Figure 3.13). In the few embryos Nvith Vasa-Positive cells, 
I hiese cells were also UbcD4 positive. The expression pattern is similar, to that in 
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Figure 3.13: Analysis of UbcD4 and Vasa colocalisation in stage 10-11 embryos. 
A,B,F: embryos photographed under lOx objective lens. C,D,E: embryos viewed 
under 40x objective lens. A: UbcD4 and Vasa staining in stage 10 embryo. B: 
UbcD4 and Vasa staining in stage 12 embryo, dorsal view. C: UbcDj staining in 
stage 10-11 embryo. D: Vasa staining in stage 10-11 embryo. E: UbcD4 and Vasa 
staining in stage 10-11 embryo.F: UbcDi' and Vasa staining in stage 10 embryo 
from grl mother. 
3.6 Production of recombinant UbcD4 and poly-
clonal antisera 
The presence of transcripts in a tissue does not guarantee that the corresponding 
protein is also present, since its expression may be under post-transcriptional 
control. The distribution of a protein is therefore likely to provide a more accurate 
indication of function than that of an rnRNA. In order to analyse the distribution 
of the tfbcD4 gene product, I attempted to raise polyclonal antibodies which could 
be used in immunostaining of embryos. 
3.6.1 Production of recombinant UbcD4 in E. coli 
A construct consisting of the UbcD4 coding sequence flanked by EcoRland BamHI 
restriction sites was synthesised by PCR and sequenced (described fl section 
4.2.1). This was cloned into the E. colt expression vector pET15b (see Table 2.3), 
which encodes a 'tag'. including six histidine residues, upstream of the multiple 
cloning site. Transcription of the tag and downstream sequence is under the con- 
trol of the T7 promoter, which is inducible with IPTG. The recombinant plasmid 
was sequenced to ensure that the tag was in frame with the UbcD4 coding se-
quence. It was then transformed into the E. coli strain BL21(DE3)pLysS (see 
Table 2.1). IPTG was added to mid-log cultures derived from a single transfor-
inant. Cells were allowed to synthesise recombinant UbcD4 for three hours, then 
pelleted and sonicated. Recombinant UbcD4 was found primarily in the soluble 
fraction (Figure 3.14). The presence of the six histidines in the N-terminal tag 
allowed the recombinant UbcD4 to be purified by nickel chelation chromatogra-
phy. Impurities were removed by washing with buffers containing progressively 
higher levels of imidazole. UbcD4 eluted in 350 mM imidazole. No copurifying 
proteins were detectable by Coomassie staining of SDS-PAGE gels ( Figure 3.14). 
Approximately 3 mg recombinant UbcD4 was obtained per litre of E. coli. A 
mock purification was carried out on a culture to which IPTG was not added. 
No overexpressed products the size of UbcD4 were observed in the cell pellets, 
and no proteins remained bound to the nickel column after washing with 120 mM 
imidazole ( Figure 3.14). 
3.6.2 Production of polyclonal anti-UbcD4 sera in mice 
Recombinant UbcD4 was dialysed into PBS and concentrated to 1 mg. m1 1 . 
100 g was injected into each of 10 mice. Two mice were injected with PBS, 
to obtain control sera. The injections were repeated after one month and again 
after two months. A week after the third injection, the mice were sacrificed and 
bled. The injections and bleeding were performed by P. Loke at the Institute for 
Cell, Animal and Population Biology, University of Edinburgh. 
3.6.2.1 Testing the specificity of recognition of recombinant UbcD4 
by Western blotting 
Preliminary testing of the antisera on dot blots and Western blots established 
that a dilution of 1 in 2000 was optimal for detection of recombinant UbcD4. 
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Figure 3.14: Expression and purification of reconihinant. UbcD4. 
Protein fractions from cells induced with IPTG. Lane 1 - molecular weight 
itiarker. Lane 2 - total cell protein before induction. Lane 3 - total cell protein 
3 hours after induction. Lane 4 - total insoluble fraction. Lane 5 - total soluble 
fraction. Lanes 6 - 9 are fractions of soluble proteins from nickel affinity chro-
iiiatography. Lane 6 - proteins which (10 not bind the nickel column. Lane 7 - 
10 triM iiiiidazole wash. Lane 8 - 120 mM imnidazole wash. Lane 9 - pure UbcD4 
eluted in 350 triM imidazole. 
Mock purification : protein fractions froni cells in the absence of JPTG. Lane 
2 - molecular weight marker. Lane 3 - total cell protein. Lanes 4 - 9 : as for A. 
The control sera showed no recognition of UbcD4. The antisera from the un-
lnhiluse(l mice were not very sensitive, as less than 10 ng of UbcD4 could not he 
detected. No significant differences were observed between the results obtained 
using antisera from individual mice, and pooled antisera. 
\Vlien tested against the purest fractions of UbcD4, the equivalent of the 
preparation which had been used for injection. the antisera detected only one 
baud. of' the size expected for UbcD4 (approxiiiiatelv 25 kDa). However when 
tested against a less pure fraction, which included some co-purifying bacterial pro-
tents, a stronger band of a larger size was observed, in addition to the UbcD4 band 
(Figure 3.15). This suggests that a highly immunogenic bacterial protein was 
present in the injected preparation, at levels too low to be detected by Coomassie 
staining of SDS-PAGE gels, and that the majority of antibodies produced recog-
nise this protein rather than UbcD4. 
No recognition of endogenous UbcD4 was observed on Western blots of cut- 
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bryonic protein extracts. A lane containing 10 pg of total embryonic protein 
yielded a smear of bands, while 1 ug yielded no bands (Figure 3.15). The an-
tisera were preabsorbed on 15-20 hour embryos and used to immunostain 0-22 
hour embryos. 15-20 hour embryos were used for preabsorption because, based 
on their mRNA levels, they would be expected to have lower levels of UbcD4 
than younger embryos. No specific staining was observed in anti-UbcD4 - stained 
embryos compared to those stained with the control sera (data not shown). 
In order to purify antibodies with high affinity for UbcD4, I cut out small 
slices, corresponding to the position of the UbcD4 band, from a nitrocellulose 
filter to which the recombinant protein preparation had been transferred. These 
slices were incubated with antisera. Unbound antibodies were removed by wash-
ing, and the antibodies which had remained bound to UbcD4 were eluted using 
an acidic glycine solution. When tested on Western blots, the antisera specifi-
cally recognised recombinant UbcD4, even when bacterial contaminants were also 
present. However no bands were observed in the embryonic extract (Figure 3.15). 
No specific immunostaining of embryos was obtained from the purified antibodies 
(data not shown). As the antibodies apparently failed to recognise endogenous 
UbcD4, possibly due to a conformational difference between the recombinant and 
endogenous proteins, they were not used in any further experiments. 
3.7 Discussion 
In general, the expression patterns of the genes analysed here give little indication 
that ubiquitinating enzymes commonly mediate specific developmental decisions 
during embryogenesis. Those genes which are transcribed in embryos generally 
show widespread distribution, often with slightly increased expression in gut or 
nervous system (e.g. UbcDl, LD06921, HL02858). Strong expression is generally 
not observed in embryos after stage 15. The transcription pattern of the El gene, 
Dubal, is consistent with these trends. This may give an overall indication of the 





Figure 3.1: Analysis of UbcD4 antisera using Western blotting. 
A : Testing pooled unpurified antisera against recombinant UbcD4. Lanes 1 - 7 
contain the following amounts of purified UbcD4 : Lane 1 - 1 pg: Lane 2 - 5 pg: 
Lane 3 - 10 pg Lane 4 - 50 pg : Lane 5 - 500 pg Lane 6 - 5 ng : Lane 7 - 
SOiig. Lane 8 - molecular weight marker. Lane 9 50 ng protein from a UbcD4 
preparation which includes some contaminating bacterial protein. 
B : Testing pooled unpurified antisera against recombinant UbcD4 and embryonic 
1)1Ot('i115. Lane 1 - molecular weight marker. Lane 2 - 20ng UhcD4. Lane 3 - 2 ng 
1.l)(D4. Lane 4 - 200 pg UbcD4. Lane 5 - 20 pg UbcD4. Lanes 6 and 7 - empty. 
Lane 8 - 10 tg total embryonic protein. Lane 9 - 1 ig total embryonic protein. 
C : Testing control sera against recombinant UbcD4 and embryonic proteins. 
Lanes as for B. 
I) : Testing affinity-purified UbcD4 antibodies against recombinant UbcD4 and 
eiiil )rvonic proteins. Lane 1 - 2 ,tg total embryonic proteins. Lane 2 - 10 	g 
eiiïhionic proteins. Lane 3 - 50 ng protein from a UbcD4 preparation containing 
sonic (opurifvmg proteins, as for lane 9 in A. Lane 4 - 50 mig UbcD4. 
The arrowheads indicate the position on the filter of the 25 kDa band of the 
1)r('st ained molecular weight markers. 
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relative ubiquitination levels in various tissues and stages, since its expression is 
a prerequisite for the functioning of any E2 or E3. 
The exception to the trend of non-specific expression is UbcD4. In stage 10-11 
embryos, UbcD4 is transcribed specifically in germ cells. This is not a commonly-
observed expression pattern. None of the other genes, encoding components of the 
ubiquitin pathway, whose expression was also analysed, showed a similar pattern. 
They were either not expressed in germ cells at all or, in the case of Dubal, 
transcripts were so abundant throughout the embryo that the germ cells could 
not be discerned. In the FlyBase database less than forty genes are reported to 
be transcribed in germ cells, and the majority of these do not show specific germ 
cell expression at any stage. Thus the presence of UbcD4 transcripts in germcells 
at this stage may be functionally significant. 
The most obvious process occurring in germ cells during stage 10-11 is their 
movement through the gut wall towards the somatic gonadal precursors in the 
lateral mesoderm. It is interesting to speculate on whether UbcD4-mediated pro-
teolysis could play a role in controlling germ cell migration. Perhaps destruction 
of a target protein is needed for normally sessile cells to initiate movement. Alter-
natively, the UbcD4 target may repress a component of the signal transduction 
pathway which allows the germ cells to respond to guidance cues. 
The molecular basis of germ cell migration is poorly understood. The third 
chromosome has been exhaustively screened for zygotic mutations specifically 
affecting gonad formation (Moore et al., 1998). The genes identified fall into 
several classes, each of which appears to direct a discrete step in the process. 
serpent and huckebein are needed for pole cell invasion of the gut wall. Attachment 
of the germ cells to the somatic mesoderm requires zfh-1, columbus and heartless. 
Coalescence of germ cells with gonadal mesoderm requires abdominal-A and -B, 
trithorax, tinman and fear -of-intimacy. 
In most cases, the molecular basis for the effect of the mutation on gonad 
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formation is not clear. However the products of two genes, wunen and columbus, 
appear to directly guide movement of germ cells. columbus, which is expressed 
in gonadal mesoderm, encodes a homologue of HMG-CoA reductase (HMGCR) 
(Van Doren et al., 1998). Ectopic expression of columbus/hmgcr can redirect germ 
cell migration to the novel site of expression (Van Doren et al., 1998). The loss-of-
function hrngcr mutations which disrupt germ cell migration are all in the catalytic 
domain (Van Doren et al., 1998). These observations suggest that germ cells 
are attracted by a factor produced by HMGCR enzymatic activity. HMG-CoA 
reductase synthesises mevalonate, which in mammals is a cholesterol precursor. 
In Drosophila, mevalonate is a precursor of various lipid biosynthetic and protein 
modification pathways. It is not yet known which pathway produces the signal 
attracting germ cells. The wunen product, a phospatidic acid phosphatase type 
2 (PAP2) (Zhang et al., 1997), is also putatively involved in lipid metabolism. 
Misexpression experiments show that Wunen activity appears to repel germ cells 
(Zhang et al., 1997). The significance of the finding that both wunen and columbus 
encode proteins with putative roles in lipid metabolism is not clear. It is possible, 
for example, that the same lipid-derived signal is produced by columbus-expressing 
cells and degraded by wunen - expressing cells, or vice versa. Alternatively they 
could produce two independent guidance cues with opposite effects on germ cells. 
It is remarkable that the screen performed by Moore et al. (1998) failed to 
identify any genes, required for gonad development, which function in the germ 
cells. Possibly such mutations would have a maternal effect only. Maternal contri-
bution of two factors, nanos (nos) and polar granule component (pgc), is required 
for pole cell migration. pgc produces a noncoding RNA (Nakamura et al., 1996). 
Nos is a zinc-finger protein which acts as a posterior morphogen but which has 
a separate role in germline development. Lack of germline Nos activity causes 
pole cells to remain clustered on the distal surface of the gut instead of migrating 
dorsally (Forbes and Lehmann, 1998). Nos presumably exerts its effect on germ 
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cell migration via its role as a regulator of transcription. 
Studies of other cell migration events in Drosophila embryos may shed light 
on the molecular mechanisms of germ cell migration. These events include the 
migration of tracheal precursor cells during formation of the respiratory system, 
and the migration of mesodermal precursor cells during gastrulation. Signalling 
by fibroblast growth factor receptors, such as Breathless and Heartless, has been 
implicated in both systems (reviewed by Forbes and Lehmann (1999)). 
Two features which distinguish the germline from the soma during early to 
mid-embryogenesis are its lack of mitotic activity and its transcriptional quies-
cence. Newly-formed pole cells divide asynchronously until cellularisation, when 
their number has reached approximately thirty. From this point until their in-
corporation into the gonad, they do not divide further. The arrest seems to be 
at the G2-M transition (Su et al., 1998). Whereas zygotic transcription begins in 
the soma at the blastodérm stage, pole cells in the early embryo shut down RNA 
polymerase II (RNAP II) - dependent transcription (Seydoux and Dunn, 1997). 
This correlates with the absence until stage 7 of a specific RNAP II phospho-
epitope which is present in transcriptionally active somatic cells (Seydoux and 
Dunn, 1997). In addition to its role in migration, Nanos has been implicated in 
clowriregulating both transcription and mitosis in pole cells. In pole cells lacking 
Nos activity, several genes normally only expressed in the gonad are prematurely 
expressed (Seydoux and Dunn, 1997; Kobayashi et al., 1996). nos pole cells 
also continue dividing after the cellular blastoderm stage, a defect which is pre-
sumably due to transcriptional deregulation (Seydoux and Dunn, 1997). It is not 
clear whether Nos is needed for regulation only of specific genes or whether it also 
plays a role in the global repression of RNAP II transcription. However it is strik-
ing that the inappropriate presence of proteins normally found only in the soma, 
or in the germline after gonadal coalescence, can cause multiple defects in germ 
cells at stage 10-11. In this context it is particularly interesting that the general 
103 
repression of RNAP II may be relieved at stage 7, but that many genes appear to 
remain specifically repressed until gonad formation. Perhaps ubiquitin-mediated 
proteolysis has a role to play in destruction of unwanted proteins, including cell-




Identification of proteins which 
interact with UbcD4 
4.1 Introduction 
Protein-protein interactions are an intrinsic part of nearly every cellular process, 
including ubiquitin-mediated proteolysis. An essential aspect of studying the 
function of a protein of interest is to identify other proteins which interact with 
it. In the case of a ubiquitin-conjugating enzyme, this approach may identify 
other components of the pathway which mediate target ubiquitination, as well as 
the targets themselves. 
Traditionally, the tools available to study interactions have been based on 
biochemistry (reviewed by Phizicky and Fields (1995)). More recently, a variety 
of methods have been developed which allow the screening of libraries for genes 
or fragments of genes whose products interact with a test protein. These have 
the great advantage that the cDNA encoding the interacting protein is immedi-
ately available. The technique which has had the greatest impact on interaction 
cloning methodology is the yeast two-hybrid system (Chien et al., 1991; Fields 
and Song, 1989). This system detects protein-protein interactions via the acti-
vation of reporter gene expression. It relies upon the modular structure of many 
eukaryotic transcription factors, which are composed of a DNA binding domain 
and a transcriptional activation domain. The two domains need not not be cova- 
105 
lently linked and can be brought together by the interaction of other proteins to 
which they are fused. The two hybrid sreen requires the construction of hybrid 
genes that encode a DNA-binding domain fused to a target protein (the 'bait'), 
and an activation domain fused to a test protein (the 'prey'). Interaction between 
the bait and prey reconstitutes a functional transcription factor which stimulates 
expression of reporter genes. Nutritional selection can be included by using a 
biosynthetic gene as a reporter (Figure 4.1). 
The selection procedure used in the yeast two-hybrid system facilititates the 
screening of a large number of coding sequences. It is also more sensitive than 
biochemical methods, due to overexpression of the hybrid proteins and amplifica-
tion of the signal by the production of multiple stable reporter enzymes from each 
transcript. Unlike biochemical methods which require multiple washing steps, a 
high rate of dissociation does not preclude detection of an interaction. 
The are several disadvantages to the yeast two-hybrid system. Some bait pro-
teins, when fused to a DNA binding domain, are themselves capable of activat-
ing transcription. The expression levels, posttranslational modifications, folding, 
stability, and nuclear localisation of the fusion proteins can all affect the results. 
Another limitation is the frequent detection of spurious interactions ('false posi-
tives'). The system can identify proteins which, although capable of interaction, 
never associate in the relevant organism because they are normally present in 
different cells, or in different cellular compartments, or at different times. Many 
false positives seem to be dependent on promoter context, and so their occurrence 
can be reduced by scoring for two reporter genes with minimal sequence similar-
ity in their promoters. There are many possible reasons why genuine interactors 
may not be recovered ('false negatives'). Prey proteins expressed as fusions may 
be unable to act as transcriptional activators due to their folding and/or stabil-
ity. Certain fusion proteins may be toxic to the yeast cell. As a result of these 
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Figure 4.1: Schematic representation of the LexA-based interaction trap. The 
yeast strain used has a chromosomal LEU2 gene, and a plasmid-borne lucZ gene 
with LexA operator sites directly upstream. A bait' protein fused to the LexA 
DNA-handing (lonlain is coexpressed with a library of prey proteins fused to 
it transcriptional activation domain. The bait-LexA hybrid protein binds the 
LexA operators 1)Iit, in the absence of an interaction with prey protein, cannot 
activate transcription of the reporter genies (i). Interaction between bait and prey 
reconstitutes a transcriptional activator at the LEU2 and lacZ prorrioters (ii). 
hot be correlated with its biological significance nor with the affinity of the two 
wild-type proteins in the relevant organism. Nonetheless the technique provides 
it powerful and versatile tool for identifying potentially important protein-protein  
lilt cracti011s. 
The fist two-hybrid system was based on the yeast Gal4 DNA-binding do-
iiiain (Fields and Song, 1989). An alternative system. developed by Gyuris et at. 
(1993), utilises the E. coh LexA protein and a yeast strain which has a (lila! 
lacZ LEU2 reporter system responsive to transcriptional activation through the 
L:i:A operator. It has the important advantage that the screen can be performed 
in a. GAL+ strain, and therefore the prey library can be expressed from the 
(L4 Li promoter. By testing whether reporter activation is dependent on galac-
tose. mutational events which lead to reporter activation can be distinguished 
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from t\V()-liVl)1i(l interactions. 
Time yeast two-hvbli(l system has proved invaluable in dissecting protein-
protein interactions involved in ubiquitin-mediated proteolysis. Although homology-
based cloning can be used to identify putative E3s within a specific family, 
interaction-based approaches must be taken to Identify novel classes of E3 or 
lil)i(fuitiuiatwn aiicillarv proteins'. The increasing awareness that RING-finger 
Proteins are common players in ubiquitinatioui is partly a result of yeast two-
IIVI)Fi(l Scl(ti5. These include screens which set out to find substrates and/or 
cognate E3s for E2s of interest, and identified novel RING finger proteins (Moyni-
but ct uI.. 1999: Lorick et al., 1999), as well as screens vluchi used medically 
iliil)oilant RING finger proteins as bait and found that the basis for their effects 
he in their participation in the ubiquitimi pathway. For example, Yokouclii ct (Li. 
1999) reported that the tumour-suppressing activit of c-Cbl is due to its abil-
it.v to j)l'ornote the ligan(1-induced uibi(1uIitiulatioii of the epidermal growth factor 
receptor. via an interaction with the E2 UbcH7. 
Yeast two hybrid screens were used to identify the components of human 
SCF (olnpleXeS. Using liCull , the closest known Cdc53 relative in humans, as 
halt. Lyapina et al. (1998) isolated hSkpl, confirmed the association in vivo and 
showed that the two proteins formed an SCF-like complex in vitro with the F-
1 ox protein Skp2. Cenciarelh et al. (1999) searched for further luuinian F-box 
proteins using liSk1)1 as a bait, and isolated a total of 26. A modified version 
of the yeast tVO-hiyl)1i(l system was used to elucidate protein-l)rotein interactions 
involved iii the formation of \BC complexes, which require time presence of more 
I han two components (Pause et al.. 1999). Elomigimis B and C, wlieii coexpressed in 
Yeast. fi)inl a stable complex which interacts with the von Hil)I)el-Lindau tumour 
suppressor protein (VHL) . Only when all three of these proteins are expressed 
can it cullin, hCUL-2, associate to form a heterotetramneric complex. By using 
I ruiilcate(l proteins in the system. Pause et al. (1999) were able to show that the 
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elongin BC dimer acts as a bridge between the cullin and the putative substrate 
recruitment subunit \/HL, reminiscent of the interactions which make up the SCF 
complex. 
Similar screens have been used to dissect physical interactions between E2s 
and Ms. Closely related E2s show high specificity in their interactions with 
various Hect-domain proteins, and the degree of interaction correlates with the 
abilities of the various E2-E3 combinations to ubiquitinate substrates (Kumar 
et at., 1997). Putative targets can be identified by using E3 proteins as baits. 
Whereas the mammalian Hect-domain E3 E6-AP was originally identified through 
its interaction with the viral E6 protein and subsequent ubiquitination of p53, 
two-hybrid screens have more recently revealed that its targets in uninfected cells 
include Src tyrosine kinases and the DNA repair protein HHr23a (Kumar et at., 
1999; Harris et at., 1999; Oda et at., 1999). 
4.2 The UbcD4 interaction trap 
I used the yeast two-hybrid system to screen for proteins which interact with 
UbcD4. UbcD4 is a class II ubiquitin-conjugating enzyme. These enzymes con-
sist of the conserved catalytic UBC domain with a C-terminal extension. Some 
class II E2s demonstrate E3-independent substrate ubiquitination in vitro. Their 
C-termini are highly divergent, suggesting that they may be involved in selec-
tion of specific substrates. Since UbcD4 may interact directly with its substrates 
in the absence of a cognate E3, a yeast two-hybrid screen may identify puta-
tive UbcD4 substrates. Other UbcD4-interacting proteins would be expected to 
include its cognate E3, and any ancillary factors which mediate either E3 recog -
nition, substrate ubiquitination or proteasomal docking of the E2-E3-substrate 
complex. 
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Figure 4.2: Flow chart for performing an interaction trap 
110 




BamHI Sall NcoI.NotI.Xh: 
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Figure 4.3. '\laps of the plasniids used to riiake hybrid proteins for the UbcD4 
interact ion trap. A: pEG202 LexA fusion plasmid. UbcD.4 was cloned into the 
EcuRJ-BamHI site. B: p,JC,4-5 B42 transcriptional activation domain (1342 TAD) 
luisioii I)laSiuli(l .A liliraiv of' Drosophila cDNAs was cloned into the pJG4-5 
IoRI-XhoJ site. Abbreviations: ADHI)rO = alcohol (lehly(l1ogerlase promoter, 
ADHter = alcohol deliyclrognase terminator, AnipR = auipicilliii resistance gene, 
C;AL Ipro = GAL] promoter, HA = liaeuiiagglutiiiin epitope, HIS3 = HISS se-
lectable uiiarker, nuc. loc. = nuclear localisation signal, 1)BRori = pBR322 origin 
of replication, pUCori = pUC origin of replication. TRP1 = TIIP1 selectable 
uujaiker, 2mm = 2 1iM origin of replication. 
4.2.1 Construction of the UbcD4 bait plasmid 
)ligouiucleotides complementary to the l)eginlling and end of the UbcD4 coding 
sequence were synthesised (D4. B 1 and D4.132 - see Table 2.5). The 'plus' arid 'nui-
mis strand ohigoniucleotides incorporated restriction sites for EcoRI and BamHI 
respectively. The coding sequence was amplified by PCR. using \Teiit polyrnerase. 
A single PCR product of the expected size, approximately 600 bp, was obtained. 
Single 'A' overhangs were added by incubation NN, ith Taq polyrnertse and dATP, 
and the pio(luct was cloned into the pGEM-T cloning vector, which has single 'T' 
overhangs. The inserts of the transformants were sequenced until an insert with 
no mutations was identified. This was then subcloned into the EcoRI/BamHI-
digested bait vector pEG202 (Figure 4.3). The insert was again sequenced to 
vemifv that the (JbcD4 sequence was in frame with that of LexA. 
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4.2.2 Preliminary tests on the LexA-UbcD4 hybrid pro-
tein 
The bait construct was transformed into the EGY48 yeast strain (see Table 2.2) 
and various tests of its suitability were performed. The lacZ reporter plasmid 
used in the two-hybrid screen, p18-34, was transformed into EGY48 along with 
the bait vector. The transformants were plated on medium lacking leucine, and 
on medium containing X-gal, in order to ensure that the bait hybrid protein 
was unable to stimulate transcription of LEU2 or lacZ. In both tests, the bait 
hybrid protein demonstrated no transcriptional activation ability. The pJK101 
reporter was used to verify that the bait protein was able to enter the nucleus and 
bind the LexA operators. This reporter has a constitutively active lacZ reporter 
with LexA operator sites positioned such that binding of a LexA fusion protein 
represses its transcription. Colonies transformed with pJK101 alone were l ac Z+, 
whereas yeast transformed with both the bait vector and pJK101 were lacZ. 
Proteins were extracted from bait- expressing yeast and analysed by Western 
blotting using a LexA antibody. A band of the expected size, approximately 
47kDa (22kDa LexA and 25kDa UbcD4), was observed after chemiluminescent 
detection, demonstrating that the full- length bait fusion protein is stable in yeast. 
These tests established that the LexA-UbcD4 bait and the EGY48 yeast strain 
were a suitable combination for use in a yeast two-hybrid screen. 
4.2.3 Primary screening for bait-prey interactions 
A library of Drosophila embryonic cDNAs fused to the B42 transcriptional ac-
tivation domain, in the pJG4-5 plasmid, was obtained as a gift from R. Finley 
(see Figure 2.3). The hybrid genes are expressed from the GALl promoter. The 
library had been generated from 3.5x10 6 independent transformants, with in-
serts sized 0.3 - 1.5 kb. EGY48 yeast, which had already been transformed with 
the bait and p1834 lacZ reporter plasmid, was transformed with 50 ig library 
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DNA, yielding 5.6x10' colonies. The yeast was scraped off the plates, washed, 
resuspended in glycerol and stored at -70 T. 
An aliquot of the transformed yeast was thawed and the replating efficiency 
was calculated. Sufficient yeast to yield 5 x 10 7 colony-forming units was thawed 
and incubated in galactose/raffinose medium without uracil, histidine or trypto-
phan (Gal/Raff/CM -Ura -His -Trp). Galactose was used to induce expression of 
the prey proteins. Raffinose was included because yeast grows poorly when galac-
tose is the only carbon source, and raffinose does not cause catabolite repression 
of the GALl promoter. After induction of library expression, the cells were plated 
on a total of 34 Gal/Raff/CM -Ura -His -Trp -Leu plates, to select for colonies 
with expression of the LEU2 reporter gene. A total of 209 colonies, which grew 
in 3 days, were streaked onto master plates and then replica plated onto Glu/CM 
-Ura -His -Trp -Leu, Glu/Xgal/CM -Ura -His -Trp, Gal/Rafl/Xgal/CM -Ura -His 
-Trp and Gal/Raff/CM -Ura -His -Trp -Leu to identify colonies which exhibited 
a galactose- dependent lacZ+LEU phenotype. Only three such colonies were 
identified. In order to increase the efficiency of the screen, another 5x10 7 colony-
forming units were plated on Gal/Raff/Xgal/CM -Ura -His -Trp -Leu, so that 
activation of both the lacZ and LEU2 reporters could be assayed simultaneously. 
54 blue colonies were obtained after 4 days incubation. 34 of these were found to 
have a reproducible galactose-dependent 1acZLEU2 phenotype. Plasmid DNA 
was isolated from these colonies and electroporated into the MC1066 strain of 
E. coli, which is uroThistrp (see Table 2.1). trp+ transformants were selected 
and screened by PCR using the primers BCO1 and BCO2 (see Table 2.5), which 
flank the multiple cloning site on the library plasmid pJG4-5. PCR screening was 
repeated until at least three pJG4-5 colonies had been identified, and the sizes 
of the PCR products were compared. This was to ensure that each original yeast 
colony had only contained one prey plasmid. pJG4-5 plasmid DNA was isolated 
from the E. coli. 
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4.2.4 Reproducibility and specificity tests 
In order to eliminate 'false positives', the specificity and reproducibility of the 
bait-prey interactions were tested. Reproducibility was tested by introducing the 
bait and reporter plasmids into EGY48 yeast and then transforming these cells 
with each of the putative UbcD4-interacting prey plasmids. The transformants 
were streaked onto Gal/Raff/CM -Ura -His -Trp -Leu and Gal/Raff/Xgal/CM 
-Ura -His -Trp. A total of 15 LexA-UbcD4/prey transformants were found to 
have a reproducible LEU2 phenotype. 12 of these also had a reproducible 1acZ 
phenotype. It was also necessary to test whether the interaction was specific to 
a UbcD4 bait, or whether it also occurred with an unrelated LexA hybrid pro-
tein. The reproducible UbcD4-interacting prey plasmids were co-transformed into 
EGY48 cells containing the reporter plasmid and a bait plasmid in which LexA 
was fused to the Bicoid homeodomain. 5 prey plasmids produced the 1acZLEU2 
phenotype in combination with the LexA-Bicoid bait, and were discarded. Of the 
reproducible and specific UbcD4-interacting preys, those which produced activa-
tion of both reporters were classified 'strong' or 'medium' interactors depending 
on the strength of lacZ activity. Those which activated only the LEU2 reporter, 
which has more LexA operators than lacZ, were classified 'weak' interactors (Fig-
ure 4.4). The inserts of the plasmids were then sequenced and their identities 
determined by BLAST searches (see Table 4.1). 
4.3 Analysis of the putative UbcD4-interacting 
proteins 
Four of the 'strong interactor' plasmids contained inserts encoding part of the 
polyubiquitin-binding subunit of the proteasome, Pros54. Of these, at least three 
had come from different plates in the primary yeast transformation and therefore 
represented independent identifications of the interaction. Two independently-
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Figure 4.4: Specificity tests on UbcD4- interact ing proteins. 
Strong interactors. The prey proteins Pros54 (I) and CG3356 (II) are co-
expressed with either the Bcd bait or a UbcD4 bait. Individual colonies were 
streaked onto Gal/Raff/X-gal/CM -Ura -His -Trp. Only colonies expressing the 
lJbcD4 bait produce a blue colour. 
Medium iiiteractor. The prey protein CG8775 was co-expressed with either 
the Bcd bait or the tJbcD4 bait. Colonies were streaked onto Gal/Raff/X-gal CM 
- [Ira. -his -lrp. Only colonies expressing the U bcD4 bait produce a blue colour. 
Weak inteiactors. The prey proteins Gt, Shaggy (Sgg), CG5839 and C05862 
were co-expressed with either the UbcD4 or Bccl baits, and colonies were streaked 
onto Cal/Raff/X-gal/CM -Ura - His -Trp - Len. In the case of Ct, CG5862 and 
(C5839, colonies expressing UbcD4 can grow better than those expressing Bcd. 
Sgg is an example of a prey which interacts with both baits. 
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Gene Gene product Hits lacZ LEU2 
Pros54 Proteasome subunit 3 -----j- +++ 
CG3356 Ubiquitin ligase 2 ++-- 
CG8775 Putative zinc metallopeptidase 1 + ++ 
CG5839 Putative zinc metallopeptidase 1 - + 
Giant Transcriptional repressor 1 - + 
CG5862 Novel protein with PCI motif 1 - + 
Table 4.1: UbcD4-interacting proteins. The third column indicates the number 
of independently-identified plasmids which encoded each protein. The fourth 
column indicates the strength of the blue colour produced on X-gal medium by 
colonies co-expressing the relevant prey with the UbcD4 bait. The fifth column 
indicates the level of growth on medium lacking leucine by the same colonies. 
gene, CG3356, which encodes a putative Hect-domain E3. The 'medium inter-
actor' CG8775, also encoded a novel protein, in this case with a putative zinc 
protease motif and similarity to mammalian aminopeptidase A. The three 'weak 
interactors' had inserts representing different genes. One encoded the transcrip-
tional repressor Giant. The other two encoded novel proteins. One of these, 
CG5839, had a putative zinc protease motif and similarity to insect aminopep-
tidase N. The other predicted protein, CG5862, was significantly similar only 
to uncharacterised ORFs in C. elegans and A. thaliana in BLAST searches. A 
PROSITE search revealed a PINT/PCI motif which may indicate an association 
with the proteasome. 
4.3.1 UbcD4 interacts with the polyubiquitin-binding sub-
unit of the proteasome. 
The most frequently-identified UbcD4 interactor is Pros54, the Drosophila ho-
mologue of the mammalian S5a and the yeast RpnlO proteins. This is the only 
proteasomal subunit which has been shown to bind ubiquitin chains with high 
affinity (Deveraux et al., 1994). S5a has two polyubiquitin binding sites, PUbS1 
and PUbS2, which interact preferentially with chains of between 4 and 8 ubiq-
uitin residues (Young et al., 1998). Pros54 is 52% identical to S5a (Figure 4.5). 
Haracska and Udvardy (1997) have shown that polyubiquitin binds to two regions 
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Figure 4.5: CLUSTALW alignment of the Drosophila Pros54 protein with yeast 
RpnlO and mouse S5a. The uhiquitin-binding region PUbS1 spans residues 196-
241 on the mammalian protein and includes the GVDP tetrapeptide conserved 
between all S5a homologues. The second ubiquitin-binding region, PUbS2, spans 
residues 263-307 of the mammalian protein and is only present in S5a horno-
logues from higher eukaryotes. Abbreviations: D . m . = Drosophila rnelanogaster, 
S.c. = Saceharomyces cerevisiae, M .rn. = M'as musculus 
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of Pros54, which include the motifs corresponding to PUbS1 and PUbS2. It is 
not clear which part of Pros54 binds UbcD4, as the shortest Pros54 fragment 
identified in the two-hybrid screen lacks only the N-terminal 55 amino acids of 
the 396 amino acid protein. 
Although RpnlO is the only subunit which has been shown to bind polyu-
biquitin, it is not absolutely required for proteasomal docking of a ubiquitinated 
substrate. Yeast strains lacking RpnlO are impaired in the degradation of only 
a subset of test substrates, and do not exhibit the phenotypes characteristic of 
proteolysis - defective proteasomal mutants (Van Nocker and Vierstra, 1993). An-
other potential delivery mechanism is an interaction between the E2-E3-substrate 
complex and the proteasome. Several recent studies demonstrate such interac-
tions. 
A significant proportion of the yeast E2 Ubc4 in the cell is associated with 
the proteasome (Tongaonkar et al., 2000). Consistent with the requirement of 
this E2 for the stress response, the interaction between Ubc4 and the proteasome 
is increased following heat stress. Purified proteasomes can conjugate ubiquitin 
to a test protein, demonstrating the presence of active ubiquitination enzymes. 
Two yeast E3s, Ubri and Ufd4, interact directly with specific subunits of the 19S 
particle of the proteasome (Xie and Varshavsky, 1999). In coimmunoprecipitation 
and GST-pulldown experiments, Ubri binds to Rpn2 and to the ATPases Rptl 
and Rpt6, while Ufd4 binds Rpt6. These results suggest that interactions between 
the E3 and the 19S particle mediate delivery of the substrate to the chaperone-like 
subunits of the 26S proteasome. 
Direct interactions between ubiquitination enzymes and the proteasome have 
not been reported in multicellular organisms. However, recent research indi-
cates that such associations may be mediated by members of the type 2 family 
of ubiquitin-like proteins, which contain a non-cleavable and non-transferable 
ubiquitin-like domain. A complex containing proteasomal subunits, the E3 E6- 
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AP, and hPlic-2 has been detected in human keratinocytes (Kleijnen et al., 2000). 
hPlic-2, which contains a non-cleavable ubiquitin-like domain, was identified by 
its ability to interact with E6-AP in a yeast two-hybrid screen. Overexpression of 
full-length hPlic-2 proteins interferes with the in vivo degradation of p53 and I-KB, 
indicating a functional involvement of hPlic with ubiquitin-mediated proteolysis. 
hPlic-2 may provide a link between the protein ubiquitination and degradation 
machineries. E6-AP interacts with another protein containing a Ubi domain, 
hHR23a (Kumar et al., 1999). hHR23a and hHR23B are human homologues of 
the yeast nucleotide excision repair (NER) protein Rad23. Functional data, and 
co-immunoprecipitation with the proteasome, have implicated hHR23 and Rad23 
in regulation of ubiquitin-mediated proteolysis (Hiyama et al., 1999; Lambertson 
et al., 1999; Schauber et al., 1998). In a yeast two-hybrid screen, hHR23A and 
hHR23B interact specifically with the polyubiquitin-binding proteasomal subunit 
S5a (Hiyama et al., 1999). 
Taken together, these studies raise the possibility that direct and indirect asso-
ciation between ubiquitination enzymes and proteasomal subunits might couple 
polyubiquitination of a substrate with its degradation. It is not clear whether 
ubiquitination enzymes are constitutively present in the proteasome or whether 
the association is subject to regulation, nor whether substrate polyubiquitination 
is a prerequisite for docking of a ubiquitination enzyme onto the proteasome. 
The finding that UbcD4 can interact with the Drosophila S5a homologue is the 
first demonstration of direct association between an E2 and the proteasome in 
multicellular organisms. 
4.3.2 UbcD4 interacts with a novel protein which may 
associate with the proteasome 
One of the three weak interactors identified in the screen is the product of the 
CG5862 gene. The predicted CG5862 amino acid sequence includes a nuclear 
localisation signal and a PINT domain. The PINT domain, also known as a 
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PCI domain, is a conserved region of unknown function found in the C-terminal 
region of several regulatory components of the 26S proteasome : yeast Rpn3, 
Rpn5, Rpn6, Rpn7and Rpn9; and mammalian p55, p58 and p44 (Hofmann and 
Bucher, 1998). The motif is also found in translation initation factor 3 subunits, 
and in other proteins (Hofmann and Bucher, 1998). All of the characterized pro-
teins containing PINT domains are parts of larger multi-protein complexes. The 
complete PINT domain is approximately 200 residues, but the highest conserva-
tion is found in the C-terminal half. Several PINT-containing proteins, including 
CG5862, have no significant similarity to the N-terminal half of the domain. The 
only sequences which are detectably similar to CG5862 on a BLAST search are 
putative proteins in A. thaliana and C. elegans (Figure 4.6). 
In situ hybridisation analysis reveals a complex expression pattern for CG5862 
in embryos (Figure 4.7). Until completion of germband retraction, CG5862 tran-
scripts are abundant throughout the embryo. In late blastoderms and early gas-
trulae, expression is particularly high in the yolk nuclei, which remain in the 
centre of the embryo after most of the nuclei have migrated to the periphery. 
During germband extension, strong staining is observed in a layer of cells along 
the inside of the germband, which may be the neuroblasts. During germband 
retraction, CG5862 expression appears in the mature salivary glands. It remains 
high in the salivary gland until the end of embryogenesis, whereas the rest of the 
embryos shows little CG5862 expression after stage 14. 
Is the CG5862 product a putative substrate for UbcD4-mediated degradation, 
or does it facilitate proteasomal docking of a UbcD4-substrate complex ? The 
presence of the PINT domain indicates that it may associate with the proteasome. 
It is becoming increasingly clear that proteasome composition is highly dynamic, 
with various factors reported to associate transiently and substoichiometrically. 
As discussed previously, proteins which can associate with both the ubiquitination 
and proteolytic machineries may facilitate coupling of the two processes. Perhaps 
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Figure 4.6: ( 1 LUSTALW alignment between the PINT domains of Drosophila 
CG5862 and its closest relatives, A. thaliana (A.t.) AL035680 and C. elegans 
(C.e.) ZK1236.7, and the S. cerevisiae (S.c.) proteasomal subunits Rp113 and 
Rpn7. The sequences shown start at positions 176, 156, 113, 355 and 300 of the 





Figure 4.7: Embryonic in situ hybridisation analysis of CG5862 expression. A - 
stage 5 embryo. B - stage 10 embryo. C - stage 12 - 13 embryo. Abbreviations: 
sg = salivary glands, yn = yolk nuclei 
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CG5862 fulfills this function for UbcD4-mediated proteolysis. 
4.3.3 Two UbcD4 interactors are gut-specific putative 
zinc metallopeptidases 
One of the plasmids encoding a strong interactor had an insert corresponding to 
the final 583 bp of the CG8775 gene. A weak interactor had an insert correspond-
ing to the final 880 bp of the CG5839 gene. Both these predicted genes encode pu-
tative zinc metallopeptidases, as they contain the zinc-binding motif common to 
all such proteins (Rawlings and Barrett, 1995). This motif is defined as HEXXH, 
where the two histidines are the zinc-binding residues and the glutamate is the 
active site residue. It can be defined more stringently as [GSTALIVN]-x(2)-H-
E- [LI VMFYW]-DEHRKP-H-x- [LIVMFYWGSPQ]. Zinc-dependent metallopep-
tidases can be classified into 21 distinct families. Based on their sequence simi-
larity to known zinc metallopeptidases, CG5839 and CG8775 both fall into the 
Ml (membrane alanyl dipeptidase) family, which includes insect and mammalian 
aminopeptidase N (APN) and mammalian aminopeptidase A (APA). This family 
share a 'membrane alanyl dipeptidase signature motif' consisting of 5 elements, 
the fourth of which contains the zinc-binding site. 
4.3.3.1 Sequence analysis of CG8775 and CG5839 
CG8775 is 38% identical and 55% similar to human aminopeptidase A (APA). 
APA is a 957 aa cell-surface protein consisting of a short N-terminal cytoplasmic 
domain followed by a transmembrane region and a large extracellular domain, 
which includes the zinc-binding site. The predicted product of CG8775 is a sim-
ilar size, 985 amino acids. The sequence of the CG5839 protein is most similar 
to insect aminopeptidase N (APN). Both insect and mammalian aminopeptidase 
N are approximately 980 amino acids long. The CG5839 product is almost twice 
as large, 1878 aa, with 49% identity between the first 930 and the second 948 
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Figure 4.8: Sequence analysis of the putative aininopeptidases CG8775 and 
CG5839. 
Diagram showing the relative positions of the cytoplasmic and transmembrane 
domains, and of the membrane alanyl dipeptidase and zinc-binding motifs, in 
human aminopeptidase A, CG8775 and CG5839. CG5839 is shown split into 
two domains, which are 49% identical to each other. Human APN has a similar 
organisation to APA and is not shown here. 
CLUSTALW alignment of the regions of human APN and APA, and the two 
putative Drosophila aminopeptidases, containing the Ml family signature. The 
sequences aligned are residues 228-422 of human APA, 281-477 of CG8755, 218-
416 of human APN and 197-387 of CG5839. The HEXXH zinc-binding motif 
begins at. position 166 of H.s. APA in the alignment shown here. Abbreviation: 
H.s.=Homo sapiens, APA=aminopeptidase A, APN=aminopeptidase N. 
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dase N than the N-terminal (33% and 29% identical to Lymantria dispar APN 
respectively). Figure 4.8 shows the results of sequence analysis of CG8775 and 
CG5839 using SMART (Sequence Analysis Modular Architecture Research Tool) 
to predict transmembrane domains and a PROSITE scan to locate the Ml family 
signature and zinc-binding motifs. 
BLAST searches of the Drosophila genome using CG8775 and CG5839 as 
query sequences suggests that there are ten other putative members of the Ml 
zinc metallopeptidase family in flies. One of these, CG5845, has a similar size 
and structure to CG5839. The remainder are a similar size to CG8775, with the 
zinc-binding region in a similar position. 
4.3.3.2 In situ hybridisation analysis of CG8775 and CG5839 expres-
sion in embryos. 
In situ hybridisation analysis shows that both metallopeptidase genes are tran-
scribed in the gut (Figure 4.9). CG8775, the aminopeptidase A homologue, is 
highly expressed in the oesophagus of stage 12 embryos. Expression is also de-
tectable in the hindgut at this stage. The oesophageal expression alone persists 
until the end of embryogenesis. Apart from maternal transcript in the blasto-
derm, expression is not detectable at any earlier stage of embryogenesis. The 
aminopeptidase N homologue CG5839 is expressed in the hindgut of stage 15-17. 
There is no maternal transcript in the blastoderm and no detectable expression 
at any stage before stage 15. 
4.3.3.3 Discussion 
Both aminopeptidase A and N cleave the N-terminal residues from substrate 
proteins. Aminopeptidase A releases glutamate, and to a lesser extent, aspar-
tate, while aminopeptidase N releases alanine. Their best-studied roles are in 
the catabolic pathway of the renin-angiotensin system in mammals (reviewed by 
Ardaillou (1997)). In brain and kidney, aminopeptidase A hydrolyses the N- 
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Figure 4.9: Embryonic in situ hybridisation analysis of the putative metallopep- 
tidase genes CG8775 and CG5839 
LA -c : CG8775 expression. ILA-C: CG5839 expression. A - stage 5 embryo. 
B - stage 12-13 embryo. C - stage 14-15 embryo. Abbreviations: fgforegut, 
hg=hindgut, mg=midgut, oe=oesophagus 
terminal aspartate of angiotensin II to generate angioterisin III. Aminopeptidase 
N hydrolyses the N-terminal arginine of angiotensin III to generate angiotensin 
IV. Angiotensin III is the main effector of vasopressin release, and hence in-
crease in blood pressure. Aminopeptidase A is also present in blood cells and has 
been proposed to play a role in early B-cell differentiation. Aminopeptidase N 
is present in the intestine, where it can act as a receptor for human coronavirus 
229E (Yeager et al., 1992). In insects such as Manduca sexta and Bombyx mon 
aminopeptidase N is found in the midgut brush-border membrane, where it can 
act as the receptor for the Bacillus thuririgiensis toxin (Hua ci al., 1998). 
Although Drosophila does not appear to have an angioterisin homologue, it has 
two putative angiotensin-converting enzyme (ACE) homologues, members of the 
M2 zinc metallopepticlase family. ACE occurs in two forms in mammals. Somatic 
ACE (sACE) consists of two highly similar domains while testicular ACE (tACE) 
is identical to the C-terminal domain of sACE. sACE converts angiotensin I to 
angiotensin II, while the physiological role of tACE is unknown. The Drosophila 
homologues, AnCE (Cornell et al., 1995) and Acer (Tatei ci al., 1995), are single- 
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domain enzymes similar to tACE. Only AnCe is capable of cleaving angiotensin 
I (Houard et al., 1998). Both enzymes are expressed during pupal development, 
although at different stages (Houard et al., 1998). During embryogenesis, An CE is 
expressed in the amnioserosa, dorsal vessel (heart primordium) and midgut (Tatei 
et al., 1995). Acer is expressed in the embryonic midgut (Taylor et al., 1996). A 
P element insertion in AnCE causes homozygotes to die during larval or pupal 
development, and transheterozygotes for two different lethal alleles exhibit male 
sterility, suggesting that AnCE may be required for contractions of the heart, gut 
or testes (Tatei et al., 1995). 
It seems likely that CG5839 and CG8775 are involved in processing pep-
tide signals which regulate gut development or function. Their interaction with 
UbcD4, if it occurs in Drosophila embryos as well as in the two-hybrid system, 
may represent E3-independent substrate selection by UbcD4. The regions of the 
aminopeptidases which interact with UbcD4 in the two-hybrid system are pre-
dicted to be extracellular, raising the question of how ubiquitination of the mature 
protein could take place. Perhaps UbcD4 could interact with the aminopeptidases 
prior to their localisation to the cell membrane. 
4.3.4 UbcD4 interacts with the gap protein Giant 
The remaining weak UbcD4 interactor identified was the C-terminal 350 amino 
acids of the Giant (Gt) protein, giant is a gap gene and encodes a 448 amino acid 
basic leucine zipper -type transcriptional repressor (Capovilla et al., 1992). 
The embryonic gt expression pattern is shown in Figure 4.10. Early in de-
velopment, two broad stripes are observed at approximately 25% and 75% egg 
length, with two additional stripes appearing towards the anterior at the cellu-
lar blastoderm stage. Expression in several patches of cells in the head persists 
throughout embryogenesis. 






Figure 4.10: Embryonic in situ hybridisation analysis of giant expression. A. 
stage 5 embryo. B - stage 10 - 11 embryo 
Transcriptional repression by Ct defines the expression domains of the pair- rule 
genes even-skipped, fushi tarazu and paired as well as the gap genes kruppel and 
hunchback (Wu et al., 1998). Its transcription pattern suggests it may be required 
for head morphogenesis at later stages, and this is confirmed by mutational anal-
ysis. gt mutants display head defects including deletion of the posterior com-
partment of the labial segment (Petschek and Mahowald, 1990) and failure to 
complete head involution (Mohler et al., 1989). The anterior compartments of 
abdominal segments 5 -7 are also deleted and there is extensive cell death in the 
epidermal components of the embryo (Petschek and Mahowald, 1990). 
4.3.5 UbcD4 interacts with a putative E3 of the Hect-
doinaiii family. 
Two independent UhcD4-interactors represented a region of approximately 500 
hp from the 3' end of the CG3356 gene. The amino acid sequence encoded by this 
region is similar to the C-termini of several E3 enzymes of the Hect-domain family. 
All members of the family share a conserved 350 amino acid C-terminal region 
defined by its homology to the mammalian E6-AP carboxy terminus. Unlike some 
other E3s, Hect domain proteins are capable of forming a covalent linkage with 
ubiquitin and of transferring ubiquitiri to specific substrates. The Hect domain is 
responsible for binding E2s and for catalysing uhiquitin transfer. The N-termini of 
these enzymes are highly divergent and are thought to be responsible for substrate 
selection. 
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D .m.CG3356 MFGFDGEYRRRPVQSLGGASHTCDRDTVIRKAALERQKRNELRQKENGAVVLQSyARSFI 
H. s .A38919 MFSFEGDFKTRPKVSLGGASRKEEKASLLHRTQEERRKREEERRRLKNAIIIQSFIRGyR 
X.l .Nedd4 
S .p . Pubi 
H. s . E6-AP 
I .m.CG3356 HRQRRKRAEREVFDIYLMGHKDG ---- IVEDESLTFLLRRNFFSIREAKDSERIHvc 
H. s .A38919 
X.1 .Nedd4 -----------------------------------------------MAAPIYGSEDD 
S .p . Pubi 	--------------------------------------------------------MSNS 
H. S .E6-AP ------------------- -------------MKRAAAKHIERYHQLTGCGNEACTN 
D .m. CG3356 QQILIQPARLLQHSSPDSLW--LLRLCI(LLDTCLLQLSLSHTAQ --- AIpLRMETFTv 
H.s.A38919 QNLIKHSSLFKQLDGSERLTCLQIKRLMSLCCRLLQNCNDDSLNVALPMRMEVFSSE 
X.1.Nedd4 EESRILRVKISGTDLAKKD--IGASDpyVKSLyVADENRE ---------- ALVQK 
S.p.Publ 	AQSRRIRVTIAADGLYKRD--VRFpDpFAvTvDGEQTH'r ---------------- 
H.s.E6-AP EFCASCPTFLRMDNNAAAIK--ALELYI(INAKCDPHPSKKG ----------------- A 
D.m.CG3356 SSVQQYMKDEAVLQYMRVFGFL RNYVRLRRLDDF'CPpLDGETLHApSpLAEALL 
H.s.A38919 NTYLPVLQDASYVVSVIQILHyM HNGYYRSLYLINSLPSSIEYSDLSRVPIAKILL 
X. 1 . Nedd4 
S.p.Publ 	AIKKTLPYWNETEVNV-TDST IQVDQKKFKKK---GQ----------------- 
H.s .E6-AP ------- 
D.m.CG3356 QLLLREVAKRASAGGQMSSMSMACRNFTRDILATPHTDPLRYFVLPCFALNVDFPFD 
H.s.A38919 ENVLK }{FTYNSCP----EGARQQFTAFTEEFLAAPFTDIFHFIIPALADA------ 
X. 1 . Nedd4 PYTFKDFLLRPRSHKSRVKGFLRLKMAYLPKNGMQEEETNEREESEQAWDVVDSNDSSS 
S .p . Pubi ----- GFL ----------- GVINLRG ----------------------- DVLD ------ 
H.s.E6-AP ---YSI ------------ RVIGRFSSAEALVQ5FRKVKHTKEELKsLQAK ------ 
D.m.CG3356 LLMRSLYDALESAPASDSTSSRRSFLFYGVETGHKTRMDSIFSSFLLNSLMVDRRQ 
H.s.A38919 ---------- QTVFPYPFLNA ---- LLLIESRCSRKSGGAPWLFYFVLTVGEYGALS 
X. 1 .Nedd4 PHQQELPAPPMPPWEaKVDNLGR --- TYYVNHNNKSQWQRPSLDVASESDNIRYIQ 
S . p . Pubi ---------- LAIGDML -------- TRDLKKSNENVVHGKIINLSTTAQSTQ---  
H.s.E6-AP ----------- DEDKDDEKEK ----- AACSAAAMEEDSEASSSRGDS$QGDNQKL- 
D.m.CG3356 LATLHQSPLLVIYVLIAEMMPNILQLPKSTLRGHANAPHRHRDGDDISEESEDEDEELP 
H.s.A38919 ---- EEG --LLVYLVLQTFLS --- QLPVS ---- PASA--SCHDSASI  SEE --- ESEEAD 
X.1.Nedd4 ---- QEAHRVFRSRHISEDLEPEHLEGVGDMPEPWETISEEMTLTAITLNQSLPPASP 
S .p . Pubi --------- V-------------------------------------------- SSAAS 
H . S. E6-AP --------------------------------- G --------------------DDVSV 
D.m.CG3356 AATLDYDMEQTCRTSGELDVKERECLLEQIAILETERVDFIVQQL.PHI9NTHLIYAL 
H.s.A38919 KPSSPE ------- DGLSVDYITEECLKKLDTKQQTNTLN--LVWRISASHV__FTTM 
X.1.Nedd4 
S.p.Publ 	GAT ------ Q ---- TSITNDPQSSQSSDV - SRPASSRA-GSPTRINAPAAS ---- PA 
H.s.E6-AP DIDAI ---------- RVYTRLLSNEKIETA-FLALVYS-PNVECILTYHNV ---- YS 
D.m.CG3356 CEICHNMIYNKHAVFEYKLLYTLAFTPKFIRAVFKLAAESTQL --- GFSAPLTL SKG 
H.s.A38919 SRG
X. 1 .Nedd4 
S.p.Pub3. 	SDEPRTFSSF --- - DQYGR ---------- PPGERRTDNLGT--- YYDHNTRSTT 
H.5 . E6-AP R-DPNYNLFIIVMNRNLHSpEy ------ EMALPLFCKAMSKL --- PLAAQGKLRL 
D.m.CG3356 VVKHQGVDTIPLLATFCMLFGRLLpT DVEFVEKLLLQVHSTINHVRLMpFSIAI 
H.s.A38919 SPMSFEDSSIIPLFYLFSSLFSHSLISI DNEFFGDPIEVVGQRQSS --- MMPFTLEL 
X.1.Nedd4 TRIVQHAE -------------DGAVGSTSNSSNHLSEPQIRRPRSLS5pTVTLSAPLG 
S .p . Publ IRNLSSVA ------------- GAAAAESSASSAVTEGVQPSSSN ------- A---- 
H.s.E6-AP SKYNADQIR-M ---------- METFQQ ITYKVISEFNSRNLVNDD---------DAI 
D.m.CG3356 IQM KTkKDISMGEIVELnFIERRSNLANYR ---- 
H.s.A38919 
X. 1 . Nedd4 
S.p.Publ 	----- ARTEASVTSNTTAGS -------------- -E --LPGWaQYTPEGIPYFV 
H.s.E6-AP VAA9KCKMVYYANVVGGEVDNN ------------- NEEDDEEIPSSELTLQELLGE 
D.m.CG3356 NVVVFVLNQIHTlDLRLGFCpEDHwTvTRLDLLDRpTD LTHSSLRGIRPFQPR--
H.s .A38919 KVINLVKMLKSDTRRNFCPPNHWLSEQEDIKADKVTQ YVPASRHVWRFRMGGPL 
X.1.Nedd4 DHNKTTTWEi. - LKFPVHMR---TKASLNp---NDLcp PGWEEi1IHMDGF1TFyD--
S.p.Pubi. DHNRTTTWV'i R Q QYIRSYGGPNNATIQQQ• SQLGPP SGWEMLTNTAvYFVD--
H.s.E6-AP ERRNKKGPPV'. LETELGVKT---LDCRKPLI•FEEFINE•LNEVLEMDKDYTFFKVE__ 
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D.m.CG3356 
H. S .A38919 
X. 1 .Nedd4 
H14 DVGLES 
ITQWEDrR QN ---- PAITGPAV -YSREKQKYDY RKKLKKPA ---------- D 
S.p.Publ HN TTTWDDR ------- PSSLDQNVQYKRDRRKLIY --- LSQPALH -------- P 
H.s.E6-AP TEN FSFMTCFILNAVTKNLGLYYDNR-IRMYSERITVLYSVQGQQ----------- 
D.m.CG3356 QGPSVLIT Y= 
H.s.A38919 FLDGINVTIr 	Y Yr_'),%'JDK-SPENE 	 IFV 
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S.p.Publ 	LPGQCHII 	FAEI--MRQSATP'- 	 KDG-----DL'Y LSr 
H.s.E6-AP LNPYLRL!4A;_;1E: I 1Q YVEEG -----iQVsE 	SK 
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H.s.A38919 LNE1!LSCV NQF KTT--NEG YP 	AQMLVGDSFARHYY LAIM KL EM 
X.1.Nedd4 W F 	 vYL, E SAT" YT QI NGLC-NEDHLSYT 	TA 	VFHGK  %Ef 
S.p.Pub]. 	Y F SHMP 	(LP E SSVP' YT QI HGI--NPEHLNY K' _____ 
13.s.E6—AP Q VEIP - M' T D-ESTKFWFI SFE---TE--GQrT1 - 	 Ô'1NC 
D.m.CG3356 kFPLAEF LTJ A YSDDIHQAL' L RN LY ED SG' S- ND TASS H.s.A38919 PAGFI LS' _TSADDIHHAL' V EN LF KS D' E- GN TVNN X.1.Nedd4 	 IRP' KMM 	--QI LKMEDVJ.SP Y N KWI--L N'PT- DM CIDEE S.p.Publ FVVS! KMIQP --K LQi EDMI' Y P. 	WI--LDN'ITGV DT SEDN 
H.s.E6-AP 	 HPMVV RM--KG FR' GDSHVL Q KDLEGN EDDMMIT QISQT 
D.m.CG3356 S - LrAQTQ1E 	 LQ IAKVQ 	 - KELSNFJL-PI13 NL-  
H.s.A38919 D-L EAQVE_FGKDkf_SAIA IH A[4'1RQ RQHCL 	Q LANV-SL 
X.1.Nedd4 N- QTYQ._S(SEMV 	DR ID IQWFVNRVQKM LE TELl-AID 
S.p.Publ. 	C- EVVT' 	- RN H EEKR' VD TVWIQKREEF 	HE SELI-PQ13  
H.s.E6—AP DL NPM' ' EDK 1 EK' FVN YSIKSVEKFK R HMTNESP 
D.m.CG3356 WLYM SNI 	I SAEIP 'LPl'__KCEGEF_PE. S VT 	LEGDP.MQRflQ 
H.s.A38919 WLRM •QQrIQV SAQVP SL.)4dSF NS _AD V KV RVTECT, EK 
X.1.Nedd4 	IKI EN . - 	MC LG-DV' N'WRQ: L KN CPN: VQWr KAULLMDA  KRIR 
S.p.Publ INVP ER -_ IS-H ,M.:,WK. D RS- -ENDQI KW 	LMDEWSN KSR 
H.s.E6-AP 	KYLrRPEIPa_45 SR-NL'FQAEET H D 	TRDSVL REP IHST'QL 
D.m.CG3356 	K 	SC PL 	D ---DP--' F QNT DM—L; 	.1S TL K - FKTVQ 
H.s.A38919 KP SC PLL H Y----—A C HNG SDLP- S MILL K EFYDETL 
X.1.Nedd4 	• N AE YGSNGQL T EQW SP-DK Rfr,: 	 - - 
S.p.Publ • T
MIV 
I- N 	D QGSDGRK T EKA EP-NK •K: 4R 	- 	KKD 
H.s.E6-AP F • TA-VGLGK-------- KMI KN PDT -j  KK 
D.rn.CG3356 M 	Y- QSGA 	LS- 
H.sA38919 MSEMY C AEMLS- 
X.1.Nedd4 	 M V NQ 	GVD 
S.p.Pub]. DH SI V ETI GQE- 
H.s.E6-AP 	KR KTYK GML- 
Figure 4.11: (continued from previous page). Alignment of the CG3356 protein 
with its closest relative, A38919 and with the Hect-domain E3s E6-AP, Necid-
4 and Pubi. Identical residues are shaded black and similar residues shaded 
grey. Abbreviations : H.s. = Homo sapiens , X.I. = Xenopus laevis, S.p. = 
Schizosaccharomyces pombe. The Hect-domain consists of the C-terminal 350 
amino acids. 
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4.3.5.1 Sequence analysis 
Overall, the amino acid sequence of CG3356 is most similar to that of a hu-
man hypothetical protein, A38919. Identity between A38919 and CG3356 is 35% 
over the entire protein and 54% in the Hect domain. The next most similar se-
quences are putative proteins from A. thaliana, S. pombe, C. elegans and another 
Drosophila ORF, CG5087. Although these gene products are similar in size to 
A38919 and CG3356, there is no significant similarity for the first 600 amino 
acids. The alignment of the full-length CG3356 protein with A38919 and with 
the known Hect-domain E3s E6-AP, Nedd-4 and Pubi is shown in Figure 4.11. 
4.3.5.2 Expression analysis 
Developmental Northern analysis of CG8356 expression shows that two tran-
scripts are present in RNA from all stages of development (Figure 4.12). The 
larger transcript is approximately 3.5-4 kb, the size expected from its predicted 
3588-bp cDNA sequence in GadFly. This band is present at low abundance. The 
smaller band, which is highly abundant in all stages, is approximately 1.5 kb. 
It may represent cross-hybridisation to a related transcript, although BLAST 
searches do not detect any strong similarity between CG3356 and a gene of this 
size. Alternatively, it may be due to processing of the CG3356 transcript. In-
terestingly there are two cDNA sequences in GenBank representing the closest 
relative of CG3356, human A38919; one encodes the full-length protein (Gen-
Bank accession BAA02799.1) and a shorter version encodes the C-terminal 415 
amino acids (GenBank accession AC004975.1). Perhaps this truncated protein is 
a product of a processed transcript. 
In situ hybridisation reveals a complex and highly dynamic expression pattern 
for CG3356 in embryos (Figure 4.13). Maternal transcripts in the blastoderm 
appear localised to both poles. During gastrulation, expression is highest in the 
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Figure 4.12: Developmental Northern analysis of CG3556 expression. Each lane 
contains 2 jig of total RNA isolated from flies at the following stages of devel-
opment : 2 - 0-3 hour embryos : 3 - 3-8 hour embryos : 4 - 8-22 hour embryos 
5 - larvae of mixed ages : 6 - pupae : 7 - adults. Lane 1 contains E. coli riboso-
mal RNA and lane 8 contains DIG-labelled RNA molecular weight markers. The 
arrowheads indicate the sizes and positions on the filter of the molecular weight 
markers after detection with AP-conjugated anti-DIG. The bottom panel shows 
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Figure 4.13: Embryonic in situ hybridisation analysis of CG;1J56 expression. A - 
stage 1-3. B - stage 6. C - stage 8. D - stage 10-11. E - stage 12-13. F - stage15. 
Abbreviations: cf = cephalic furrow, ci = clypeolabrum, gb = gerrnband, gi = 
gnatbal lobes, ih = involuting head, prng = posterior midgut, st = stomodeum, 
tp = tracheal pits, pmg=posterior midgut. 
stage 8-9 embryos, high expression is seen at the extending tip of the germhand. 
At stage 10-11, expression is weak in most of the embryo, with CG3356 positive 
regions in the stomodeum, the gnathal lobes, along the ventral midline and in 
the invaginating tracheal pits. At stage 12, CG3356 expression is strongest in 
the newly-formed segmental furrows and in the clypeolabrum. After this stage, 
transcription fades in all regions except in the head. When head involution has 
been completed, CG3356 expression is no longer detectable. 
One notable feature of the embryonic CC3 956 expression pattern is that, from 
stage 10 onwards, expression seems to he highest in epidermal tissues as they un-
dergo morphogenetic movements. The major rnorphogenetic movements include 
head involution, formation of the tracheal pits, mesectoderm involution and for-
mation of the segmental furrows. The earliest events of head involution occur at 
stage 10. These are the invagination of the foregut primordium (stomodeum) and 
the formation of three gnat.hal segments (mandible, maxillary and labial) and the 
anteriormost head segment (clypeolabrum). After dorsal closure has been corn-
pleted, the clypeolabrumn moves to the interior of the embryo. The tracheal system 
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develops from the invagination of defined clusters of epidermal cells during stage 
10-11. By stage 12, the embryo becomes subdivided into 16 metameric units, cor-
responding with deep grooves in the epidermis, the segmental furrows. All these 
tissues exhibit high levels of CG3356 expression at various points between stages 
10 and 15. In each case, expression does not persist past the stage at which the 
relevant structure is forming. In younger embryos, expression is more widespread 
and is found in endodermal regions also, for example in the posterior midgut pri-
mordium. The extending germband consists of both ectodermal and endodermal 
tissues. However the correlation between CG3356 expression and morphogenetic 
movement is seen in all embryos after the blastoderm stage. 
4.3.5.3 Discussion 
The expression pattern of CG3356 suggests that, in embryos, it may have a role 
in regulating morphogenesis, particularly in the epidermis. Perhaps a CG3356 
substrate is involved in a process common to foregut, tracheal and segmental 
furrow formation. There are a number of genes affecting formation of all these 
tissues, primarily members of the segment polarity class such as decaperttaplegic 
and 18-wheeler. However Northern analysis shows that it is also transcribed in 
larvae, pupae and adults. This suggests either that CG3356 has multiple targets, 
or that its target is present throughout all stages. The sequence of CG3356 gives 
no indication of the identity of its substrate. There are no identifiable protein-
protein interaction motifs, and the Hect-domain proteins most similar to CG3356 
have not been studied. 
Unlike CG3356, UbcD4 is transcribed only in embryos. In embryos, the ex-
pression patterns of the two genes share some region of overlap, for example the 
cephalic furrow and the extending germ band, but have clear differences also. In 
particular, CG3356 expression is not detectable in the germ cells. This indicates 
that UbcD4 must be able to recognise substrates in the absence of CG3356, either 
independently or by co-operating with a different E3. Similarly, CG3356 must 
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co-operate with additional E2s. 
E2s can be divided into subclasses according to their functional co-operativity 
with different types of E3. The E2s which interact with Hect-domain E3s share a 
conserved phenylalanine residue at approximately position 63 in the UBC domain 
(Nuber and Scheffner, 1999). This residue is present in UbcD4. Individual E2s 
within this family co-operate preferentially with different subsets of Hect domain 
proteins, and this is due to selective physical interactions between the E2 and 
the Hect domain. For example, the human E3 E6-AP interacts specifically with 
the closely related E2s UbcH7 and UbcH8 in a yeast two-hybrid screen, and also 
co-operates specifically with these E2s in ubiquitin transfer (Kumar et al., 1997). 
The structure of the E6-AP - UbcH7 complex reveals the determinants of E2-E3 
specificity (Huang et al., 1999) (Figure 4.14). The E2-binding groove on the Hect 
domain is only moderately conserved between different E3s. UbcH7 has two Hect-
binding loops termed Li and L2. Li contacts the Hect domain at five residues, 
four of which are well conserved between Hect-specific E2s. However three of 
the four Hect-binding residues in L2 are variable, suggesting that this region 
could determine the specificity of co-operation between E2s and Hect-domain 
E3s. Overall, UbcDi is the Drosophila E2 most similar to UbcD4. Two of its 
L2 Hect-binding residues are identical to the corresponding residues in UbcD4. 
However the Drosophila E2 most like UbcD4 in L2 is Alt 1/CG4502. Three of the 
Hect-binding residues are identical, and the fourth is similar, between the two 
enzymes (Figure 4.14). Alti also has the conserved phenylalanine residue in Li 
which classifies it as a Hect-specific E2. Perhaps Alti is one of the other E2s 
which can co-operate with CG3356. 
4.4 Discussion 
The lack of suitable antibodies meant that none of the interactions described here 
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Figure 4.14: The interaction between E2s and Hect domain Ms. 
The E6-AP Hect domain - UhcH7 complex. The E6-AP N-terminal lobe 
and C-terminal lobe are coloured red and green respectively. UhcH7 is coloured 
blue. The two active-site loops are yellow. The ilect-binding loops of UhcH7 are 
labelled Li (residues 57-65) and L2 (residues 95-100). The dotted line indicates 
the open line of sight between the active-site cysteines of UbdH7 and E6-AP. 
Taken from Huang et al. (1999). 
Alignment, of the UbdHT Li and L2 sequences with the corresponding residues 
in UhcD4 and Altl/CG4502. Residues identical in all three proteins are in red, 
those identical in two proteins are in blue. Arrowheads indicate the residues 
in UbcH7 which contact the E6-AP Hect domain. The numbers indicate the 
positions of Li and L2 in the UhcD4 sequence. 
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the disadvantage of the two-hybrid system, in that they allow interactions be-
tween proteins which may never encounter one another in the embryo. However, 
the screen succeeded in uncovering proteins with which UbcD4 can interact re-
producibly and specifically. Two of the six interactors identified, the proteasomal 
subunit Pros54 and the E3 CG3356, are components of the ubiquitin - protea-
some pathway and a third, CG5862, has a domain which suggests it may associate 
with the proteasome. These proteins are therefore good candidates for ancillary 
factors in UbcD4-mediated degradation. The remaining three interactors, the 
metallopeptidases CG8775 and CG5839 and the transcriptional repressor Giant, 
may be UbcD4 substrates. Can any information on the possible role of UbcD4 
be inferred from its interactors ? Since most are novel proteins, this is difficult. 
However it is notable that four of the six interactors have embryonic expression 
patterns which suggest post-germband retraction roles in the head and foregut. 
gt is transcribed in specific groups of cells in the head and stomodeum, and 
is required for formation of both tissues. Foregut is really an extension of the 
gnathal segments of the head and is determined by the same genes (spalt, the 
head gap genes including gt, and the Antennapedia- complex genes Deformed and 
Sex combs reduced). The expression pattern of gt in the head is dynamic and 
highly specific. Perhaps ubiquitin-mediated proteolysis is required as well as tran-
scriptional regulation to ensure that Gt is eliminated from particular cells when 
necessary. CG3356 is expressed in the stomodeum, gnathal lobes and clypeo-
labrum. CG5862 and CG8775 are specifically transcribed in the salivary glands 
and oesophagus respectively. CG5839 is the exception, being transcribed in the 
hindgut. UbcD4 is strongly but not specifically expressed in head and foregut at 
this stage. 
The results of the screen yield little information on possible roles for UbcD4 
in germ cell development. A putative UbcD4 substrate in germ cells need not be 
specifically transcribed in germ cells - it may be a widely-expressed protein whose 
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destruction is required in migrating germ cells. However presence in the germ 
cells is obviously a prerequisite. Neither the E3 CG3356, nor the putative metal-
lopeptidases CG8775 and CG5839, nor gt, are transcribed in germ cells. CG5862 
transcripts are not present in mature gonads, but are abundant throughout the 
embryo at the stage when germ cells migrate. There are many reasons why the 
screen may have failed to identify the UbcD4 substrate in germ cells. Interactions 
which required an intact N-terminus in the prey protein may have been missed, 
as many of the library cDNAs had incomplete 5' ends. The mRNA may be rare, 
resulting in underrepresentation of the cDNA in the library, or recognition may 
require an E3 or other cellular factor. Proof that UbcD4 is involved in germ cell 
development, or in head and foregut development, requires mutational analysis. 
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Chapter 5 
Mutational analysis of genes 
encoding ubiquitinating enzymes. 
While gene expression and protein-protein interaction data can give information 
on specific processes in which protein ubiquitination is involved, direct proof of bi-
ological function requires mutational analysis. This chapter describes experiments 
which aimed to disrupt the function of various genes encoding ubiquitinating en-
zymes, and to analyse the resulting defects in embryos. The techniques used were 
a) P element mutagenesis and b) RNA interference. 
5.1 P element mutagenesis 
5.1.1 Introduction 
Spontaneous mutations in Drosophila are often due to mobile genetic elements. 
The P element was discovered through its association with male recombination 
and with 'hybrid dysgenesis' - a collective term for the defects found in the off-
spring of crosses between females from certain laboratory stocks and males from 
wild strains. The phenomenon is due to the mobilisation of P elements in the 
germline of the hybrid offspring. The discovery of P elements, and their use in 
insertional mutagenesis, has been reviewed by Grigliatti (1998). 
Complete P elements consist of the transposase coding sequence flanked by 
31 bp inverted repeats. Defective elements carry deletions in the transposase 
gene and cannot transpose autonomously. However if the ends of the element are 
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present, they can be mobilised if transposase is provided in trans. The transposase 
gene consists of four exons. In somatic tissue, the third intron is not removed by 
splicing, hence transposition occurs only in the germline. 
P elements transpose by a 'cut and paste' mechanism, in which the donor 
element is excised and reinserted into a recipient site. They display a preference 
for inserting into the 5' UTR of genes. Excision of a P element leaves behind 
a double-strand DNA break which is repaired using either the sister chromatid 
or the homologous chromosome as a template. If the sister chromatid is used, 
the end result of transposition is a net gain of one P element copy. Aberrant 
repair can lead to various types of imprecise excision, leaving either insertions or 
deletions at the original site of insertion. Thus P elements can cause mutations 
both by inserting into genes and by imprecise excision 
These features of P element transposition have been adapted to create a 
method for insertional mutagenesis. Two important modifications have been the 
separation of the source of transposase from the mobile element, and the develop-
ment of defective elements which carry selectable markers and bacterial plasmid 
sequences. The most frequently used type of element consists of P element flank-
ing sequences within which is a wild-type eye colour marker gene, a lacZ gene, an 
antibiotic resistance gene and E. coli origin of replication. The P element flank-
ing sequences are capable of being acted on by exogenously-supplied transposase. 
The eye colour gene, usually rosy (ry) or a white (w) derivative, allows detection 
of flies carrying the element. The lacZ gene is under the control of the weak P 
element promoter and its expression is sensitive to the effects of nearby promoters 
- this is useful in 'enhancer trap' screens for genes expressed in particular tissues. 
The plasmid sequences allow rescue of part of the element, along with its flanking 
sequence, by digestion, ligation and transformation into E. coli of fly genomic 
DNA. 
The source of transposase is a stably-integrated P element in which the third 
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intron is deleted, causing somatic as well as germline production of transposase. 
Crossing flies carrying this element, known as P[ryz.2-3], with flies carrying 
a marked transposable P element produces Fl flies in which transposase and 
transposable element are both present. Mutagenised chromosomes are 'cloned' 
by producing stocks from individual F2 flies. Flies carrying the potentially mu-
tagenised chromosome but not the transposase source are selected, so that any 
insertions produced are stable. Mutations in novel genes, which function in a par-
ticular process, can be detected by screening for specific phenotypes. Flanking 
sequences can be directly cloned by plasmid rescue of the P element. Insertions 
in or near a specific characterised gene can be detected by PCR amplification of 
genomic DNA using a P element-specific primer and a gene-specific primer. 
The Drosophila Genome Project provides a series of cytologically mapped P 
element insertions which disrupt genes essential for viability. In many cases, the 
sequence flanking the insertions has been determined. Searches of the P element 
flanking sequences in FlyBase failed to reveal any uncharacterised insertions in 
E2 or E3 - encoding genes. However a putative insertion in the El gene, Dubal, 
had previously been identified by Dr. P zur Lage. I analysed the phenotypes 
resulting from disruption of Dubal. 
5.1.2 Analysis of an insertion in Dubal 
A P element insertion mapping to the same polytene band as Dubal (46A1 -A2 
on the second chromosome) was identified in FlyBase by P. zur Lage. The allele 
caused by the insertion was called 1(2)0340 5. A stock carrying the allele, P1329, 
was obtained from the Bloomington Stock Centre (see Table 2.4). All P1329 
adults are heterozygous for 1(2)03405, indicating that homozygosity is lethal. 
The allele is balanced by the CyO chromosome. 
Using primers complementary to the P element inverted repeats (P31 - see 
Table 2.5) and to Dubal sequences (Y4104 and 6067 - see Table 2.5), I amplified 
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P31 	 P31 
4- + 
Dubal r 	t4104 	 ATG 
	 W)67 
	
453 	600 	853 	 1021 	1994 	 3229 
Figure 5.1: The P element insertion in allele 1(2)0305 of Dubal. The Dubal 
transcription unit, up to the end of the second exon, is shown in grey (from 
GadFly entry FBan0001782). The bent arrow indicates the transcription start site 
and wide areas represent exons. The position of the translation initiation codon 
(ATG) is shown. The P element is in white, with black triangles representing 
the terminal inverted repeats. Numbers in hold represent positions relative to 
the predicted transcriptional start site. Arrows represent the primers used in 
determining the position of the insertion. 
the region flanking the insertion. Sequencing the PCR, products revealed that 
the P element was positioned at nucleotide 600 of the cDNA, 253 nucleotides 
upstream of the translation initiation codon (see Figure 5.1). 
5.1.2.1 Excision of the P element from 1(2)0305 to generate viable 
revertants 
The mutant allele in stock P1329, 1(2)0305, is a recessive lethal. In order to show 
that the P element insertion, rather than a separate mutation, is responsible for 
the lethality, I excised the element using the method described by Torok et al. 
(1993) (see Figure 5.2). Four lines were obtained, each of which yielded viable 
liomozygotes for the 1(2)0305 derivative allele. Amplification and sequencing of 
Dubal from each line revealed that excision of the P element was precise. While 
this result shows that the inviability of 1()0305 homozygotes requires the pres-
ence of the P element, it does not prove that the phenotype is due to disruption 
of Dubal expression. Proving this would require rescue of the phenotype by pro-
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Figure 5.2: Scheme for excision of the P element from the 1(2)0305 allele of 
Dubal. Stock numbers are in bold. P1329 males were mated en masse to virgin 
females from the stock B2535, which carry the P[ryA2-3] transposase gene. The 
male progeny which carried both the P element and the transposase gene (Sb, 
Ubx,ryj were mated to virgin females of the genotype Sco/CyO;ry506. Male 
progeny in which excision of the P element had occurred (Cy, ry, S co+, sb+, 
Sp- ) were crossed individually to virgin Sco/CyO ; ry506 females. Progeny carry-
ing the chromosome from which the P element had excised (P*)  were intercrossed, 
yielding Cy flies which were homozygous for the excision site. Abbreviations: Cy 
= Curly, Sb = Stubble, Ubx = Ultrabithorax, ry = rosy, Sco = Scutoid, Sp = 
Sternopleural. 
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5.1.2.2 Analysis of lethal phase of 1(2)03405 homozygotes. 
In order to determine whether 1(2)03405 homozygotes can complete embryoge-
nesis, 200 P1329 embryos were scored for their ability to hatch. 30% of P1329 
embryos failed to hatch, compared to 7% in the wildtype strain Oregon R53. 
Flies were generated which carried a second chromosome, with either 1(2)03405 
or CyO, in an Oregon R53 background. 11% of embryos failed to hatch in the 
1(2)034051+ strain, and 32% in the CyO/+ strain. These data suggest that 
the approximately 25% higher level of embryonic lethality in P1329 compared to 
wildtype is solely due to the inviability of CyO homozygote embryos. 1(2)03405 
homozygote embryos appear to complete embryogenesis. 
In order to identify 1(2)03405 homozygote larvae, and monitor their develop-
ment, I generated flies carrying 1(2)03405 over the balancer chromosome CyO-30 
(see Table 2.4). This is a second chromosome carrying CyO, a UAS-Green Flu-
orescent Protein (GFP) transgene, and a GAL4 transgene under the control of 
the Kruppel promoter (Casso et al., 2000). The GFP transgene is expressed at 
low levels in embryos and first instar larvae, and at higher levels in second and 
third instar larvae and pupae. 1(2)034 05 homozygotes can be identified by their 
lack of green fluorescence. Pupae and wandering larvae collected from the sides 
of a bottle of flies were all GFP (100 out of 100 scored in each case) (Figure 
5.3). When embryos were collected for one hour and allowed to develop at 25 ° C, 
GFP- larvae appeared to develop successfully to third instar, but not to pupate 
(Figure 5.3). 1(2)03405 is therefore a third instar larval lethal allele of Dubal. 
5.1.2.3 The P element insertion in 1(2)03405 does not completely 
abolish expression of Dubal 
In situ hybridisation analysis of Dubal expression was carried out on embryos 
from the P1329 stock. Dubal expression was not completely abolished in any 
embryos. Figure 5.4 shows embryos representative of the lowest levels of Dubal 
staining, which are presumed to be 1(2)034 05 homozygotes. Dubal expression 
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Figure 5.3: Identification of I()OJO5 honiozvgote larvae by lack of (;FP exprc-
sion. All individuals are from a stock carrying 1(2)034051Cy0-30 except for E 
and C, which are from Oregon R53. Anterior is to the right. A and B: Second 
instar larvae, GFP and GFP respectively. C and D: Third instar larvae, CFP 
and CFP respectively. E and F: Wandering larvae. All 1(2)03405/CyO-30 wan-
dering larvae were CFP+ (F). E shows the level of autofluorescence in a wildtype 
(Oregon 11,53) wandering larva. C and H: pupae. All 1(2)03051Cy0-30 pupae 
were CFP+ (H). C shows the level of autofluorescence in a wildtype pupa. 
no  





Figure 5.4: In situ hybridisation analysis of Dubal expression in embryos from 
the P1329 strain. The embryos shown in LA and 1.13 are representative of those 
with the lowest levels of Dubal expression, and are therefore putative 1(2)0305 
homozygotes. The embryos in H.A. and 11.13 were probed with Dubal sense RNA, 
and show background levels of staining. A - stage 9. B - stage 12. C -stage 15. 
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is clearly detectable above background staining. This indicates that 1(2)03405 
is a hypomorphic allele of Dubal, reducing but not abolishing its expression in 
embryos. The embryos with lowest Dubal expression display no obvious abnor-
malities. 
5.1.2.4 Discussion 
Since at least one ubiquitin-conjugating enzyme, UbcDl, mutates to embryonic 
lethality, and Dubal is expected to be essential for UbcDl function, it is perhaps 
surprising that 1(2)03405 homozygotes can complete embryogenesis. However, it 
appears that these embryos express a low level of Dubal mRNA, which may be 
sufficient for normal function. In addition, the Dubal produced from maternal 
transcripts may perdure throughout embryogenesis. The inviability of larvae 
homozygous for 1(2)03405 may reflect their requirement for a greater amount of 
Dubal, and/or degradation of the maternal protein. Alternatively the P element 
may disrupt a larva-specific enhancer of Dubal. The possibility that the P element 
also interferes with a neighbouring gene, essential for larval viability, cannot be 
discounted. 
5.1.3 P element mutagenesis of UbcD4 
As discussed in chapter 3, the expression pattern of UbcD4 makes it a good candi-
date for a ubiquitination enzyme which regulates specific embryogenic processes, 
germ cell migration in particular. In order to prove its developmental function 
by mutational analysis, I attempted to create a P element insertion in UbcD by 
'local jumping'. 
5.1.3.1 Introduction 
Local jumping is based on the observation that transposing P elements preferen- 
tially insert close to their original position. Estimates of the magnitude of the 
effect vary. In a transposition experiment performed by Golic (1994), almost 80% 
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of transpositions were to sites so close to the parental element that they could 
not be resolved cytologically. However Tower et al. (1993) estimate that approx-
imately 20% of transposing elements insert 2-128 kb from the original element, 
and that many more insert inside the orginal element. Nevertheless it is clear 
that the probabilility of mutating a specific gene can be significantly enhanced 
by mobilising a P element located close to it. 
5.1.3.2 Experimental procedure 
The map position of UbcD4 when this experiment was carried out was estimated 
as 67C05-11 (Kirby, 1996). The element in the FlyBase database which mapped 
closest to this was inserted in the 1(3)02240 allele at position 67C04-05, and 
carried in stock P1558. This was chosen as the starting element for an attempted 
UbcD4 mutagenesis. The mutagenic scheme is shown in Figure 5.5. Stocks were 
screened for insertions in UbcD4 by carrying out PCR amplification on genomic 
DNA from pools of 20 flies. Separate reactions were carried out with the P 
element - specific P31 primer and each of two UbcD4- specific primers, E2p5 and 
E2p1 (see Figure 5.6). Control reactions had been performed to establish that 
such a scheme could detect one insertion-carrying fly in a pool of 20. 
5.1.3.3 Results and discussion 
Almost 1400 stocks carrying possible new insertions were created and screened. 
No insertions in UbeD4 were detected. The failure to jump an element into UbcD4 
was not due to lack of transposase production, as flies in which the element had 
excised were observed. One stock was created which enabled a PCR product 
of approximately 500 bp to be amplified in both P31 - E2p5 and P31 - E2p1 
reactions. The product was also amplified in reactions with P31 alone and was 
presumably due to reinsertion of the P element 500 bp from its starting position. 
This event demonstrates that functional transposase was produced and that the 
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Figure 5.5: Scheme to mobilise the P element in strain P1558 to create an insertion 
in UbcD. Stock numbers are written in bold. P1558 males were mated en 
masse to virgin females of the genotype Dr20/TM3, ry, Sb. The male P[lacZ, 
ry+J/DrMZ0 progeny were mated to B2535 females which carry the P[ry42-3] 
transposase gene. F2 flies which carried both the P element and the transposase 
gene (Sb, Ubx, wj were mated to virgin females of the genotype Dr 0/TM3, 
ry, Sb. Male progeny which lacked the transposase gene (Sb+, Dr") were crossed 
individually to virgin DT-4"0/TM3, ry, Sb females. ry, DrMZ0  progeny were 
intercrossed, yielding stocks of flies carrying each potentially mutagenised third 
chromosome. Abbreviations: Cy = Curly, Sb = Stubble, Ubx = Ultrabithorax, ry 
= rosy, Sco = Scutoid, Ser = Serrate, Dr = Drop. 
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Figure 5.6: 	Strategy for screening mutagenised stocks for insertions in 
UbcD4. The grey box represents the UbcD4 transcription unit (GadFly entry 
FBgnOO15321) and the wide areas represent exons. The bent arrow indicates the 
predicted transcription start site. Arrowheads show the positions of the primers 
used in the screen. Numbers represent positions relative to the transcription start 
site. The shaded boxes represent the PCR products which would be generated 
by P element insertions at various positions in the gene. 
was occurring efficiently, it might be expected that more than one such event 
should have been detected. It is probable that UbcD4 was outside the zone 
of enhanced transposition (approximately 130 kb) from 1(3)020. Since the 
completion of the genorne sequence, the map position of UbcD4 has been revised 
from 67C05-11 to 671311-13. 1(3)0240 maps to 67C04-05. According to the 
GeneSeen database, this represents a distance of approximately 800 kb. 
P elements insert nonrandomly but the basis for their specificity is not under-
stood. They display a preference for euchromatic sites over heterochromatic (Berg 
and Spradling, 1991) and a tendency to insert at the 5' ends of genes (Spraciling 
et at., 1995). Local sequence composition also affects the probability of insertion. 
While a consensus sequence cannot be obtained, insertion sites tend to be GC rich 
(O'Hare and Rubin, 1983; Liao et at., 2000). Structural parameters such as DNA 
bendability, B-DNA twist and protein-induced deforniahility deviate significantly 
from random at insertion hot spots', arguing that P elements recognise aspects 
of DNA structure rather that sequence composition (Liao et al., 2000). Given our 
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lack of understanding of P element insertion site specificity, it is difficult to say 
whether the region in which UbcDi is located is suitable for P element insertion. 
5.2 Double-stranded RNA-mediated interference 
with UbcD4 expression 
5.2.1 Introduction 
Double-stranded RNA-mediated interference is a recently-discovered method to 
disrupt gene function in a number of organisms. The phenomenon was discovered 
by C. elegans workers attempting to silence expression of a specific gene using 
antisense RNA. Double-stranded RNA (dsRNA) was found to be several orders of 
magnitude more effective than either sense or antisense strands alone (Fire et al., 
1998). RNA interference is now a standard method of analysing gene function in 
C. elegans (reviewed by Fire (1999)). Introduction of dsRNA corresponding to 
either the UTR or coding region of a particular gene can silence the endogenous 
gene, producing a phenocopy of a null mutation. The dsRNA can be introduced 
by injection or by feeding worms on E. coli which have been engineered to ex-
press the appropriate dsRNA. Interference can be inherited by the progeny of the 
treated worms. The effect can cross cell boundaries and appears to be amplified, 
since a small number of molecules of dsRNA can completely silence a gene. RNAi 
has also been demonstrated in plants, zebrafish, mice and Drosophila (reviewed 
by Sharp (1999)). 
RNAi can be produced in a cell-free extract of Drosophila syncytial blasto-
derms, and this system is being used to investigate its mechanism (Tuschl et al., 
1999; Zamore et al., 2000). Silencing is caused by degradation of the cognate 
mRNA, within the sequence spanned by the dsRNA (Tuschl et al., 1999; Zamore 
et al., 2000). Pieces of dsRNA 20-25 nucleotides in length appear to be intermedi-
ates in the process (Zamore et al., 2000). The current model for dsRNA-mediated 
mRNA degradation (reviewed by Bass (2000)) proposes that dsRNA is targeted 
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by a dsRNA endonuclease and cleaved into small fragments. These 20-25mers are 
thought to bind to a ribonuclease, possibly the same enzyme which cleaves the 
dsRNA, and to act as a template for sequence-specific cleavage of the endogenous 
mRNA. This could proceed by exchange of the mRNA with the dsRNA sense 
strand and cleavage of the mRNA at the same site, regenerating the nuclease 
bound to a short piece of dsRNA. This model could account for the apparently 
catalytic nature of the interference. It is possible that the signal is also amplified 
by an RNA-dependent RNA polymerase. 
In Neurospora, C. elegans and plants, introduction of a transgene causes post-
transcriptional silencing of the endogenous gene. This phenomenon shares some 
features with RNAi (reviewed by Birchler et al. (2000)). In plants and Neurospora, 
some cases of silencing are achieved by elimination of specific transcripts (Cogoni 
and Macmo, 1997; Voinnet et at., 1998). Small RNA fragments corresponding 
to the affected gene are observed specifically in plants whose transgenes induce 
silencing of the endogenous gene (Hamilton and Baulcombe, 1999). Silencing 
induced by a repetitive transgene array in the C. elegans germline can persist 
after the transgene has been removed, implicating a non-DNA interfering factor 
(Dernburg et al., 2000). The sequence requirements for silencing suggest that 
this factor may be RNA (Dernburg et at., 2000). Genetic analysis has identified 
at least nine C. elegans genes required for efficient RNAi (Ketting et at., 1999; 
Tabara et at., 1999; Smardon et at., 2000; Grishok et al., 2000). Some are only 
required for RNAi, while rde-2 and mut-7 are also needed for transgene-mediated 
gene silencing (Dernburg et at., 2000) and for germline silencing of transposition 
(Ketting et at., 1999; Tabara et at., 1999). It has therefore been suggested that 
these phenomena use different mechanisms to generate the same interfering agent, 
which activates a common silencing pathway. 
Injection of Drosophila embryos with dsRNA potently phenocopied null alleles 
of twist (Misquitta and Paterson, 1999), fushi tarazu and even-skipped (Kennerdell 
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and Carthew, 1998), although the strength of interference varied between individ-
uals and with dose of injected dsRNA (Kennerdell and Carthew, 1998). Interfer-
ence with tra mt rack showed that the effect could persist, as Tramtrack functions 
at stage 11-12, approximately 6 hours after the time of injection. However RNAi 
was not equally effective at silencing all genes : for hedgehog and wingless, in-
terference was localised to the site of injection (Kennerdell and Carthew, 1998). 
Currently the technique has only been used to study gene function in embryos or 
in cultured cells (Clemens et al., 2000; Jones et al., 2000), since the silencing does 
not persist to later developmental stages (Misquitta and Paterson, 1999). How-
ever a method to express dsRNA as an extended hairpin-loop in transgenic flies 
has recently been developed (Kennerdell and Carthew, 2000). Using this system, 
silencing can be stably inherited and induced at any developmental stage. 
RNAi is increasingly widely used to investigate the function of Drosophila 
genes for which no mutant is available (Kennerdell and Carthew, 1998; Misquitta 
and Paterson, 1999; Clemens et al., 2000; Jones et al., 2000). I injected embryos 
with double-stranded UbcD4 RNA in an attempt to silence UbcDj expression. I 
examined the effect of the dsRNA on the embryos' ability to complete embryo-
genesis, and on the ability of the pole cells to migrate from the posterior midgut 
to the mesoderm. 
5.2.2 Experimental procedure 
Sense and antisense UbcD4 RNAs were synthesised by in vitro transcription. 
Equimolar amounts of the two strands were mixed and annealed (Figure 5.7). 
The dsRNA was stored as an ethanol precipitate and dissolved in injection buffer, 
at a concentration of approximately 2 ,aM, immediately before use. 
Embryos were collected for one hour before being dechorionated, dessicated 
and injected with either UbcD4 dsRNA or with injection buffer alone. The em-






Figure 5.7: Preparation of UbcD4 double-stranded RNA. Aliquots of sense and 
antisense UbcD4 RNA, and of a mixture of the two strands which had been allowed 
to anneal, were electrophoresed on a 1.2 % agarose gel. 1 - HaeIII-digested OX174 
DNA, 2 - sense UbcD4 RNA, 3 - antisense UbcD4 RNA, 4 - double-stranded UbcD4 
RNA. The arrows indicate the sizes of the OX174 bands. 
at the time of injection. The injection of buffer alone was performed so that any 
defects caused by the experimental procedure could be distinguished from those 
caused by the dsRNA. The volume of dsRNA or buffer injected was approximately 
100 - 300 p1, as estimated from the diameter of a drop injected into halocarbon oil. 
This corresponds to 0.2 - 0.6 fmoles of dsRNA per embryo. 0.2 fmnoles dsRNA per 
embryo is the recommended starting dose for an RNAi experiment (Kennerdell 
and Carthew, pers. comm.). 
Two series of injections were performed. In the first, 400 embryos each were 
injected with UbcD4 dsRNA and with buffer alone. The embryos on two coverslips 
(60 embryos) were incubated at 25°C for 24 hours to determine the percentage 
which hatched. After this time, unhatched embryos were collected and fixed. 
The remaining embryos were incubated at 18 °C for various periods up to 16 
hours, before being fixed and manually devitellinised. Timepoints of 12 - 16 hours 
were used to allow the embryos to reach stage 9-11, when pole cell migration 
normally occurs. Shorter incubation periods were used to examine the effect 
of dsRNA on gastrulation and germhand extension. In order to assess whether 
UbcD4 expression had been disrupted by injection of dsRNA, in situ hybridisation 
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was performed. The embryos were subsequently stained with Vasa protein to 
visualise their germ cells. 
In the second series, 400 embryos each were again injected with UbcDi dsRNA 
and with buffer. Again, 60 embryos were incubated at 25 ° C for 24 hours to 
determine their ability to hatch. The remaining embryos were incubated for 12-
15 hours at 25 ° C before being fixed, devitellinised and stained for UbcD4 mRNA 
and for Vasa protein as before. After this period, embryos would be expected 
to have reached stage 12-16 of embryogenesis. This experiment was designed to 
investigate whether dsRNA-injected embryos had a defect in late embryogenesis. 
5.2.3 Results 
Figure 5.8 shows the number of embryos on each of four coverslips (30 embryos 
per coverslip) which had failed to hatch 24 hours after injection with either UbcDj 
dsRNA or injection buffer. Embryos injected with UbcD4 dsRNA showed a con-
sistently lower ability to hatch than those injected with buffer alone. 
The mortality of the buffer-injected embryos may be due to a variety of factors. 
Insufficiently dessiccated embryos, or embryos injected with too blunt a needle, 
leak cytoplasm at the time of injection: since the cytoplasm contains morphogens, 
this can impair embryogenesis. Over- dessiccatedembryos undergo 'funnelling' at 
the time of injection, which may cause morphological abnormalities. Embryos 
covered with too much halocarbon oil may receive insufficient oxygen, while those 
covered with too little oil may dry out. While these conditions would be expected 
to vary between batches of embryos injected at different times, the hatching rate 
of buffer-injected embryos showed little variability between coverslips. 
The injection procedure would also be expected to contribute to the mortality 
observed in dsRNA - injected embryos. However, as they showed a consistently 
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Figure 5.8: Hatching counts for embryos injected with UbcD4 double-stranded 
RNA and with injection buffer alone. 4 coverslips of embryos (30 embryos per 
coverslip) were injected with either UbcD4 dsRNA or with injection buffer alone 
then incubated at 25 ° C for 24 hours. The first bar shows the average number of 
embryos per coverslip which had failed to hatch after injection with buffer and 
the second bar shows this number for UbcD4 dsRNA - injected embryos. The 
error bars show the standard deviations. 
While normal UbcD4 staining was observed in control embryos which had not 
been through the injection procedure, only background levels of staining were 
observed in both dsRNA - treated and buffer - treated embryos. This implies 
that some aspect of the injection or manual devitellinisation procedure renders 
the embryos unsuitable for in situ hybridisation and makes it impossible to verify 
that injection with dsRNA causes degradation of the UbcD4 mRNA. 
No morphological defects were observed in embryos undergoing gastrulation, 
germband extension or early germband retraction (Figure 5.9, LA - I.C). However 
a high proportion (approximately 60 %) of embryos undergoing later germband 
retraction appeared morphologically abnormal. Commonly the amnioserosa was 
displaced anteriorly, covering part of the head (Figure 5.9, I.D - LE). This was 
not seen in control embryos at the same stage (Figure 5.9 ILA and II.B) although 
in some control embryos the amniserosa did bulge considerably, possibly due to 
squashing of the embryo during the experimental procedure. 
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Abnormalities were also seen in post-retracted embryos. Dorsal closure and 
head involution normally occur simultaneously during stages 14 and 15. However, 
in UbcD4 dsRNA - treated sample, many embryos appeared to have completed 
head involution without completing dorsal closure. The embryos shown in Figure 
5.9, I.G. and I.H., have the head morphology of a stage 15-17 embryo but the edge 
of the germ band is visible and part of the amnioserosa is exposed. Similar defects 
were observed in approximately half the dsRNA-treated embryos but not in the 
buffer-injected embryos. Figure 5.9 1.1 and II.0 show embryos from the dsRNA - 
treated sample and control sample respectively, with the normal appearance of a 
stage 15-16 embryo. 
It is not clear whether the affected embryos can eventually achieve dorsal 
closure and continue development. The embryos which had failed to hatch after 
24 hours varied in appearance. Most of the control embryos showed no identifiable 
structures, suggesting that embryogenesis had not progressed past the time of 
injection. The remainder appeared to have developed to stage 17, but failed to 
hatch (data not shown). These had not shown any muscular movement when 
examined prior to fixing and were probably either dead or paralysed, rather than 
merely delayed. Approximately the same proportion of dsRNA-injected embryos 
had no structures, and some also appeared to be normal stage 17 embryos which 
had failed to hatch (Figure 5.9, I.J). Others seem to have arrested development 
slightly earlier. The embryo in Figure 5.9, I.K. has a completed head involution 
but its midgut appears to lack the constrictions which normally appear at stage 
15. Figure 5.9. LL shows an embryo with the midgut appearance characteristic 
of stage 15 embryos but with an apparently malformed head. Approximately a 
quarter of the unhatched dsRNA-injected embryos appeared to have arrested at 
stage 15 or 16, compared to only one of the controls. However the numbers of 
embryos sucessfully retrieved and fixed were small (30 dsRNA injected embryos 
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No significant defects in pole cell movements were observed in dsRNA- treated 
embryos. Pole cells associated with the posterior midgut primordium during gas-
trulation and germband extension (Figure 5.9, l.A - I. B), and migrated posteriorly 
towards the mesoderm during early germband retraction (Figure 5.9, I.C, LE). 
They then divided into two groups on either side of the ventral midline, and co-
alesced (Figure 5.9, I.F, I.G). In some embryos, a number of pole cells remained 
associated with the posterior midgut (Figure 5.9, I.F), but this was also observed 
in some buffer - treated embryos (data not shown). 
5.2.4 Discussion 
Due to the failure of the UbcD4 in situ hybridisation on both dsRNA and buffer 
- injected embryos, it is not possible to determine whether silencing of UbcD4 ex-
pression was achieved. The lower hatching rate of dsRNA - treated embryos than 
of control embryos implies that embryogenesis was impaired by the dsRNA. How -
ever, a third of the dsRNA - injected embryos survived. The extent of UbcD 
silencing may have varied between embryos due to injection of different doses 
of dsRNA. Although other workers report potent interference using 0.1 fmoles 
dsRNA per embryo, and detectable interference with doses as low as 0.01 fmoles 
(Kennerdell and Carthew, 1998; Misquitta and Paterson, 1999), the sensitivity of 
the interference may vary between genes. Another possibility is that the dsRNA 
may have failed to spread through the embryo, resulting in UbcD4 silencing lo-
calised to the site of injection. This phenomenon has been observed with several 
genes including engrailed, wingless and frizzled (Kennerdell and Carthew, 1998). 
While all embryos were injected from the posterior end, the precise site of injection 
may have varied considerably. 
One aim of this experiment was to examine whether UbcD1 expression is 
required for pole cell migration from the posterior midgut to the mesoderm at 
stages 10-12. The results provide no evidence for this. The timing and direction 
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of pole cell movement appeared to be unaffected by injection of dsRNA. This 
cannot be taken as clear evidence against a role for UbcD4 in pole cell migration, 
as it is not certain that silencing in the pole cells was achieved. As previously 
stated, silencing may have been localised to the injection site. In addition, the 
timing of injection meant that the pole cell membranes were formed whereas the 
remainder of the embryo was syncytial. Although dsRNA is able to cross the 
membranes of cultured cells, (Clemens et al., 2000) , it is not clear how efficient 
this process is in the embryo. 
Injection of UbcD4 dsRNA had no effect on stages 3 - 11 of embryogenesis. All 
the deformities observed were in embryos of stage 12 or later. Anterior displace-
ment of the amnioserosa during germband retraction, and delay of dorsal closure 
until after completion of head involution, were specifically present in a high pro-
portion of dsRNA - treated embryos. Unhatched embryos in dsRNA-treated and 
control embryos included embryos which had apparently died at the time of in-
jection, and embryos which had reached stage 17 but failed to hatch. However 
the dsRNA-treated sample specifically included embryos which had arrested at 
stage 15 - 16 with possible gut or head abnormalities. Although inconclusive, 
these results suggest a specific requirement for UbcD4 in morphogenetic events 
from stage 12 until completion of embryogenesis. It is difficult to say which de-
fects may be directly due to loss of UbcD4 function. However, UbcD4 mRNA is 
abundant in stage 12-14 embryos but less so in stage 15-17 embryos. If this re-
flects the relative requirement for UbcD4 during those stages, perhaps the defects 
in germband retraction and dorsal closure are directly due to interference with 
UbcD4 expression, and the later defects are indirect. 
Germ band retraction is the process by which the germband recedes to the 
posterior of the embryo and the amnioserosa, a membraneous structure, spreads 
out to cover the whole of the dorsal surface. Dorsal closure is the process by 
which lateral ectodermal cells elongate dorsaiward, spread over the amniserosa 
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and ultimately fuse at the dorsal midline to form the dorsal epidermis. Both 
processes are primarily driven by changes in cell shape and packing, rather than 
in cell number or arrangement (Martinez Arias, 1993; Glise et al., 1995). 
Dorsal closure is the better-studied of the two movements. 'Dorsal-open' mu-
tants fall into two classes (reviewed by Noselli and Agnes (1999)). One class con-
sists of members of the Jun amino-terminal kinase (JNK) signalling pathway,such 
as basket and hemiopterous. The other class are involed in regulating aspects of 
cell architecture such as the cytoskeleton ( zipper, cap pucino) and gap junctions 
(coracle, canoe). The link between the signalling cascade and changes in the cy -
toskeleton may be provided by the Rho subfamily of small Ras-related GTPases 
(Magie et al., 1999). The ligand which activates JNK signalling has not been iden-
tified. Germband retraction seems to be driven by a signal from the amnioserosa 
(Lamka and Lipshitz, 1999): this depends on amnioserosal expression of u-shaped, 
pebbled/hindsight and serpent. Expression of a dominant-negative version of the 
Rho-related Rac protein causes defects in germband retraction (Harden et al., 
1995). This raises the possibility that dorsal closure and germband retraction 
depend on similar downstream pathways, driven by small GTPases, which trans-
duce external signals to the cytoskeleton. If UbcD4 is involved in both processes, 





Targeted proteolysis has several advantages as a biological control mechanism. It 
changes the protein composition of a cell rapidly and irreversibly. It provides a 
way of limiting protein function, so that changes in patterns of gene expression 
can have an effect. The pathway is modular in nature, consisting of a specific 
recognition process and a non-specific degradation process. Thus it can be easily 
adapted to new roles - a substrate can be modified for recognition by a ubiqui-
tinating enzyme, without the need to adapt a new protease. Systematic genetic 
and biochemical analysis of ubiquitinating enzymes in yeast has revealed the cen-
tral role of ubiquitin-mediated proteolysis in controlling cell behaviour. In many 
cases, this information has been successfully extrapolated to higher organisms. 
However comparatively little is known of the role of the ubiquitin-proteasome 
pathway in regulating processes specific to multicellular organisms. The research 
presented here aimed to identify developmental roles for the ubiquitin-proteasome 
pathway, using Drosophila embryogenesis as a model system. 
The overall importance of ubiquitination to the Drosophila embryo may be 
gauged by studying the ubiquitin activating enzyme, which carries out the first 
step in all ubiquitinating reactions. Identification of specific roles requires study 
of E2s and E3s, which target different subsets of proteins for degradation. 
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6.1 The overall importance of ubiquitination in 
Drosophila embryogenesis 
Dubal is abundantly transcribed at most developmental stages. This is not sur -
prising, since ubiquitin-mediated proteolysis is a housekeeping as well as a reg-
ulatory mechanism. It is also expected to be required for progression through 
the cell-cycle. However, the expression pattern of Dubal in embryos does not 
correlate well with patterns of cell division. For example, it is abundantly ex-
pressed in stage 10-14 embryos, which are largely quiescent. It is particularly 
highly expressed in the germband of gastrulating embryos, and in gut and ner-
vous system primordia during later stages. This may indicate an increased level 
of ubiquitin-mediated proteolysis in these tissues. In contrast, Dubal mRNA is 
scarce in stage 15 - 17 embryos. The major activity during these stages is conden-
sation of the central nervous system - presumably ubiquitination has little or no 
part to.play in this. The identification of a P element insertion in Dubal did not 
prove the importance of the process to embryogenesis, since the allele was weak 
and homozygous mutants died as third instar larvae. However it suggests that a 
low level of Dubal expression is sufficient for normal functioning of the ubiquitin 
pathway in embryos. 
Overall, the expression patterns of the E2 and E3-encoding genes studied 
did not suggest specific developmental roles, with most genes having fairly uni-
form temporal and spatial expression throughout the embryo (see Chapter 3). In 
agreement with the Dubal results, several genes were expressed most highly in 
gut and/or nervous system primordia (UbcDl, UbcD2, UbcD3, UbcDlO, Su(dx), 
HERC-2). No genes showed high expression during stages 15-17. 
Compared to the rapid accumulation of information on the roles of protein 
ubiquitination in other systems, Drosophila embryogenesis remains relatively un-
derexplored in this regard. The roles of UbcDl in photoreceptor development 
and chromosome segregation, and of UbcD3/Bendless in axon guidance, were de- 
162 
scribed in Chapter 3. The only more recent report on a Drosophila E2 shows 
that Courtless, the Ubc7 homologue, is involved in male courtship behaviour and 
spermatogenesis (Orgad et al., 2000). Of the Drosophila E3s, the roles of Hyd, 
Su(dx), and Slimb in proliferation control and signal transduction have been de-
scribed in previous chapters. More recently, a Hect-domain E3 which interacts 
genetically and biochemically with Courtless, and which is required for axon guid-
ance, has been discovered (A. Myatt, pers. comm.). The recent completion of 
the Drosophila genome sequence, which revealed many novel E2s and E3s, should 
facilitate more rapid progress. 
6.2 Specific roles of the E2 UbcD4 in embryo-
genesis 
The E2 UbcD4 was chosen for further analysis due to its strong and specific 
expression in embryos. Northern analysis showed that UbcD4 mRNA was not 
present in larvae, pupae or adults, making a housekeeping role unlikely. Like 
many other E2s, it is highly expressed in the germband of stage 5 - 9 embryos 
and in gut and nervous tissue of stage 12 - 14 embryos. However, during stages 
10 and 11, UbcD4 expression is limited to the pole cells, the precursors of the 
germline. Subsequent experiments aimed to identify binding partners for UbcD4, 
and to examine the consequences of its loss of function, with particular interest 
in confirming a germline role for the enzyme. 
The UbcD4 - interacting proteins identified were primarily candidates for an-
cillary factors in UbcD4 substrate selection, including an E3, the proteasomal 
subunit Pros54 and a novel protein whose PCI domain suggests possible pro-
teasomal association. The candidate substrates identified were two aminopepti-
dases and the transcription factor Giant. These results must be interpreted with 
caution, since the interactions were not confirmed to occur in the embryo. In 
addition, it is not clear whether an E2 would be expected to interact strongly 
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with its substrate in the absence of regulatory factors. Nevertheless, the yeast 
two-hybrid system has been successfully used by other workers to identify E2 and 
E3 substrates, and the interactions were specific and reproducible. 
The most direct way to examine the developmental role of a gene is by mu-
tational analysis. Since no UbcD4 mutants were available, the technique of RNA 
interference was used to silence UbcD4 expression in embryos. The lack of UbcD4 
antibodies, and the failure of in situ hybridisation analysis, meant that it is not 
certain whether and to what extent silencing was achieved. However the prelimi-
nary results indicate a requirement for UbcD4 in the main morphogenetic events 
of stages 11-14, germband retraction and dorsal closure. 
6.3 Conclusions 
The three different approaches taken to study UbcD4 function (expression anal-
ysis, interaction trap and RNA interference) do not identify a common role for 
the protein. The interaction trap did not identify a clear candidate for a germcell 
UbcD4 target protein. The PCI-domain protein is widely expressed in stage 10 - 
11 embryos, and may be present in germ cells. Presumably Pros54 is expressed in 
germ cells, since proteasomes are ubiquitous. None of the other UbcD4 interactors 
showed detectable expression in germ cells. If the interactions are physiologically 
relevant, they indicate that UbcD4 targets may be important in development of 
ectodermally-derived gut tissues: the aminopeptidases are only expressed in ei-
ther fore- or hindgut, while Giant is involved in both head and foregut formation. 
The PCI-domain protein is highly expressed in salivary glands, which are foregut 
derivatives. The putative E3 deviates from this pattern, however, having a com-
plex expression pattern which seems to correlate with morphogenetic movements 
of the ectoderm. 
The RNA interference results also failed to support a requirement for UbcD4 
in pole cell migration. However, although the pole cells in dsRNA injected em- 
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bryos successfully reached their target in the mesoderm, it is not known whether 
they were functionally normal. UbcD4 may be involved in another aspect of 
germcell development, such as regulating transcriptional quiescence. In addition, 
there may be some functional redundancy between UbcD4 and another E2. It 
is not clear whether foregut development was affected by dsRNA, since these 
structures were not easily visualised in the injected embryos. While the defects 
in germband retraction and dorsal closure were the only obvious effects of UbcD4 
dsRNA injection, they may be indirect consequences of a more subtle develop-
mental failure. 
6.4 Future work 
The availability of UbcD4 antisera should allow the results obtained in these 
experiments to be clarified. The protein expression pattern may differ from that 
of the mRNA, giving a better indication of gene function. UbcD4 antibodies 
togther with antibodies raised against its putative interactors would facilitate 
confirmation that the interactions occur in the embryo. In vitro ubiquitination 
assays using purified proteins could be used to distinguish UbcD4 substrates 
from ancillary factors involved in substrate recognition. Anti-UbcD4 staining 
of dsRNA-injected flies would show whether and to what extent silencing was 
achieved. Another possible means of confirming the results obtained with dsRNA 
injection would be to generate a line of flies expressing a hairpin-loop UbcD4 RNA. 
This approach would avoid the defects observed in injected embryos which are 
solely due to the experimental procedure. 
It is possible that specific developmental roles for the ubiquitin system may be 
identified more easily by studying E3s rather than E2s, as they probably target a 
smaller number of substrates. The novel Hect-domain E3 identified in the UbcD4 
two-hybrid screen has a highly regulated expression pattern in embryos and is an 
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